AU2013203791A1 - Anthranilic acid diamide derivative with hetero-aromatic and hetero-cyclic substituents - Google Patents

Abstract

Abstract The present invention relates to novel insecticides of the formula (I) in which R', R2 , R3 , R4 , R, R, A, Q, and n can have the meaning as set forth in the description, a plurality of methods for the production of said insecticides, and the use of said insecticides as active ingredients, in particular, the use of said insecticides as a pest control agent. C:\NRPortbl\DCC\TZM\5066460 .DOC - 11/4/13

Description

WO 2007/144100 - I - PCT/EP2007/005016 Anthranilic acid diamide derivative with hetero-aromatic and hetero-cyclic substituents The present invention relates to new insecticides, to a number of processes for their preparation and to their use as active compounds, more particularly to their use as pest control agents. It is already known that certain anthranilamides (e.g. WO 01/70671, WO 03/015519, WO 03/016284, 5 WO 03/015518, WO 03/024222, WO 03/016282, WO 03/016283, WO 03/062226, WO 03/027099, WO 04/027042, WO 04/033468, WO 2004/046129, WO 2004/067528, WO 2005/118552, WO 2005/077934, WO 2005/085234, WO 2006/023783, WO 2006/000336, WO 2006/040113, WO 2006/111341, WO 2007/006670, WO 2007/024833, WO 2007/620877) possess insecticidal properties. 10 The activity of these compounds, though good, is nevertheless found wanting in certain cases. New anthranilamides have now been found, of the formula (I) RkN .R2 (R4),0 / NR 0S A R6~ in which R' represents hydrogen, amino or hydroxyl or represents C-C 0 -alkyl, C 2 -C-alkenyl, 15 CrCralkyny or C 3

-C

6 -cycloalkyl each of which is unsubstituted or substituted one or more times by identical or different substituents selectable independently of one another from halogen, cyano, nitro, hydroxyl, C-C 4 alkoxy, CI-C 4 -alkylthio, C-C 4 -alkylsulphinyl, C,-C 4 alkylsulphonyl, (C-C 4 -alkoxy)carbonyl, C-C 4 -alkylamino, di(CI-C 4 -alkyl)amino, C-C 6 cycloalkylamino or (C-C 4 -alkyl)C 3

-C

6 -cycloalkylamino, 20 R 2 represents hydrogen, C-C 6 -alkyl, C 2 -Cralkenyl, C 2 -Cvalkynyl, C 3

-C

6 -cycloalkyl,

CI-C

4 -alkoxy, C-C 4 -alkylamino, di(C-C 4 -alkyl)amino, C-C 6 -cycloalkylanuino, C 2

-C

6 alkoxycarbonyl or C 2

-C

6 -alkylcarbonyl, R3 represents hydrogen or represents C,-C 6 -alkyl, C-C-alkoxy, C 2

-C

6 -alkenyl, C 2

-C

6 -alkynyl each of which is optionally substituted one or more times by identical or different 25 substituents selectable independently of one another from halogen, cyano, nitro, hydroxyl,

C,-C

6 -alkyl, C-C 6 -cycloalkyl, C 1

-C

4 -alkoxy, C-C 4 -haloalkoxy, Cl-C 4 -alkylthio, C-C 4 -alkyl- WO 2007/144100 -2 - PCT/EP2007/005016 sulphinyl, C-C 4 -alkylsulpbonyl, C-C 4 -alkylsulphimino, C-C 4 -alkylsulphimino-C-C 4 -alkyl,

C,-C

4 -alkylsulphimino-C 2 -C-alkylcarbonyl, C-C 4 alkylsulphoximino, C-C 4 -alkyl sulphoximino-C-C 4 -alkyl, Ci-C 4 -alkylsulphoximino-C 2 -C-alkylcarbonyl, C 2 -C-alkoxy carbonyl, C 2

-C

6 -alkylcarbonyl or C-C 6 -trialkylsilyl, 5 R 3 further represents CI-C 6 -alkyl, CI-Cralkoxy, C 2

-C

6 -alkenyl, C 2

-C

6 -alkynyl each of which is optionally substituted one or more times by identical or different substituents selectable independently of one another from amino, C 3

-C

6 -cycloalkylamino or a 5- or 6-membered heteroaromatic ring,

R

3 likewise further represents C 3

-C

12 -cycloalkyl, C-Ci 2 -cyloalkyl-Cr-CalkyI and 10 CrCirbicycloalkyL the substituents being selectable independently of one another from halogen, cyano, nitro, hydroxyl, amino, C-C 6 -alkyl, C 3

-C

6 -cycloalkyl, C 3

-C

6 -cycloalkyl amino, C-C 4 -alkoxy, C-C 4 -haloalkoxy, CI-C 4 -alkylthio, C-C 4 -alkylsulphinyl, C-C 4 -alkyl sulphonyl, C-C 4 -alkylsulphimino, C-C 4 -alkylsulphimino-C-C 4 -alkyl, CI-C 4 -alkyl sulphimino-C 2 -C-alkylcarbonyl, C-C 4 -alkylsulphoxinino, C-C 4 -alkylsulphoximino 15 CrC 4 -alkyl, C-C 4 -alkylsulphoximino-C 2 -Cs-alkylcarbonyl, C 2

-C

6 -alkoxycarbonyl,

C

2 -Cralkylcarbonyl, C 3 -Ctrialkylsilyl or a 5-or 6-membered heteroaromatic ring,

R

2 and R 3 can be joined to one another via two to six carbon atoms and form a ring which where appropriate additionally contains a further nitrogen, sulphur or oxygen atom and where appropriate may be substituted one to four times by C-C 2 -alkyl, halogen, cyano, amino or 20 C-C 2 -alkoxy,

R

2 and R 3 further together represent =S(C-C 4 -alkyl) 2 or =S(O)(Cj-C 4 -alkyl) 2 , t represents hydrogen, halogen, cyano, nitro, C 1

-C

4 -alkyl, C-C 4 -haloalkyl, C 2

-C

6 -alkenyl,

C

2

-C

6 -haloalkenyl, C 2

-C

6 -alkynyl, C,-C 4 -alkoxy, C-C 4 -haloalkoxy, SF 5 , C-C 4 -alkylthio,

CI.C

4 -alkylsulphinyl, C-C 4 -alkylsulphonyl, C-C 4 -haloalkylthio, C-C 4 -haloalkylsulphinyl, 25 C-C 4 -haloalkylsulphonyl, C-C 4 alkylamino, di(C 1

-C

4 -alkyl)amino, C 3

-C

6 -cycloalkylamino, (CrCralkoxy)imino, (Ci-C 4 -alkyl)(CI-C 4 -alkoxy)imino, (Ci-C 4 -haloalkyl)(CI-C 4 -alkoxy) imino or C 3

-C

6 -trialkylsilyl, or two RWs, via adjacent carbon atoms, form a ring which represents -(CH2) 3 -, -(CH 2

)

4 -, -(CH 2

)

5 -, (CH=CH-) 2 -, -OCH 2 0-, -O(CH2)0-, -OCF 2 0-, -(CF 2 )20-, -O(CF 2

)

2 0-, -(CH=CH-CH=N) 30 or -(CH=CH-N=CH)-, two R's further, via adjacent carbon atoms, form the following fused rings, which where appropriate are substituted one or more times by identical or different substituents selectable independently of one another from hydrogen, CI-C-alkyl, CrC 6 -cycloalkyl, C-C 6 -haloalkyl, WO 2007/144100 -3- PCT/EP2007/005016

C

3

-C

6 -halocycloalkyl, halogen, C,-C 6 -alkoxy, C-C 4 -alkylthio(C-C 6 -alkyl), C,-C 4 -alkyl sulphinyl(C-C 6 -alkyl), C-Cralkylsulphonyl(C-Cralkyl), C-C 4 -alkylamino, di(C-C 4 alkyl)amino or C-C 6 -cycloalkylamino, N N N0 N N N NN H H N N N ,N N N N O < KN N NA H S N 0 \ H N N NN Nw N N N H H 5 n represents 0 to 3,

R

5 represents CI-C 6 -alkyl, C 3

-C

6 -cycloalkyl, C-C 5 -haloalkyl, C,-C 6 -halocycloalkyl,

C

2

-C

6 -alkenyl, C 2

-C

6 -haloalkenyl, C 2

-C

6 -alkynyl, C 2

C

6 -haloalkynyl, C 1

-C

4 -alkoxy, C-C haloalkoxy, C-Cr-alkylthio, C-C 4 -alkylsulphinyl, C-C 4 -alkylsulphonyl, C-C 4 haloalkylthio, CrC 4 -haloalkylsulphinyl, C 1

-C

4 -haloalkylsulphonyl, halogen, cyano, nitro or 10 C 3

-C

6 -trialkylsilyl, R6 represents hydrogen, C-C 6 -alkyl, C 2

-C

6 -alkenyl, C 2

-C

6 -alkynyl, C 3

-C

6 -cycloalkyl, C,-C-haloalkyl, C 2

-C

6 -haloalkenyl or

R

6 further represents C3-C 6 -cycloalkoxy, 15 R' represents independently at each occurrence hydrogen, C-C 6 -alkyl, C 3

-C

6 -cycloalkyl,

C

1

-C

6 -haloalkyl, halogen, cyano, nitro, C-C 4 -alkoxy, C-C 4 -haloalkoxy, C-C 4 -alkylthio or

C,-C

4 -haloalkylthio, In represents 0 to 4, WO 2007/144100 -4- PCT/EP2007/005016 X represents N, CH, CF, CCI, CBr or CI, A represents -CH 2 -, -CH 2 0-, -CH 2 0CH-, -CH2S-, -CH2SCH 2 -, -CH 2 N(C,-C-alkyl)-,

-CH

2 N(Ci-Cralkyl)CH 2 -, -CH[C0 2

(C-C

6 -alkyl)]-, -CH(CN)-, -CH(CrC 6 -alkyl)-, -C(di-CI-C 6 -alkyl)-, -CH 2

CH

2 - or -C=NO(C-C-alkyl)-, 5 Q represents a 5- or 6-membered heteroatomatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system, the ring system being unsubstituted or substituted one or more times by identical or different substituents selectable independently of one another from hydrogen, C,-C 6 -alkyl, C 2

-C

6 -Ralkenyl, C 2 -Cralkynyl, C 3

-C

6 -cycloalkyl, 01-C 6 -haloalkyl, CrCrhaloalkenyl, C 2

-C

6 -haloalkynyl, C-C 6 -halocycloalkyl, halogen, CN, C0 2 H, CO 2

NH

2 , 10 NO 2 , OH, C-C 4 -alkoxy, O,-C 4 -haloalkoxy, C-C 4 -alkylthio, CI-C 4 -alkylsulphinyl,

C-C

4 -alkylsulphonyl, C-C 4 -haloalkylthio, C-C 4 -haloalkylsulphinyl, C-C 4 -haloalkyl sulphonyl, C-C 4 -alkylamino, di(C-C 4 -alkyl)amino, C 3

-C

6 -cycloalkylanino, (C-C-alkyl)carbonyl, (C-C 6 -alkoxy)carbonyl, (C-C 6 -alkyl)aminocarbonyl, di(C,-Cr alkyl)aminocarbonyl, tri(0 1

-C

2 -alkyl)silyl and (O,-C 4 -alkyl)(C-C 4 -alkoxy)imino, 15 Q further represents a 5- or 6-membered heteroaromatic or heterocyclic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system, the ring or the ring system being unsubstituted or substituted one or more times by identical or different substituents selectable independently of one another from hydrogen, CI-C 6 -alkyl, C 2 -Cralkenyl, C 2 -Cralkynyl, C 3 C-cycloalkyl, C-C 6 -haloalkyl, 0 2

-C

6 -haloalkenyl, C 2

-C

6 -haloalkynyl, C 3

-C

6 -halocycloalkyl, 20 halogen, CN, CO 2 H, CO 2

NH

2 , NO 2 , OH, C-C 4 -alkoxy, C,-C 4 -haloalkoxy, C,-C 4 -alkylthio, C, C 4 -alkylsulphinyl, C-C 4 -alkylsulphonyl, C-C 4 -haloalkylthio, 0 1

-C

4 -haloalkylsulphinyl, Ci-C 4 -haloalkylsulphonyl, C-C 4 -alkylamino, di(C-C-alkyl)amino, C 3 -C-cycloalkylamino,

(C-C

6 -alkyl)carbonyl, (C-C 6 -alkoxy)carbonyl, (CrC 6 -alkyl)aminocarbonyl, di(C,-C 4 alkyl)aminocarbonyl, tri(C-C 2 -alkyl)silyl and (C-C 4 -alkyl)(C-C 4 -alkoxy)imino, 25 or the substituents being selectable independently of one another from phenyl or a 5- or 6-membered heteroaromatic ring, it being possible for phenyl or the ring to be unsubstituted or substituted one or more times by identical or different C-C 6 -alkyl, C 2

-C

6 -alkenyl, C2-C 6 -alkynyl, 0 3 -Crcycloalkyl, C-C 6 -haloalkyl, C-C 6 -haloalkenyl, C 2

-C

6 -haloalkynyl,

C

3

-C

6 -halocycloalkyl, halogen, CN, NO 2 , OH, Cr-C 4 -alkoxy, CI-C 4 -haloalkoxy substituents, 30 and the compounds of the general formula (1) also encompass N-oxides and salts. Finally it has been found that the compounds of the formula (I) according to the invention possess very good insecticidal properties and can be used, not only in crop protection but also in materials protection, for controlling unwanted pests, such as insects.

WO 2007/144100 -5 - PCT/EP2007/005016 The compounds of the invention may where appropriate take the form of mixtures of different possible isomeric forms, more particularly of stereoisomers, such as, for example, E and Z isomers, threo and erythro isomers, and optical isomers, and also, where appropriate, of tautomers. The E and the Z isomers, the threo and erythro isomers, and the optical isomers, any desired mixtures of these 5 isomers, and also the possible tautomeric forms are all claimed. A general definition of the anthranilamides of the invention is given by the formula (1). Preferred radical definitions for the formulae given above and below are specified below. These definitions apply equally to the end products of the formula (I) as to all intermediates. R' preferably represents hydrogen, CI-C 6 -alkyl, C 2

-C

6 -alkenyl, C 2 -Cralkynyl, C 3

-C

6 -cycloalkyl, 10 cyano(C-Cra]kyl), C-C 6 -haloalkyl, C 2

-C

6 -haloalkenyl, C 2

-C

6 -haloalkynyl, CrC 4 -alkoxy

CI-C

4 -alkyl, C-C 4 -alkylthio-C-C 4 -alkyl, C-C 4 -alkylsulphinyl-C-C 4 -alkyl or C-C 4 -alkyl sulphonyl-C-C-alkyl. R' more preferably represents hydrogen, methyl, cyclopropyl, cyanomethyl, methoxymethyl, methylthiomethyl, methylsulphinylmethyl or methylsulphonylmethyl. 15 R' very preferably represents hydrogen. R2 preferably represents hydrogen or C-C 6 -alkyl. R2 more preferably represents hydrogen or methyl. R2 very preferably represents hydrogen. R' preferably represents hydrogen or represents C-C 6 -alkyl, C-C 6 -alkoxy, C-C 6 -alkenyl or 20 C 2

-C

6 -alkynyl each of which is unsubstituted or substituted one or more times by identical or different substituents selectable from halogen, cyano, nitro, hydroxyl, CI-C 6 -alkyl,

C

3

-C

6 -cycloalkyl, C-C 4 -alkoxy, C-C 4 -haloalkoxy, C,-C 4 -alkylthio, C-C 4 -alkylsulphinyl,

C

1

-C

4 -alkylsulphonyl, C-C 4 -alkylsulphimino, C-C 4 -alkylsulphimino-C-C 4 -alkyl,

C,-C

4 -alkylsulphimino-C 2

-C

5 -alkylcarbonyl, C-C 4 -alkylsulphoximino, C-C 4 -alkyl 25 sulphoximino-C-C 4 -alkyl, C,-C 4 -alkylsulphoximino-C 2 -C-alkylcarbonyl, C 2

-C

6 -alkoxy carbonyl, C 2

-C

6 -alkylcarbonyl or C 3

-C

6 -trialkylsilyl, R further preferable represents C 3

-C

12 -cycloalkyl and C 4 -Cirbicycloalkyl, the substituents being selectable independently of one another from halogen, cyano, nitro, hydroxy, CI-C-alkyl, C 3 -Cecycloalkyl, C-C 4 -alkoxy, C,-C 4 -haloalkoxy, C-C 4 -alkylthio, C-C 4 -alkyl 30 sulphinyl, C-C 4 -alkylsulphonyl, CIzC 4 alkylsulphimino, C-C 4 -alkylsulphimino-C-C 4 -alkyl,

C

1

-C

4 -alkylsulphimino-C 2 -C-alkylcarbonyl, C-C-alkylsulphoximino, C-C 4 -alkyl- WO 2007/144100 - 6 - PCT/EP2007/005016 sulphoximino-C-C 4 -alkyl, C-C 4 -alkylsulphoximino-C 2

-C

5 -alkylcarbonyl, C 2

-C

6 -alkoxy carbonyl, C-C 6 -alkylcarbonyl or C 3

-C

6 -trialkylsilyl, R3 more preferably represents hydrogen or represents CI-C 6 -alkyl, CI-C6-alkoxy each of which is unsubstituted or substituted one or more times by identical or different substituents 5 selectable independently of one another from halogen, cyano, nitro, hydroxyl, CI-C 6 -alkyl, CrC 6 -cycloalkyl, C-C 4 -alkoxy, C-C 4 -haloalkoxy, C-C 4 -alkylthio, C-C 4 -alkylsulphinyl,

CI-C

4 -alkylsulphonyl, C-C 4 -alkylsulphimino, C-C 4 -alkylsulphimino-C-C 4 -alkyl,

C

1

-C

4 -alkylsulphimino-C 2 -C-alkylcarbonyl, C-C 4 -alkylsulphoximino, C-C 4 -alkyl sulphoximino-C-C 4 -alkyl, C-C 4 -alkylsulphoximino-C 2 -C-alkylcarbonyl, C 2

-C

6 -alkoxy 10 carbonyl, C 2 -Cralkylcarbonyl or C 3

-C

6 -trialkylsilyl,

R

3 finther more preferably represents C 3

-C

6 -cycloalkyl which is unsubstituted or substituted one or more times by identical or different substituents selectable independently of one another from halogen, cyano, nitro, hydroxyl, C-C 6 -alkyl, C 3

-C

6 -cycloalkyl, CI-C 4 -alkoxy,

C,-C

4 -haloalkoxy, C-C 4 -alkylthio, C,-C 4 -alkylsulphinyl, C-C 4 -alkylsulphonyl, 15 C- 4 -alkylsulphimino, C-C 4 -alkylsulphimino-C-C 4 -alkyl, C-C 4 -alkylsulphimino

C

2

-C

5 -alkylcarbonyl, C-C 4 -alkylsulphoximino, C-C 4 -alkylsulphoximino-C-C 4 -alkyl, Ci-C 4 -alkylsulphoximino-C 2

-C

5 -alkylcarbonyl, C 2

-C

6 -alkoxycarbonyl, C 2

-C

6 -alkylcarbonyl or CrC 6 -trialkylsilyl, R3 very nreferably represents CI-C 4 -alkyl (methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, 20 sec-butyl or tert-butyl) or cyano-C-C 3 -alkyl (cyanomethyl, 1-cyanoethyl, 2-cyanoethyl, 1 -cyano-n-propyl, 2-cyano-n-propyl, 3-cyano-n-propyl, I-cyanoisopropyl, 2 cyanoisopropyl).

R

3 with particular preference represents methyl, isopropyl or cyanomethyl.

R

4 referably represents hydrogen, C-C 4 -alkyl, C-C 4 -haloalkyl, halogen, cyano, C-C 4 -alkoxy, 25 C-C 4 -haloalkoxy, C-C 4 -alkylthio or C 1

-C

4 -haloalkylthio. Preferably, moreover, two adjacent radicals R 4 represent -(CH 2

)

3 -, -(CH 2

)

4 -, -(CH 2

)

5 -, (CH=CH-) 2 -, -OCH20-, -O(CH 2

)

2 0-, -OCF20-, -(CF 2

)

2 0-, -O(CF 2 )20-, -(CH=CH-CH=N) or -(CH=CH-N=CH)-.

R

4 more preferably represents hydrogen, C-C 4 -alkyl, CC 2 -haloallcyl, halogen, cyano or 30 C-C 2 -haloalkoxy. More preferably, moreover, two adjacent radicals R 4 represent -(CH 2

)

4 -,

-(CH=CH-)

2 -, -O(CH 2

)

2 0-, -O(CF 2

)

2 0-, -(CH=CH-CH=N)- or -(CH=CH-N=CH)-.

WO 2007/144100 -7- PCT/EP2007/005016 very preferably represents hydrogen, methyl, trifluoromethyl, cyano, fluorine, chlorine, bromine, iodine or trifluoromethoxy. Very preferably, moreover, two adjacent radicals R 4 represent -(CH 2

)

4 -, or -(CH=CH-) 2 -.

R

4 with particular reference represents chlorine or bromine, 5 R 4 further with particular preference represents iodine or cyano. With particular preference, moreover, two adjacent radicals R represent -(CH=CH-) 2 -. R' prefembly represents C-C 4 -alkyl, C 3

-C

6 -cycloalkyl, C-C 4 -haloalkyl, C-C 6 -halocycloalkyl,

C

2

-C

6 -alkenyl, C 2

-C

4 -haloalkenyl, C 2

-C

4 -alkynyl, C-C-haloalkynyl, CI-C 4 -alkoxy, Cl-C 4 -haloalkoxy, C-C 4 -alkylthio, C 1

-C

4 -alkylsulphinyl, C-C 4 -alkylsulphonyl, C-C 4 -halo 10 alkylthio, C-C 4 -haloalkylsulphinyl, C-C 4 -haloalkylsulphonyl, halogen, cyano, nitro or Cr

C

6 -trialkylsilyl. RS more preferably represents C-C 4 -alkyl, C 3

-C

6 -cycloalkyl, C-C 4 -haloalkyl, C,-C-halocycloalkyl, C 2

-C

6 -alkenyl, C 2

-C

4 -haloalkenyl, C 2

-C

4 -alkynyl, C 2

-C

4 -haloalkynyl,

C

1

-C

4 -alkoxy, C-C 4 -haloalkoxy, fluorine, chlorine, bromine, iodine, cyano, nitro or 15 C 3

-C

6 -trialkylsilyl. R' very preferably represents methyl, fluorine, chlorine, bromine or iodine. RW with particular preference represents methyl or chlorine.

R

6 preferably represents CI-Cralkyl or (R), 20 R 6 further preferably represents C 3

-C

6 -cycloalkoxy.

R

6 more preferably represents methyl or (R7)m

R

7 independently at each occurrence preferably represents hydrogen, halogen, cyano,

CI-C

4 -alkyl, CI-C 4 -alkoxy, C-C 4 -haloalkyl, C-C 4 -haloalkoxy, C-C 4 -haloalkylsulphonyl or 25 (C,-C 4 -alkyl)C 1

-C

4 -alkoxyiniino, WO 2007/144100 -8- PCT/EP2007/005016

R

7 independently at each occurrence more oreferably represents hydrogen, halogen or

C

1

-C

4 -haloalkyl,

R

7 very preferably represents fluorine, chlorine or bromine, Rt 7 with particular preference represents chlorine. 5 m preferably represents 1, 2 or 3, m more preferably represents I or 2, m very preferably represents 1, X preferably represents N, CH, CF, CCI, CBr or CI, X more nrmferably represents N, CH, CF, CCI or CBr, 10 X very preferably represents N, CCI or CH. A preferably represents -CHr 2 , -CH 2 0-, -CH20CHr, -CH 2 S-, -CH 2 SCHr, -CH2N(C-C alkyl)-, -CH 2

N(C-C

6 -alkyl)CH 2 -, -CH(CN)-, -CH(C-C 6 -alkyl)-, -C(di-C-C 6 -alkyl)-,

-CH

2

CH

2 - or -C=NO(C-C-alkyl)-, A more nreferabhl represents -CHR 2 -, -CH(CH 3 ), C(CH3) 2 or CH 2

CH

2 , 15 A further more preferably represents -CH(CN)-, A very preferably represents CH 2 or CH(CH 3 ), A with particular preference represents CH 2 .. Q preferable represents an optionally mono- or polysubstituted 5- or 6-membered aromatic heterocyclic ring of series Q-1 to Q-53 or an aromatic 9-membered fused heterobicyclic ring 20 system Q-54 to Q-56, the substituents being selectable independently of one another from Cj

C

3 -alkyl, C-C 3 -haloalkyl, CI-C 2 -alkoxy, halogen, cyano, hydroxyl, nitro or C-C-halo alkoxy. Q further preferably represents an optionally mono- or polysubstituted 5- or 6-membered aromatic heterocyclic ring of series Q-1 to Q-53 and Q-58 to Q-59, an aromatic 9-membered 25 fused heterobicyclic ring system Q-54 to Q-56 and also represents a 5-membered heterocyclic ring Q-60 to Q-61, the substituents being selectable independently of one another from C-C 3 -alkyl, C-C 3 -haloalkyl, C-C-alkoxy, halogen, cyano, hydroxyl, nitro or

C

1 -C2-haloalkoxy, WO 2007/144100 - 9 - PCT/EP2007/005016 or the substituents being selectable independently of one another from phenyl or a 5- or 6-membered heteroaromatic ring, it being possible for phenyl or the ring to be substituted where appropriate one or more times by identical or different C-C 6 -alkyl, C-C 6 -alkenyl,

C

2

-C

6 alkynyl, C 3

-C

6 -cycloalkyl, C-C- 6 -haloalkyl, C 2

-C

6 -haloalkenyl, C-C 6 -haloalkynyl, 5 C 3

-C

6 -halocycloalkyl, halogen, CN, NO 2 , OH, CI-C 4 -alkoxy or C-C 4 -haloalkoxy substituents, Q more preferably represents an optionally mono- or polysubstituted 5- or 6-membered aromatic heterocyclic ring of series Q-36 to Q-40 or an aromatic 9-membered fused heterobicyclic ring system Q-54 to Q-56, the substituents being selectable independently of 10 one another from C,-C 3 -alkyl, C 1

-C

3 -haloalkyl, C 1

-C

2 -alkoxy, halogen, cyano, hydroxyl, nitro or C-C 2 -haloalkoxy. Q further more preferable represents an optionally mono- or polysubstituted 5- or 6-membered aromatic heterocyclic ring of series Q-36 to Q-40 and Q-58 to Q-59, an aromatic 9-membered fused heterobicyclic ring system Q-54 to Q-56 and also represents a 5 15 membered heterocyclic ring Q-60 to Q-61, the substituents being selectable independently of one another from C-C 3 -alkyl, C-C 3 -haloalkyl, C 1

-C

2 -alkoxy, halogen, cyano, hydroxyl, nitro or C-C 2 -haloalkoxy, or the substituents being selectable independently of one another from phenyl or a 5- or 6-membered heteroaromatic ring, it being possible for phenyl or the ring to be unsubstituted 20 or substituted one or more times by identical or different C 1

-C

6 -alkyl, C 2

-C

6 -alkenyl,

C

2

-C

6 -alkynyl, C 3

-C

6 -cycloalkyl, C-C 6 -haloalkyl, C-C 6 -haloalkenyl, C-C 6 -haloalkynyl,

C

3

-C

6 -halocycloalkyl, halogen, CN, NO 2 , C-C 4 -alkoxy or CI-Crhaloalkoxy substituents, Q very nreferabiy represents an optionally mono- or polysubstituted aromatic heterocyclic ring of series Q-37, Q-38, Q-39, Q-40, Q-58 and Q-59, and also represents a 5-membered 25 heterocyclic ring Q-60, the substituents being selectable independently of one another from

C,-C

3 -alkyl, C-C 3 -haloalkyl, CI-C 2 -alkoxy, halogen, cyano, hydroxyl, nitro or

C-C

2 -haloalkoxy, or the substituents being selectable independently of one another from phenyl or a 5- or 6-membered heteroaromatic ring, it being possible for phenyl or the ring to be unsubstituted 30 or substituted one or more times by identical or different C-C 6 alkyl, C 2

-C

6 -alkenyl,

C

2

-C

6 -alkynyl, C 3

-C

6 -cycloalkyl, Ci-C 6 -haloalkyl, C 2

-C

6 -haloalkenyl, C 2

-C

6 -haloalkynyl,

C

3

-C

6 -halocycloalkyl, halogen, CN, NO 2 , C-C 4 -alkoxy or C-C 4 -haloalkoxy substituents, Q further very preferably represents an optionally mono- or polysubstituted aromatic heterocyclic ring of series Q-37, Q-38, Q-39, Q-40, Q-58 and Q-59, and also represents a WO 2007/144100 - 10- PCT/EP2007/005016 5-membered heterocyclic ring Q-60, the substituents being selectable independently of one another from Ci-Cralkyl, C,-C 3 -haloalkyl, halogen, cyano, nitro or C,-C 2 -haloalkoxy, or the substituents being selectable independently of one another from phenyl or a 5- or 6-membered heteroaromatic ring, it being possible for phenyl or the ring to be unsubstituted 5 or substituted one or more times by identical or different C-C 6 -alkyl, C 2

-C

6 -alkenyl,

C,-C

6 -alkynyl, C-C-cycloalkyl, C-C-haloalkyl, C 2

-C

6 -halcalkenyl, C 2

-C

6 -haloalkynyl,

C

3

-C

6 -halocycloalkyl, halogen, CN, NO 2 , C-C 4 -alkoxy or CI-C 4 -haloalkoxy substituents, Q with particular preference represents an aromatic heterocyclic ring Q-37, Q-40, Q-58 and Q-59 which is unsubstituted or substituted once, twice or three times on carbon atoms, and 10 also represents a 5-membered heterocyclic ring Q-60, the substituents being selectable independently of one another frbm chlorine, fluorine, iodine, bromine, cyano, trifluoromethyl and pentafluoroethyl, or the substituents being selectable independently of one another from phenyl, it being possible for the phenyl ring to be unsubstituted or substituted one or more times by identical 15 or different CI-C-alkyl, C 2

-C

6 -alkenyl, C 2

-C

6 -alkynyl, C 3

-C

6 -cycloalkyl, C,-C 6 -haloalkyl, C-C-haloalkenyl, C-C 6 -baloalkynyl, C 3

-C

6 -halocycloalkyl, halogen, CN, NO 2 or Cl-C 4 -haloalkoxy substituents, Q further with particular prefernce represents an optionally mono- or polysubstituted aromatic heterocyclic ring of series Q-37, Q-40, Q-58 and Q-59, and also represents a 5-membered 20 heterocyclic ring Q-60, the substituents being selectable independently of one another from chlorine, fluorine, iodine, cyano, trifluoromethyl and pentafluoroethyl, or the substituents being selectable independently of one another from phenyl, it being possible for the phenyl ring to be unsubstituted or substituted one or more times by identical or different chlorine, fluorine, iodine, bromine, cyano, trifluoromethyl and pentafluoroethyl 25 substituents, WO 2007/144100 - 11 - PCT/EP2007/005016 N N N 0-8 Q-9 Q-10 0-11 0-12 Q-13 Q-14 H H Q-15 Q-16 0-17 0-18 0-19 0-20 Q-21 b N N 0-22 0-23 0-24 Q-25 0-26 0-27 Q-28 0N H 0 H Q-23 Q-34 Q-31 Q- 0-4 Q-4 Q-4 N N N Q-56 Q-7 Q- 8 Q-5 0-9 Q- 0 Q-1 bN N% 0 /\ S NO N\ 0-42 0-4 0-4 0-45 0-26 0-8 0-29 \ -N N\J O II'llN N N N 0-29 0-31 0-31 0-32 Q-343 0-35 NW I II N 0-6 0-7 -58 0- 9 Q4 00 -42 WO 2007/144100 - 12- PCT/EP2007/005016 Emphasis is given to compounds of the formula (I-1) R NRz N-R R A R -A in which R', R 2 , t, R R, R, A, Q and X have the above-indicated general, preferred, more preferred, very preferred and particularly preferred definitions. 5 Radicals substituted by halogen, haloalkyl for example, are halogenated one or more times up to the maximum possible number of substituents. In the case of multiple halogenation, the halogen atoms can be alike or different. Halogen here stands for fluorine, chlorine, bromine or iodine, in particular for fluorine, chlorine or bromine. Preference, more preference, great preference and particular preference is given to compounds which 10 carry in each case the substituents stated as being preferred, more preferred, very preferred and particularly preferred. Saturated or unsaturated hydrocarbon radicals such as alkyl or alkenyl, both alone and in conjunction with heteroatoms, as in alkoxy, for example, may where possible be in each case linear or branched. Unsubstituted or substituted radicals may be substituted one or more times, and in the case of 15 multiple substitutions the substituents can be alike or different. The definitions of radicals and elucidations given generally or in ranges of preference above may, however, also be combined arbitrarily with one another, in other words combined between the respective ranges and the ranges of preference. They apply to the end products and also to the precursors and intermediates accordingly. 20 It has additionally been found that anthranilamides of the formula (1) are obtained by one of the following processes. Anthranilamides of the formula (I) WO 2007/144100 - 13- PCT/EP2007/005016 R3 R2 RtN (R4), 0 N R Re/NN a in which A, R', R 2 , R 3 , R 4 , R 3 , R', Q and n have the definitions stated above are obtained by (A) reacting anilines of the fonnula (H) R', N R R NR (R% 0 / NR Rs H 5 in which A, R', R 2 , R 3 , R 4 , R 5 and n have the definitions stated above with carbonyl chlorides of the formula (HI) 0 CI A in which R 6 , A and Q have the definitions stated above, in the presence of an acid-binding 10 agent, (B) reacting anilines of the formula (II) R3 2 RN .R' (R% ) NR H in which A, R', R 2 , R 3 , R 4 , Rt and n have the definitions stated above with a carboxylic acid of the formula (IV) WO 2007/144100 -14- PCT/EP2007/005016 0 HO A R N'N 0 in which R', A and Q have the definitions stated above in the presence of a condensing agent, or by (C) synthesizing anthranilamides of the formula () in which R' represents hydrogen by reacting 5 benzoxazinones of the formula (V) (R4), N R6N 0 in which RW, R 5 , R', A, Q and n have the definitions stated above with an amine of the formula (XV) RN .R2 H (XV) 10 in which R 2 and R 3 have the definitions stated above, in the presence of a diluent.

WO 2007/144100 - 15- PCT/EP2007/005016 Elucidation of the processes and intermediates Process (A) Using, for example, 2-amino-5-chloro-3,N-dimethylbenzamide and 5-(3,5-bistrifluoromethyl pyrazol-1-ylmethyl)-2-(3-chloropyridin-2-yl)-2H-pyrazole-3-carbonyl chloride as starting 5 materials, the course of process (A) of the invention can be illustrated by the following formula scheme. N CI CN CI N/ O NHH H + N-N N-N * NH2 CF CFNN Cil a 3 ~ CF3 A general definition of the aminobenzamides required as starting materials when carrying out process (A) of the invention is given by the formula (H). In this formula (II) A, R', R 2 , R 3 , R 4 , RW and n 10 preferably, more preferably, very preferably and with particular preference represent those definitions which have already been given for these radicals in connection with the description of the compounds of the formula (I) according to the invention as being preferred, more preferred, etc. Process (A) of the invention is carried out in the presence of an acid-binding agent. Suitable for this purpose are all organic or inorganic bases that are customary for such coupling reactions. With 15 preference it is possible to use alkali metal or alkaline earth metal hydrides, hydroxides, amides, alkoxides, acetates, carbonates or hydrogen carbonates, such as, for example, sodium hydride, sodium amide, lithium diisopropylamide, sodium methoxide, sodium ethoxide, potassium tert-butoxide, sodium hydroxide, potassium hydroxide, sodium acetate, sodium carbonate, potassium carbonate, potassium hydrogen carbonate, sodium hydrogen carbonate or ammonium carbonate, and also tertiary 20 amines, such as trimethylamine, triethylamine, tributylamine, diisopropylethylamine, NN-dimethyl aniline, NN-dimethylbenzylamine, pyridine, N-methylpiperidine, N-methylmorpholine, N,N-di methylaminopyridine, diazabicyclooctane (DABCO), diazabicyclononene (DBN) or diazabicyc loundecene (DBU). It is also possible where appropriate to use polymer-supported acid-binding agents, such as polymer-bound diisopropylamine and polymer-bound dimethylaminopyridine, for 25 example. Process (A) of the invention where may appropriate be carried out in the presence of an inert organic diluent that is customary for such reactions. These diluents include preferably aliphatic, alcyclic or aromatic hydrocarbons, such as, for example, petroleum ether, hexane, heptane, cyclohexane, methyl- WO 2007/144100 -16- PCT/EP2007/005016 cyclohexane, benzene, toluene, xylene, or decalin; halogenated hydrocarbons, such as, for example, chlorobenzene, dichlorobenzene, dichloromethane, chloroform, tetrachloromethane, dichloroethane or trichloroethane; ethers, such as diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl tert-amyl ether, dioxane, tetrahydroflran, 1,2-dimethoxyethane, 1,2-diethoxyethane or anisole; 5 ketones, such as acetone, butanone, methyl isobutyl ketone or cyclohexanone; nitriles, such as aceto nitrile, propionitrile, n- or isobutyronitrile or benzonitrile; amides, such as NN-dimethylformamide, N,N-dimethylacetamide, N-methylformanilide, N-methylpyrrolidone or hexamethylphosphoramide; mixtures thereof with water, or pure water. With particular preference it is possible to use toluene, tetrahydrofuran and NN-dimethylformamide. 10 The reaction temperatures when carrying out process (A) of the invention can be varied within a relatively wide range. It is usual to operate at temperatures of 0*C to 150"C, preferably at temperatures of 20*C to 100*C. The process of the invention is carried out in general under atmospheric pressure. It is, however, also possible to carry out the process of the invention under elevated or reduced pressure - in general of 15 between 0.1 bar and 10 bar. Aminobenzamides of the formula (II) are known (cf. e.g. M. J. Komet, J. Hererocyl. Chem. 1992, 29, 103-105; G. P. Lahm et al., Bioorg. Med. Chem. Letters 2005,15,4898-4906; WO 2003/016284, WO 2006/062978). Pyrazolecarbonyl chlorides of the formula (III) are new. They can be prepared, for example, by 20 (D) reacting pyrazolecarboxylic acid derivatives of the formula (IV) HO 0 !/ ANQ(IV) N-N RG/ in which A, Q and R have the definitions stated above with a chlorinating agent (e.g. thionyl chloride and oxalyl chloride) in the presence of an inert diluent (e.g. toluene and dichloromethane) in the presence of a catalytic amount of NN-dimethylformamide. 25 Pyrazolecarboxylic acid derivatives of the formula (IV) are new. They can be prepared, for example, by (E) reacting pyrazolecarboxylic esters of the formula (VI) WO 2007/144100 - 17- PCT/EP2007/005016

,R

0 0 A(VI) W N-N R in which A, Q and R 6 have the definitions stated above and R represents C I-C6-alkyl with an alkali metal hydroxide (e.g. sodium hydroxide or potassium hydroxide) in the presence of an inert diluent (e.g. dioxane/water or ethanol/water). 5 Pyrazolecarboxylic esters of the formula (VI) are new. They can be prepared, for example, by (F) reacting pyrazolecarboxylic ester derivatives of the formula (VII) ,R 0 N-N W' R' in which A, R' and R have the definitions stated above and Z represents chlorine, bromine, iodine, methylsulphonyl or toluenesulphonyl with a heteroaromatic of the fonnula (VIII) or with a boronic 10 acid and/or boronic ester of the formula (IX), in which R' represents H, CH 3 , C 2

H

5 or R'-R' represents C(CH 3

)

2

C(CH

3

)

2 and Q has the definitions stated above, in the presence of a transition metal (e.g. tetrakis(triphenylphosphine)palladium(0)) and a base (e.g. potassium carbonate or sodium carbonate) in the presence of a solvent (e.g. tetrahydrofuran, acetonitrile, or dioxane). OR' 0-H (Vill) Q-B (IX) OR' 15 Heteroaromatics and heterocycles of the fonnula (VIII) are known, in some cases indeed being available commercially, or can be obtained by known processes (cf. e.g. H.V. Dias et al., Organometallics 1996, 15, 5374-5379; M.D. Threadgill et al., J. Fluorine Chem. 1993, 65, 21-23; M. Abdul-Ghani et al., J. Fluorine Chem. 1990, 48, 149-152; T. Kitazaki, Chem. Pharn Bull. 1996, 44, 314-327; DE 1995-19504627; WO 2004080984, WO 2005095351). 20 Heterocyclic boronic acids or boronates of the formula (IX) are known, in some cases indeed being available commercially, or can be obtained by known processes (cf. e.g. W. Li, D.P. Nelson, M.S. Jensen, R.S. Hoerrner, D. Cai, R.D. Larsen, P.J. Reider, J. Org. Chem. 2002, 67, 5394-5397). Pyrazolecarboxylic ester derivatives of the formula (VII) can be prepared, for example, by WO 2007/144100 -18- PCT/EP2007/005016 (G) reacting alcohols of the formula (X) ,R 0 0 OHX) N-N in which R, R 6 and A have the definitions stated above with a sulphonyl chloride (e.g. methylsulphonyl chloride or toluenesulphonyl chloride) or a halogenating agent (e.g. thionyl 5 chloride) in the presence where appropriate of a solvent (e.g. dichloromethane) and in the presence where appropriate of a base (e.g. triethylamine or pyridine). The reaction temperatures when carrying out process (G) of the invention can be varied within a relatively wide range. It is usual to operate at temperatures of O'C to 150 0 C, preferably at temperatures of 0*C to 60 0 C. 10 Alcohols of the formula (X) can be prepared, for example, by (H) reacting pyrazoldicarboxylic esters of the formula (XI) eR O'R (XI) N R' in which R and R' have the definitions stated above with a reducing agent (e.g. lithium aluminium hydride or diisobutylaluminium hydride) in the presence of a solvent (e.g. tetrahydrofran or diethyl 15 ether). The reaction temperatures when carrying out process (H) of the invention can be varied within a relatively wide range. It is usual to operate at temperatures of -100*C to 20*C, preferably at temperatures of -78*C to 0*C. Pyrazoldicarboxylic esters of the fonnula (X) can be prepared, for example, by 20 (1) reacting hydrazines or their corresponding salts of the formula (XII) HNH HN (XII) R in which RW has the definition stated above with a triketone (X1I1) of the formula (XIII) WO 2007/144100 -19- PCT[EP2007/005016 0 0 0 0 R (XIII) R OR'.d N R" in which R has the definition stated above, R" represents methyl or ethyl or R"-R" represents (CH 2

)

4 or (CH 2

)

2 0(CH 2

)

2 , in the presence of a solvent (e.g. methanol or ethanol). Hydrazines or their corresponding salts of the formula (XII) are known, being in some cases 5 commercially available, or can be prepared by general methods of synthesis (cf. e.g. Advanced Organic Chemistry, Fourth Edition, Jerry March, John Wiley & Sons, Inc. New York, 1992, page 1288). Triketones of the formula (XII) are known and can be prepared by general synthesis methods (cf. e.g. Cvetovich, Raymond J.; Pipik, Brenda; Harner, Frederick W.; Grabowski, Edward J. J.; 10 Tetrahedron Lett. 2003, 44, 5867 - 5870). The reaction temperatures when carrying out process (I) of the invention can be varied within a relatively wide range. It is usual to operate at temperatures of 0 to 800C, preferably at temperatures of 40 0 C to 60 0 C. Process (B) 15 Using, for example, 2-amino-5-chloro-3,N-dimethylbenzamide and 5-(3,5-bistrifluoromethyl pyrazol-1-ylmethyl)-2-(3-chloropyridin-2-yl)-2H-pyrazole-3-carboxylic acid as starting materials, the course of process (B) of the invention can be illustrated with the following formula scheme. OH N H N it N CI NNHH H h

NH

2 CFki

CF

3 A N-N CCFa -4t CF, The anthranilamides of the formula (II) required as starting materials when carrying out process (B) 20 of the invention have already been described in connection with process (A) of the invention. A general definition of the heterocyclic carboxylic acids further required as starting materials when carrying out process (B) of the invention is given by the formula (IV). In this formula (IV) R 6 , A and Q represent preferably, more preferably, very preferably and with particular preference those WO 2007/144100 - 20 - PCT/EP2007/005016 definitions which have already been stated in connection with the description of the compounds of the formula (1) of the invention as being preferred, more preferred, etc. for these radicals. Process (B) of the invention is carried out in the presence of a condensing agent. Suitability for this purpose is possessed by all agents customary for such coupling reactions. Mention may be made, by 5 way of example, of acid halide formers such as phosgene, phosphorus tribromide, phosphorus trichloride, phosphorus pentachloride, phosphorus oxychloride or thionyl chloride; anhydride farmers such as ethyl chloroformate, methyl chloroformate, isopropyl chloroformate, isobutyl chloroformate or methanesulphonyl chloride; carbodiimides, such as N,N'-dicyclohexylcarbodiimide (DCC) or other customary condensing agents, such as phosphorus pentoxide, polyphosphoric acid, 10 1,1'-carbonyldiimidazole, 2-ethoxy-N-ethoxycarbonyl-1,2-dihydroquinoline (EEDQ), triphenyl phosphine/carbon tetrachloride, bromotripyrrolidinophosphonium hexafluorophosphate, bis(2-oxo-3 oxazolidinyl)phosphine chloride or benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate. Polymer-supported reactants, such as polymer-bound cyclohexylcarbodiimide, for example, may likewise be used. 15 Process (B) of the invention is carried out where appropriate in the presence of a catalyst. Mention may be made, by way of example, of 4-dimethylaminopyridine, 1-hydroxybenzotriazole or dimethylformamide. Process (B) of the invention may where appropriate be carried out in the presence of an inert organic diluent typical for such reactions. Such diluents include preferably aliphatic, alicyclic or aromatic 20 hydrocarbons, such as, for example, petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin; halogenated hydrocarbons, such as, for example, chlorobenzene, dichlorobenzene, dichloromethane, chloroform, tetrachloromethane, dichloroethane or trichloroethane; ethers, such as diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl tert-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane or 25 anisole; ketones, such as acetone, butanone, methyl isobutyl ketone or cyclohexanone; nitriles, such as acetonitrile, propionitrile, n- or isobutyronitrile or benzonitrile; amides, such as NN-dimethyl formamide, N,N-dimethylacetamide, N-methylformanilide, N-methylpyrrolidone or hexamethylphos phoramide; mixtures thereof with water, or pure water. With particular preference it is possible to use dichloromethane and NN-dimethylformamide. 30 The reaction temperatures when carrying out process (B) of the invention can be varied within a relatively wide range. It is usual to operate at temperatures of 0*C to 150"C, preferably at temperatures of 0*C to 80"C.

WO 2007/144100 -21 - PCT/EP2007/005016 The process of the invention is carried out in general under atmospheric pressure. It is, however, also possible to carry out the process of the invention under elevated or reduced pressure - in general of between 0.1 bar and 10 bar. Process (C) 5 Using 2-[3-{[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]methyl}-1-(3-chloropyridin-2-yl)-1H-pyrazol 5-yl]-6-chloro-8-methyl-4H-3,I-benzoxazin-4-one and methylamine, the course of process (C) of the invention can be illustrated with the following formula scheme. 0 N H

CF

3 / 0 elN N\ N-N I + N - CF 3 Na NH2 CI CF3 N j C CF 3 A general definition of the benzoxazinones required as starting materials when carrying out process 10 (C) of the invention is given by the formula (V). In this formula (V) R 4 , R, R 6 , A, Q and n preferably, more preferably, very preferably and with particular preference represent those definitions which have already been given above in connection with the description of the compounds of the formula (1) of the invention as being preferred, more preferred, etc. for those radicals. Benzoxazinones of the formula (V) are new. They are obtained, for example, by 15 (J) reacting pyrazolecarboxylic acid derivatives of the formula (IV) HO O A% N-N RG/P in which R 6 , A and Q have the definitions stated above with anthranilic acids of the formula (XIV) WO 2007/144100 -22- PCT/EP2007/005016 OH (R) 0 (XIV)

NH

2 in which R 4 , R and n have the definitions stated above, in the presence of a base (e.g. triethylamine or pyridine) and in the presence of a sulphonyl chloride (e.g. methanesulphonyl chloride) and also, where appropriate, in the presence of a diluent (e.g. acetonitrile). 5 The pyrazolecarboxylic acid derivatives of the formula (IV) required as starting materials when carrying out process (J) of the invention have already been described above in connection with process (A) of the invention. A general definition of the anthranilic acids additionally required as starting materials when carrying out process (J) of the invention is given by the formula (XIV). In this formula (XIV) R4, R5 and n 10 preferably, more preferably, very preferably and with particular preference represent those definitions which have already been given above in connection with the description of the compounds of the formula (I) of the invention as being preferred, more preferred, etc. for those radicals. Anthranilic acids of the formula (XIV) are known and can be prepared by general synthesis methods (cEf. e.g. Baker et al., J. Org. Chem. 1952; 149-153; G. Reissenweber et al., Angew. Chem 1981, 93, 15 914-915, P.J. Montoya-Pelaez, J. Org. Chem. 2006, 71, 5921-5929; P. E. Sheibley, J. Org. Chem. 1938, 3, 414-423, WO 2006023783). The compounds of the formula (I) may where appropriate occur in different polymorphic forms or as a mixture of different polymorphic forms. Not only the pure polymorphs but also the polymorph mixtures are subject matter of the invention and can be used in accordance with the invention. 20 The active compounds according to the invention, in combination with good plant tolerance and favourable toxicity to warm-blooded animals and being tolerated well by the environment, are suitable for protecting plants and plant organs, for increasing the harvest yields, for improving the quality of the harvested material and for controlling animal pests, in particular insects, arachnids, helminths, nematodes and molluscs, which are encountered in agriculture, in horticulture, in animal 25 husbandry, in forests, in gardens and leisure facilities, in the protection of stored products and of materials, and in the hygiene sector. They may be preferably employed as plant protection agents. They are active against normally sensitive and resistant species and against all or some stages of development. The abovementioned pests include: From the order of the Anoplura (Phthiraptera), for example, Damalinia spp., Haemnatopinus spp., 30 Linognathus spp., Pediculus spp., Trichodectes spp.

WO 2007/144100 -23 - PCT/EP2007/005016 From the class of the Arachnida, for example, Acarus siro, Aceria sheldoni, Aculops spp., Aculus spp., Amblyomma spp., Argas spp., Boophilus spp., Brevipalpus spp., Bryobia praetiosa, Chorioptes spp., Dermanyssus gallinae, Eotetranychus spp., Epitrimerus pyri, Eutetranychus spp., Eriophyes spp., Hemitarsonemus spp., Hyalomma spp., Ixodes spp., Latrodectus mactans, Metatetranychus spp., 5 Oligonychus spp., Ornithodoros spp., Panonychus spp., Phyllocoptruta oleivora, Polyphagotarsonemus latus, Psoroptes spp., Rhipicephalus spp., Rhizoglyphus spp., Sarcoptes spp., Scorpio maums, Stenotarsonemus spp., Tarsonenus spp., Tetranychus spp., Vasates lycopersici. From the class of the Bivalva, for example, Dreissena spp. From the order of the Chilopoda, for example, Geophilus spp., Scutigera spp. 10 From the order of the Coleoptera, for example, Acanthoscelides obtectus, Adoretus spp., Agelastica alni, Agriotes spp., Amphimallon solstitialis, Anobium punctatum, Anoplophora spp., Anthonomus spp., Anthrenus spp., Apogonia spp., Atomaria spp., Attagenus spp., Bruchidius obtectus, Bruchus spp., Ceuthorhynchus spp., Cleonus mendicus, Conoderus spp., Cosmopolites spp., Costelytra zealandica, Curculio spp., Cryptorhynchus lapathi, Dermestes spp., Diabrotica spp., Epilachna spp., 15 Faustinus cubae, Gibbium psylloides, Heteronychus arator, Hylamorpha elegans, Hylotrupes bajulus, Hypera postica, Hypothenemus spp., Lachnosterna consanguinea, Leptinotarsa decemlineata, Lissorhoptrus oryzophilus, Lixus spp., Lyctus spp., Meligethes aeneus, Melolontha melolontha, Migdolus spp., Monochamus spp., Naupactus xanthographus, Niptus hololeucus, Oryctes rhinoceros, Oryzaephilus surinamensis, Otiorrhynchus sulcatus, Oxycetonia jucunda, Phaedon cochleariae, 20 Phyllophaga spp., Popillia japonica, Premnotrypes spp., Psylliodes chrysocephala, Ptinus spp., Rbizobius ventralis, Rhizopertha dominica, Sitophilus spp., Sphenophorus spp., Sternechus spp., Symphyletes spp., Tenebrio molitor, Tribolium spp., Trogoderma spp., Tychius spp., Xylotrechus spp., Zabrus spp. From the order of the Collembola, for example, Onychiurus armatus. 25 From the order of the Dermaptera, for example, Forficula auricularia. From the order of the Diplopoda, for example, Blaniulus guttulatus. From the order of the Diptera, for example, Aedes spp., Anopheles spp., Bibio hortulanus, Calliphora erythrocephala, Ceratitis capitata, Chrysomyia spp., Cochliomyia spp., Cordylobia anthropophaga, Culex spp., Cuterebra spp., Dacus oleae, Dermatobia hominis, Drosophila spp., Fannia spp., 30 Gastrophilus spp., Hylemyia spp., Hyppobosca spp., Hypoderma spp., Liriomyza spp., Lucilia spp., Musca spp., Nezara spp., Oestrus spp., Oscinella frit, Pegomyia hyoscyami, Phorbia spp., Stomoxys spp., Tabanus spp., Tannia spp., Tipula paludosa, Wohlfahrtia spp.

WO 2007/144100 -24 - PCT/EP2007/005016 From the class of the Gastropoda, for example, Arion spp., Biomphalaria spp., Bulinus spp., Deroceras spp., Galba spp., Lymnaea spp., Oncomelania spp., Succinea spp. From the class of the helminths, for example, Ancylostoma duodenale, Ancylostoma ceylanicum, Acylostoma braziliensis, Ancylostoma spp., Ascaris lubricoides, Ascaris spp., Brugia malayi, Brugia 5 timori, Bunostomum spp., Chabertia spp., Clonorchis spp., Cooperia spp., Dicrocoelium spp, Dictyocaulus filaria, Diphyllobothrium latum, Dracunculus medinensis, Echinococcus granulosus, Echinococcus multilocularis, Enterobius vermicularis, Faciola spp., Haemonchus spp., Heterakis spp., Hymenolepis nana, Hyostrongulus spp., Loa Loa, Nematodirus spp., Oesophagostomum spp., Opisthorchis spp., Onchocerca volvulus, Ostertagia spp., Paragonimus spp., Schistosomen spp., 10 Strongyloides fuellebomi, Strongyloides stercoralis, Stronyloides spp., Taenia saginata, Taenia solium, Trichinella spiralis, Trichinella nativa, Trichinella britovi, Trichinella nelsoni, Trichinella pseudopsiralis, Trichostrongulus spp., Trichuris trichuria, Wuchereria bancrofli. It is furthermore possible to control protozoa, such as Eimeria. From the order of the Heteroptera, for example, Anasa tristis, Antestiopsis spp., Blissus spp., 15 Calocoris spp., Campylomma livida, Cavelerius spp., Cimex spp., Creontiades dilutus, Dasynus piperis, Dichelops furcatus, Diconocoris hewetti, Dysdercus spp., Euschistus spp., Eurygaster spp., Heliopeltis spp., Horcias nobilellus, Leptocorisa spp., Leptoglossus phyllopus, Lygus spp., Macropes excavatus, Miridae, Nezara spp., Oebalus spp., Pentomidae, Piesma quadrata, Piezodoms spp., Psallus seriatus, Pseudacysta persea, Rhodnius spp., Sahlbergella singularis, Scotinophora spp., 20 Stephanitis nashi, Tibraca spp., Triatoma spp. From the order of the Homoptera, for example, Acyrthosipon spp., Aeneolamia spp., Agonoscena spp., Aleurodes spp., Aleurolobus barodensis, Aleurothrixus spp., Anrasca spp., Anuraphis cardui, Aonidiella spp., Aphanostigma piri, Aphis spp., Arboridia apicalis, Aspidiella spp., Aspidiotus spp., Atanus spp., Aulacorthum solani, Bemisia spp., Brachycaudus helichrysii, Brachycolus spp., 25 Brevicoryne brassicae, Calligypona marginata, Cameocephala fulgida, Ceratovacuna lanigera, Cercopidae, Ceroplastes spp., Chaetosiphon fragaefolii, Chionaspis tegalensis, Chlorita onukii, Chromaphis juglandicola, Chrysomphalus ficus, Cicadulina mbila, Coccomytilus halli, Coccus spp., Cryptomyzus ribis, Dalbulus spp., Dialeurodes spp., Diaphorina spp., Diaspis spp., Doralis spp., Drosicha spp., Dysaphis spp., Dysmicoccus spp., Empoasca spp., Eriosoma spp., Erythroneura spp., 30 Euscelis bilobatus, Geococcus coffee, Homalodisca coagulata, Hyalopterus arundinis, Icerya spp., Idiocerus spp., Idioscopus spp., Laodelphax striatellus, Lecanium spp., Lepidosaphes spp., Lipaphis erysimi, Macrosiphum spp., Mahanarva fimbriolata, Melanaphis sacchari, Metcalfiella spp., Metopolophium dirhodum, Monellia costalis, Monelliopsis pecanis, Myzus spp., Nasonovia ribisnigri, Nephotettix spp., Nilaparvata lugens, Oncometopia spp., Orthezia praelonga, Parabemisia 35 myricae, Paratrioza spp., Parlatoria spp., Pemphigus spp., Peregrinus maidis, Phenacoccus spp., WO 2007/144100 -25- PCT/EP2007/005016 Phloeomyzus passerinii, Phorodon humuli, Phylloxera spp., Pinnaspis aspidistrae, Planococcus spp., Protopulvinaria pyriformis, Pseudaulacaspis pentagon, Pseudococcus spp., Psylla spp., Pteromalus spp., Pyrilla spp., Quadraspidiotus spp., Quesada gigas, Rastrococcus spp., Rhopalosiphum spp., Saissetia spp., Scaphoides titanus, Schizaphis graminum, Selenaspidus articulatus, Sogata spp., 5 Sogatella furcifera, Sogatodes spp., Stictocephala festina, Tenalaphara malayensis, Tinocallis caryaefoliae, Tomaspis spp., Toxoptera spp., Trialeurodes vaporariorum; Trioza spp., Typhlocyba spp., Unaspis spp., Viteus vitifolii. From the order of the Hymenoptera, for example, Diprion spp., Hoplocampa spp., Lasius spp., Mono morium pharaonis, Vespa spp. 10 From the order of the Isopoda, for example, Armadillidium vulgare, Oniscus asellus, Porcellio scaber. From the order of the Isoptera, for example, Reticulitermes spp., Odontotermes spp. From the order of the Lepidoptera, for example, Acronicta major, Aedia leucomelas, Agrotis spp., Alabama argillacca, Anticarsia spp., Barathra brassicae, Bucculatrix thurberiella, Bupalus piniarius, Cacoecia podana, Capua reticulana, Carpocapsa pomonella, Cheimatobia brumata, Chilo spp., 15 Choristoneura furniferana, Clysia ambiguella, Cnaphalocems spp., Earias insulana, Ephestia kuehniella, Euproctis chrysorrhoea, Euxoa spp., Feltia spp., Galleria mellonella, Helicoverpa spp., Heliothis spp., Hofmannophila pseudospretella, Homona magnanima, Hyponomeuta padella, Laphygma spp., Lithocolletis blancardella, Lithophane antennata, Loxagrotis albicosta, Lymantria spp., Malacosoma neustria, Mamestra brassicae, Mocis repanda, Mythimna separata, Oria spp., 20 Oulema oryzae, Panolis flammea, Pectinophora gossypiella, Phyllocnistis citrella, Pieris spp., Plutella xylostella, Prodenia spp., Pseudaletia spp., Pseudoplusia includens, Pyrausta nubilalis, Spodoptera spp., Thermesia gemmatalis, Tinea pellionella, Tineola bisselliella, Tortrix viridana, Trichoplusia spp. From the order of the Orthoptera, for example, Acheta domesticus, Blatta orientalis, Blattella germanica, Gryllotalpa spp., Leucophaea maderae, Locusta spp., Melanoplus spp., Periplaneta 25 americana, Schistocerca gregaria. From the order of the Siphonaptera, for example, Ceratophyllus spp., Xenopsylla cheopis. From the order of the Symphyla, for example, Scutigerella immaculata. From the order of the Thysanoptera, for example, Baliothrips biformis, Enneothrips flavens, Frankliniella spp., Heliothrips spp., Hercinothrips femoralis, Kakothrips spp., Rhipiphorothrips 30 cruentatus, Scirtothrips spp., Taeniothrips cardamoni, Thrips spp. From the order of the Thysanura, for example, Lepisma saccharine.

WO 2007/144100 - 26 - PCT/EP2007/005016 The phytoparasitic nematodes include, for example, Anguina spp., Aphelenchoides spp., Belonoaimus spp., Bursaphelenchus spp., Ditylenchus dipsaci, Globodera spp., Heliocotylenchus spp., Heterodera spp., Longidorus spp., Meloidogyne spp., Pratylenchus spp., Radopholus similis, Rotylenchus spp., Trichodorus spp., Tylenchorhynchus spp., Tylenchulus spp., Tylenchulus senipenetrans, Xiphinema 5 spp. If appropriate, the compounds according to the invention can, at certain concentrations or application rates, also be used as herbicides, safeners, growth regulators or agents to improve plant properties, or as microbicides, for example as fungicides, antimycotics, bactericides, viricides (including agents against viroids) or as agents against MLO (mycoplasma-like organisms) and RLO (rickettsia-like 10 organisms). If appropriate, they can also be employed as intermediates or precursors for the synthesis of other active compounds. The active compounds can be converted to the customary formulations, such as solutions, emulsions, wettable powders, water- and oil-based suspensions, powders, dusts, pastes, soluble powders, soluble granules, granules for broadcasting, suspension-emulsion concentrates, natural materials impregnated 15 with active compound, synthetic materials impregnated with active compound, fertilizers and microencapsulations in polymeric substances. These formulations are produced in a known manner, for example by mixing the active compounds with extenders, that is liquid solvents and/or solid carriers, optionally with the use of surfactants, that is emulsifiers and/or dispersants and/or foam-formers. The formulations are prepared either in suitable 20 plants or else before or during the application. Suitable for use as auxiliaries are substances which are suitable for imparting to the composition itself and/or to preparations derived therefrom (for example spray liquors, seed dressings) particular properties such as certain technical properties and/or also particular biological properties. Typical suitable auxiliaries are: extenders, solvents and carriers. 25 Suitable extenders are, for example, water, polar and nonpolar organic chemical liquids, for example from the classes of the aromatic and non-aromatic hydrocarbons (such as paraffins, alkylbenzenes, alkylnaphthalenes, chlorobenzenes), the alcohols and polyols (which, if appropriate, may also be substituted, etherified and/or esterified), the ketones (such as acetone, cyclohexanone), esters (including fats and oils) and (poly)ethers, the unsubstituted and substituted amines, amides, lactams 30 (such as N-alkylpyrrolidones) and lactones, the sulphones and sulphoxides (such as dimethyl sulphoxide). If the extender used is water, it is also possible to employ, for example, organic solvents as auxiliary solvents. Essentially, suitable liquid solvents are: aromatics such as xylene, toluene or alkylnaphthalenes, chlorinated aromatics and chlorinated aliphatic hydrocarbons such as WO 2007/144100 -27- PCT/EP2007/005016 chlorobenzenes, chloroethylenes or methylene chloride, aliphatic hydrocarbons such as cyclohexane or paraffins, for example petroleum fractions, mineral and vegetable oils, alcohols such as butanol or glycol and also their ethers and esters, ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents such as dimethyl sulphoxide, and also water. 5 Suitable solid carriers are: for example, ammonium salts and ground natural minerals such as kaolins, clays, tale, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth, and ground synthetic minerals, such as finely divided silica, alumina and silicates; suitable solid carriers for granules are: for example, crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite, and also synthetic 10 granules of inorganic and organic meals, and granules of organic material such as paper, sawdust, coconut shells, maize cobs and tobacco stalks; suitable emulsifiers and/or foam-formers are: for example, nonionic and anionic emulsifiers, such as polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, for example alkylaryl polyglycol ethers, alkylsulphonates, alkyl sulphates, arylsulphonates and also protein hydrolysates; suitable dispersants are nonionic and/or ionic 15 substances, for example from the classes of the alcohol-POE- and/or -POP-ethers, acid and/or POP POE esters, alkyl aryl and/or POP- POE ethers, fat and/or POP-POE adducts, POE- and/or POP polyol derivatives, POE- and/or POP-sorbitan or -sugar adducts, alkyl or aryl sulphates, alkyl- or arylsulphonates and alkyl or aryl phosphates or the corresponding PO-ether adducts. Furthermore, suitable oligo- or polymers, for example those derived from vinylic monomers, from acrylic acid, 20 from EO and/or PO alone or in combination with, for example, (poly)alcohols or (poly)amines. It is also possible to employ lignin and its sulphonic acid derivatives, unmodified and modified celluloses, aromatic and/or aliphatic sulphonic acids and their adducts with formaldehyde. Tackifiers such as carboxymethylcellulose, natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, as well as natural 25 phospholipids such as cephalins and lecithins, and synthetic phospholipids, can be used in the formulations. It is possible to use colorants such as inorganic pigments, for example iron oxide, titanium oxide and Prussian Blue, and organic dyestuffs, such as alizarin dyestuffs, azo dyestuffs and metal phthalocyanine dyestuffs, and trace nutrients such as salts of iron, manganese, boron, copper, cobalt, 30 molybdenum and zinc. Other possible additives are perfumes, mineral or vegetable, optionally modified oils, waxes and nutrients (including trace nutrients), such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc. Stabilizers, such as low-temperature stabilizers, preservatives, antioxidants, light stabilizers or other WO 2007/144100 -28- PCT/EP2007/005016 agents which improve chemical and/or physical stability may also be present. The formulations generally comprise between 0.01 and 98% by weight of active compound, preferably between 0.5 and 90%. The active compound according to the invention can be used in its commercially available 5 formulations and in the use forms, prepared from these formulations, as a mixture with other active compounds, such as insecticides, attractants, sterilizing agents, bactericides, acaricides, nematicides, fungicides, growth-regulating substances, herbicides, safeners, fertilizers or semiochemicals. Particularly favourable mixing components are, for example, the following compounds: Fungicides: 10 Inhibitors of nucleic acid synthesis benalaxyl, benalaxyl-M, bupirimate, chiralaxyl, clozylacon, dimethirimol, ethirimol, furalaxyl, hymexazol, metalaxyl, metalaxyl-M, ofurace, oxadixyl, oxolinic acid Inhibitors of mitosis and cell division benomyl, carbendazim, diethofencarb, faberidazole, pencycuron, thiabendazole, thiophanate 15 methyl. zoxamide Inhibitors of respiratory chain complex I diflumetorim Inhibitors of respiratory chain complex II boscalid, carboxin, fenfiram, flutolanil, furametpyr, mepronil, oxycarboxin, penthiopyrad, 20 thifluzamide Inhibitors of respiratory chain complex III azoxystrobin, cyazofamid, dimoxystrobin, enestrobin,.famoxadone, fenamidone, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, pyraclostrobin, picoxystrobin, trifloxystrobin 25 Decouplers dinocap, fluazinam WO 2007/144100 -29- PCT/EP2007/005016 Inhibitors of ATP production fentin acetate, fentin chloride, fentin hydroxide, silthiofam Inhibitors of amino acid biosynthesis and protein biosynthesis andoprim, blasticidin-S, cyprodinil, kasugamycin, kasugamycin hydrochloride hydrate, 5 mepanipyrim, pyrimethanil Inhibitors of signal transduction fenpiclonil, fludioxonil, quinoxyfen Inhibitors of lipid and membrane synthesis chlozolinate, iprodione, procymidone, vinclozolin 10 ampropylfos, potassium-ampropylfos, edifenphos, iprobenfos (IBP), isoprothiolane, pyrazophos toiclofos-methyl, biphenyl iodocarb, propamocarb, propamocarb hydrochloride Inhibitors of ergosterol biosynthesis 15 fenhexamid, azaconazole, bitertanol, bromuconazole, cyproconazole, diclobutrazole, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, furconazole, firconazole-cis, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, paclobutrazole, penconazole, propiconazole, prothioconazole, 20 simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole, voriconazole, imazalil, imazalil sulphate, oxpoconazole, fenarimol, flurprimidole, nuarimol, pyrifenox, triforine, pefurazoate, prochloraz, triflumizole, viniconazole, aldimorph, dodemorph, dodemorph acetate, fenpropimorph, tridemorph, fenpropidin, 25 spiroxamine, naftifine, pyributicarb, terbinafine WO 2007/144100 - 30 - PCT/EP2007/005016 Inhibitors of cell wall synthesis benthiavalicarb, bialaphos, dimethomorph, flumorph, iprovalicarb, polyoxins, polyoxorim, validamycin A Inhibitors of melanin biosynthesis 5 capropamid, diclocymet, fenoxanil, phthalid, pyroquilon, tricyclazole Resistance inductors acibenzolar-S-methyl, probenazole, tiadinil Multisite captafol, captan, chlorothalonil, copper salts such as: copper hydroxide, copper naphthenate, 10 copper oxychloride, copper sulphate, copper oxide, oxine-copper and Bordeaux mixture, dichlofluanid, dithianon, dodine, dodine free base, ferbam, folpet, fluorofolpet, guazatine, guazatine acetate, iminoctadine, iminoctadine albesilate, iminoctadine triacetate, mancopper, mancozeb, maneb, metiram, metiram zinc, propineb, sulphur and sulphur preparations containing calcium polysulphide, thiram, tolylfluanid, zineb, ziram 15 Unknown mechanism amibromdol, benthiazole, bethoxazin, capsimycin, carvone, chinomethionat, chloropicrin, cufraneb, cyflufenamid, cymoxanil, dazomet, debacarb, diclomezine, dichlorophen, dicloran, difenzoquat, difenzoquat methyl sulphate, diphenylamine, ethaboxam, ferimzone, flumetover, flusulphamide, fluopicolide, fluoroimide, hexachlorobenzene, 8-hydroxyquinoline sulphate, 20 irumamycin, methasulphocarb, metrafenone, methyl isothiocyanate, mildiomycin, natamycin, nickel dimethyl dithiocarbamate, nitrothal-isopropyl, octhilinone, oxamocarb, oxyfenthiin, pentachlorophenol and salts, 2-phenylphenol and salts, piperalin, propanosine-sodium, proquinazid, pyrrolenitrin, quintozene, tecloftalam, teenazene, triazoxide, trichlamide, zarilamid and 2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine, N-(4-chloro-2-nitrophenyl)-N 25 ethyl-4-methylbenzenesulphonamide, 2-amino-4-methyl-N-phenyl-5-thiazolecarboxamide, 2 chloro-N-(2,3-dihydro-1,1,3-trimetbyl-1H-inden-4-yl)-3-pyridinecarboxamide, 3-[5-(4-chloro phenyl)-2,3-dimethylisoxazolidin-3-yl]pyridine, cis-l-(4-chlorophenyl)-2-(lH-1,2,4-triazol-1 yl)cycloheptanol, 2,4-dihydro-5-methoxy-2-methyl-4-[[[-[3-(trifluoromethyl)phenyl] ethylidene]amino]oxy]methyl]phenyl]-3H-1,2,3-triazol-3-one (185336-79-2), methyl 1-(2,3 30 dihydro-2,2-dimethyl-lH-inden-1-yl)-1H-imidazole-5-carboxylate, 3,4,5-trichloro-2,6 pyridinedicarbonitrile, methyl 2-[[[cyclopropyl[(4-methoxy- WO 2007/144100 -31 - PCT/EP2007/005016 phenyl)imino]methyl]thio]methyl]-.alpha.-(methoxymethylene)benzacetate, 4-chloro-alpha propynyloxy-N-[2-[3-metboxy-4-(2-propynyloxy)phenyl]ethyl]benzacetamide, (2S)-N-[2-[4 [[3-(4-cblorophenyl)-2-propynyl]oxy]-3-methoxyphenyl]ethyl]-3-methyl-2-[(methylsulphon yI)amino]butanamide, 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)[1,2,4] 5 triazolo[1,5-a]pyrimidine, 5-chloro-6-(2,4,6-trifluorophenyl)-N-[(IR)-1,2,2-trimethylpropyl] [1,2,4]triazolo[1,5-a]pyrimidin-7-amine, 5-chloro-N-[(IR)-1,2-dimethylpropyl]-6-(2,4,6 trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidin-7-amine, N-[l-(5-bromo-3-chloropyridin-2 yl)ethyl]-2,4-dichloronicotinamide, N-(5-bromo-3-chloropyridin-2-yl)methyl-2,4-dichloro nicotinamide, 2-butoxy-6-iodo-3-propylbenzopyranon-4-one, N-((Z)-[(cyclopropylmethoxy) 10 imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}-2-benzacetamniide, N-(3-ethyl-3,5,5 trimethylcyclohexyl)-3-formylamino-2-hydmxybenzamide, 2-[[[[1-[3(1 -fluoro-2-phenyl ethyl)oxyjphenyl]ethylidene]amino]oxy]methyl]-alpha-(methoxyimino)-N-metbyl-alphaE benzacetamide, N-{2-[3-chloro-5-(trifluommethyl)pyridin-2-yl]ethyl)-2-(trifluoro methyl)benzamide, N-(3',4'-dichlorw-5-fluorobiphenyl-2-yl)-3-(difluoromethyl)-1-methyl-IH 15 pyrazole-4-carboxamide, N-(6-methoxy-3-pyridinyl)cyclopropanecarboxamide, 1-[(4 methoxyphenoxy)methyl]-2,2-dimethylpropyl-IH-imidazole-l-carboxylic acid, 0-[1-[(4 methoxyphenoxy)methyl]-2,2-dimethylpropyl]-lH-imidazole-1-carbothioic acid, 2-(2-{[6-(3 chloro-2-methylphenoxy)-5-fluoropyrimidin-4-yl]oxy}phenyl)-2-(methoxyimino)-N-methyl acetamide 20 Bactericides: bronopol, dichlorophen, nitrapyrin, nickel dimethyldithiocarbamate, kasugamycin, octhilinone, firancarboxylic acid, oxytetracycline, probenazole, streptomycin, tecloftalam, copper sulphate and other copper preparations.

WO 2007/144100 -32- PCT/EP2007/005016 Insecticides/acaricides/nematicides: Acetylcholine esterase (AChE) inhibitors carbamates, for example alanycarb, aldicarb, aldoxycarb, allyxycarb, aminocarb, bendiocarb, benfuracarb, 5 bufencarb, butacarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, cloethocarb, dimetilan, ethiofencarb, fenobucarb, fenothiocarb, formetanate, fxmathiocarb, isoprocarb, metam-sodium, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, promecarb, propoxur, thiodicarb, thiofanox, trimethacarb, XMC, xylylcarb, triazamate organophosphates, 10 for example acephate, azamethiphos, azinphos (-methyl, -ethyl), bromophos-ethyl, bromfenvinfos (-methyl), butathiofos, cadusafos, carbophenothion, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos (-methyl/-ethyl), coumaphos, cyanofenphos, cyanophos, chlorfenvinphos, demeton-S-methyl, demeton-S-methylsulphone, dialifos, diazinon, dichlofenthion, dichlorvos/DDVP, dicrotophos, dimethoate, dimethylvinphos, 15 dioxabenzofos, disulfoton, EPN, ethion, ethoprophos, etrimfos, famphur, fenarniphos, fenitrothion, fensulfothion, fenthion, flupyrazofos, fonofos, formothion, fosmethilan, fosthiazate, heptenophos, iodofenphos, iprobenfos, isazofos, isofenphos, isopropyl 0-salicylate, isoxathion, malathion, mecarbam, methacrifos, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, parathion (-methyl/ 20 ethyl), phenthoate, phorate, phosalone, phosmet, phosphamidon, phosphocarb, phoxim, pirimiphos (-methyl/-ethyl), profenofos, propaphos, propetamphos, prothiofos, prothoate, pyraclofos, pyridaphenthion, pyridathion, quinalphos, sebufos, sulphotep, sulprofos, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, triclorfon, vamidothion 25 Sodium channel modulators / voltage-dependent sodium channel blockers pyrethroids, for example acrinathrin, allethrin (d-cis-trans, d-trans), beta-cyfluthrin, bifenthrin, bioallethrin, bioallethrin-S-cyclopentyl isomer, bioethanomethrin, biopermethrin, bioresmethrin, chlovaporthrin, cis-cypennethrin, cis-resmethrin, cis-permethrin, clocythrin, 30 cycloprothrin, cyfluthrin, cyhalothrin, cypermethrin (alpha-, beta-, theta-, zeta-), cyphenothrin, deltamethrin, empenthrin (IR isomer), esfenvalerate, etofenprox, fenfluthrin, fenpropathrin, fenpyrithrin, fenvalerate, flubrocythrinate, flucythrinate, flufenprox, flumethrin, fluvalinate, fubfenprox, ganma-cyhalothrin, imiprothrin, kadethrin, lambda cyhalothrin, metofluthrin, permethrin (cis-, trans-), phenothrin (IR-trans-isomer), prallethrin, WO 2007/144100 -33- PCT/EP2007/005016 profluthrin, protrifenbute, pyresmethrin, resmethrin, RU 15525, silafluofen, tau-fluvalinate, tefluthrin, terallethrin, tetramethrin (IR isomer), tralomethrin, transfluthrin, ZXI 8901, pyrethrins (pyrethrum) DDT 5 oxadiazines, for example indoxacarb semicarbazone, for example metaflumizone (BAS3201) Acetylcholine receptor agonists/antagonists 10 chloronicotinyls, for example acetamiprid, clothianidin, dinotefran, imidacloprid, nitenpyram, nithiazine, thiacloprid, thiamethoxam nicotine, bensultap, cartap Acetylcholine receptor modulators 15 spinosyns, for example spinosad, GABA-controlled chloride channel antagonists organochlorines, for example camphechlor, chlordane, endosulfan, gamma-HCH, HCH, heptachlor, lindane, 20 methoxychlor fiproles, for example acetoprole, ethiprole, fipronil, pyrafluprole, pyriprole, vaniliprole Chloride channel activators mectins, 25 for example abamectin, emamectin, ernamectin-benzoate. ivermectin, lepimectin, milbemycin Juvenile hormone mimetics, for example diofenolan, epofenonane, fenoxycarb, hydroprene, kinoprene, methoprene, pyriproxifen, triprene WO 2007/144100 -34.- PCT/EP2007/005016 Ecdysone agonists/disruptors diacylhydrazines, for example chromafenozide, halofenozide, methoxyfenozide, tebufenozide Chitin biosynthesis inhibitors 5 benzoylureas, for example bistrifluron, chlofluazuron, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, penfluron, teflubenzuron, triflumuron buprofezin 10 cyromazine Oxidative phosphorylation inhibitors, ATP disruptors diafenthiuron organotin compounds, for example azocyclotin, cyhexatin, fenbutatin-oxide 15 Oxidative phosphorylation decouplers acting by interrupting the H-proton gradient pyrroles, for example chlorfenapyr dinitrophenols, for example binapacyrl, dinobuton, dinocap, DNOC 20 Site-I electron transport inhibitors METIs, for example fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad, tolfenpyrad hydramethylnon dicofol 25 Site-H1 electron transport inhibitors rotenone WO 2007/144100 -35- PCT/EP2007/005016 Site-III electron transport inhibitors acequinocyl, fluacrypyrim Microbial disruptors of the insect gut membrane Bacillus thuringiensis strains 5 Lipid synthesis inhibitors tetronic acids, for example spirodiclofen, spiromesifen tetramic acids, for example spirotetramat, cis-3-(2,5-dimethylphenyl)-4-hydroxy-8-methoxy- 10 azaspiro[4.5]dec-3-en-2-one carboxamides, for example flonicamid octopaminergic agonists, for example amitraz 15 Inhibitors of magnesium-stimulated ATPase, propargite nereistoxin analogues, for example tbiocyclam hydrogen oxalate, thiosultap-sodium Ryanodin receptor agonists 20 benzoic acid dicarboxamides, for example flubendiamid anthranilamides, for example rynaxypyr (3-bromo-N-{4-chloro-2-methyl-6-[(methylamino)carbonyl]phenyl} 1-(3-chloropyridin-2-y)-1 H-pyrazole-5-carboxamide) WO 2007/144100 - 36 - PCT/EP2007/005016 Biologicals, hormones or pheromones azadirachtin, Bacillus spec., Beauveria spec., codlemone, Metarrhizium spec., Paecilomyces spec., thuringiensin, Verticillium spec. Active compounds with unknown or unspecific mechanisms of action 5 fumigants, for example aluminium phosphide, methyl bromide, sulphuryl fluoride antifeedants, for example cryolite, flonicandd, pymetrozine mite growth inhibitors, 10 for example clofentezine, etoxazole, hexythiazox amidoflumet, benclothiaz, benzoximate, bifenazate, bromopropylate, buprofezin, chinomethionat, chlordimeform, chlorobenzilate, chloropicrin, clothiazoben, cycloprene, cyflumetofen, dicyclanil, fenoxacrim, fentrifanil, flubenzimine, flufenerim, flutenzin, gossyplure, hydramethylnone, japonilure, metoxadiazone, petroleum, piperonyl butoxide, 15 potassium oleate, pyridalyl, sulfluramid, tetradifon, tetrasul, triarathene, verbutin A mixture with other known active compounds, such as herbicides, fertilizers, growth regulators, safeners, semiochemicals, or else with agents for improving the plant properties, is also possible. When used as insecticides, the active compounds according to the invention can furthermore be present in their commercially available formulations and in the use forms, prepared from these 20 formulations, as a mixture with synergists. Synergists are compounds which increase the action of the active compounds, without it being necessary for the synergistic agent added to be active itself. For increasing the activity, ammonium or phosphonium salts and/or penetration promoters can be added in particular. When used as insecticides, the active compounds according to the invention can furthermore be 25 present in their commercially available formulations and in the use forms, prepared from these formulations, as mixtures with inhibitors which reduce degradation of the active compound after use in the environment of the plant, on the surface of parts of plants or in plant tissues. The active compound content of the use forms prepared from the commercially available formulations can vary within wide limits. The active compound concentration of the use forms can be 30 from 0.00000001 to 95% by weight of active compound, preferably between 0.00001 and 1% by weight.

WO 2007/144100 - 37 - PCT/EP2007/005016 The compounds are employed in a customary manner appropriate for the use forms. All plants and plant parts can be treated in accordance with the invention. Plants are to be understood as meaning in the present context all plants and plant populations such as desired and undesired wild plants or crop plants (including naturally occurring crop plants). Crop plants can be plants which can 5 be obtained by conventional plant breeding and optimization methods or by biotechnological and genetic engineering methods or by combinations of these methods, including the transgenic plants and including the plant cultivars protectable or not protectable by plant breeders' rights. Plant parts are to be understood as meaning all parts and organs of plants above and below the ground, such as shoot, leaf, flower and root, examples which may be mentioned being leaves, needles, stalks, stems, 10 flowers, fruit bodies, fruits, seeds, roots, tubers and rhizomes. The plant parts also include harvested material, and vegetative and generative propagation material, for example cuttings, tubers, rhizomes, offshoots and seeds. Treatment according to the invention of the plants and plant paits with the active compounds is carried out directly or by allowing the compounds to act on the surroundings, habitat or storage space 15 by the customary treatment methods, for example by immersion, spraying, evaporation, fogging, scattering, painting on, injecting and, in the case of propagation material, in particular in the case of seeds, also by applying one or more coats. As already mentioned above, it is possible to treat all plants and their parts according to the invention. In a preferred embodiment, wild plant species and plant cultivars, or those obtained by conventional 20 biological breeding methods, such as crossing or protoplast fusion, and parts thereof, are treated. In a further preferred embodiment, transgenic plants and plant cultivars obtained by genetic engineering methods, if appropriate in combination with conventional methods (Genetically Modified Organisms), and parts thereof are treated. The terms "parts", "parts of plants" and "plant parts" have been explained above. 25 Particularly preferably, plants of the plant cultivars which are in each case commercially available or in use are treated according to the invention. Plant cultivars are to be understood as meaning plants having novel properties ("traits") which have been obtained by conventional breeding, by mutagenesis or by recombinant DNA techniques. These can be cultivars, bio- or genotypes. Depending on the plant species or plant cultivars, their location and growth conditions (soils, climate, 30 vegetation period, diet), the treatment according to the invention may also result in superadditive ("synergistic") effects. Thus, for example, reduced application rates and/or a widening of the activity spectrum and/or an increase in the activity of the substances and compositions which can be used according to the invention, better plant growth, increased tolerance to high or low temperatures, increased tolerance to drought or to water or soil salt content, increased flowering performance, easier WO 2007/144100 -38- PCT/EP2007/005016 harvesting, accelerated maturation, higher harvest yields, higher quality and/or a higher nutritional value of the harvested products, better storage stability and/or processability of the harvested products are possible, which exceed the effects which were actually to be expected. The transgenic plants or plant cultivars (obtained by genetic engineering) which are preferably to be 5 treated according to the invention include all plants which, by virtue of the genetic modification, received genetic material which imparts particularly advantageous, useful traits to these plants. Examples of such traits are better plant growth, increased tolerance to high or low temperatures, increased tolerance to drought or to water or soil salt content, increased flowering performance, easier harvesting, accelerated maturation, higher harvest yields, higher quality and/or a higher nutritional 10 value of the harvested products, better storage stability and/or processability of the harvested products. Further and particularly emphasized examples of such traits are a better defence of the plants against animal and microbial pests, such as against insects, mites, phytopathogenic fungi, bacteria and/or viruses, and also increased tolerance of the plants to certain herbicidally active compounds. Examples of transgenic plants which may be mentioned are the important crop plants, 15 such as cereals (wheat, rice), maize, soya beans, potatoes, sugar beet, tomatoes, peas and other vegetable varieties, cotton, tobacco, oilseed rape and also fruit plants (with the fruits apples, pears, citrus fruits and grapes), and particular emphasis is given to maize, soya beans, potatoes, cotton, tobacco and oilseed rape. Traits that are emphasized in particular are increased defence of the plants against insects, arachnids, nematodes and slugs and snails by virtue of toxins formed in the plants, in 20 particular those formed in the plants by the genetic material from Bacillus thuringiensis (for example by the genes CrylA(a), CrylA(b), CryIA(c), CryIIA, CryIIIA, CryflIB2, Cry9c, Cry2Ab, Cry3Bb and CryIF and also combinations thereof) (referred to hereinbelow as "Bt plants"). Traits that are also particularly emphasized are the increased defence of the plants against fungi, bacteria and viruses by systemic acquired resistance (SAR), systemin, phytoalexins, elicitors and resistance genes and 25 correspondingly expressed proteins and toxins. Traits that are flrthermore particularly emphasized are the increased tolerance of the plants to certain herbicidally active compounds, for example imidazolinones, sulphonylureas, glyphosate or phosphinotricin (for example the "PAT" gene). The genes which impart the desired traits in question can also be present in combination with one another in the transgenic plants. Examples of "Bt plants" which may be mentioned are maize varieties, cotton 30 varieties, soya bean varieties and potato varieties which are sold under the trade names YIELD GARD@ (for example maize, cotton, soya beans), KnockOut@ (for example maize), StarLink@ (for example maize), Boligard@ (cotton), Nucotn@ (cotton) and NewLeaf@ (potato). Examples of herbicide-tolerant plants which may be mentioned are maize varieties, cotton varieties and soya bean varieties which are sold under the trade names Roundup Ready@ (tolerance to glyphosate, for 35 example maize, cotton, soya beans), Liberty Link@ (tolerance to phosphinotricin, for example oilseed rape), IM1I@ (tolerance to imidazolinones) and STS@ (tolerance to sulphonylureas, for example maize). Herbicide-resistant plants (plants bred in a conventional manner for herbicide tolerance) WO 2007/144100 -39 - PCT/EP2007/005016 which may be mentioned include the varieties sold under the name Clearfield@ (for example maize). Of course, these statements also apply to plant cultivars having these genetic traits or genetic traits still to be developed, which plant cultivars will be developed and/or marketed in the future. The plants listed can be treated according to the invention in a particularly advantageous manner with 5 the compounds of the general formula I and/or the active compound mixtures according to the invention. The preferred ranges stated above for the active compounds or mixtures also apply to the treatment of these plants. Particular emphasis is given to the treatment of plants with the compounds or mixtures specifically mentioned in the present text. The active compounds according to the invention act not only against plant, hygiene and stored 10 product pests, but also in the veterinary medicine sector against animal parasites (ecto- and endoparasites), such as hard ticks, soft ticks, mange mites, leaf mites, flies (biting and licking), parasitic fly larvae, lice, hair lice, feather lice and fleas. These parasites include: From the order of the Anoplurida, for example, Haematopinus spp., Linognathus spp., Pediculus spp., Phtirus spp., Solenopotes spp. 15 From the order of the Mallophagida and the suborders Amblycerina and Ischnocerina, for example, Trimenopon spp., Menopon spp., Trinoton spp., Bovicola spp., Werneckiella spp., Lepikentron spp., Damalina spp., Trichodectes spp., Felicola spp. From the order of the Diptera and the suborders Nematocerina and Brachycerina, for example, Aedes spp., Anopheles spp., Culex spp., Simulium spp., Eusimulium spp., Phlebotomus spp., Lutzomyia 20 spp., Culicoides spp., Chrysops spp., Hybomitra spp., Atylotus spp., Tabanus spp., Haematopota spp., Philipomyia spp., Braula spp., Musca spp., Hydrotaea spp., Stomoxys spp., Haeratobia spp., Morellia spp., Fannia spp., Glossina spp., Calliphora spp., Lucilia spp., Chrysomyia spp., Wohlfahrtia spp., Sarcophaga spp., Oestrus spp., Hypoderma spp., Gasterophilus spp., Hippobosca spp., Lipoptena spp., Melophagus spp. 25 From the order of the Siphonapterida, for example, Pulex spp., Ctenocephalides spp., Xenopsylla spp., Ceratophyllus spp. From the order of the Heteropterida, for example, Cimex spp., Triatoma spp., Rhodnius spp., Panstrongylus spp. From the order of the Blattarida, for example, Blatta orientalis, Periplaneta americana, Blattela 30 germanica, Supella spp. From the subclass of the Acari (Acarina) and the orders of the Meta- and Mesostigmata, for example, Argas spp., Ornithodorus spp., Otobius spp., Ixodes spp., Amblyomma spp., Boophilus spp., WO 2007/144100 -40 - PCT/EP2007/005016 Dermacentor spp., Haemophysalis spp., Hyalomma spp., Rhipicephalus spp., Dermanyssus spp., Raillietia spp., Pneumonyssus spp., Sternostoma spp., Varroa spp. From the order of the Actinedida (Prostigmata) and Acaridida (Astigmata), for example, Acarapis spp., Cheyletiella spp., Ornithocheyletia spp., Myobia spp., Psorergates spp., Demodex spp., 5 Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodectes spp., Pterolichus spp., Psoroptes spp., Chorioptes spp., Otodectes spp., Sarcoptes spp., Notoedres spp., Knemidocoptes spp., Cytodites spp., Laminosioptes spp. The active compounds of the formula (I) according to the invention are also suitable for controlling arthropods which infest agricultural productive livestock, such as, for example, cattle, sheep, goats, 10 horses, pigs, donkeys, camels, buffalo, rabbits, chickens, turkeys, ducks, geese and bees, other pets, such as, for example, dogs, cats, caged birds and aquarium fish, and also so-called test animals, such as, for example, hamsters, guinea pigs, rats and mice. By controlling these arthropods, cases of death and reduction in productivity (for meat, milk, wool, hides, eggs, honey etc.) should be diminished, so that more economic and easier animal husbandry is possible by use of the active compounds 15 according to the invention. The active compounds according to the invention are used in the veterinary sector and in animal husbandry in a known manner by enteral administration in the form of, for example, tablets, capsules, potions, drenches, granules, pastes, boluses, the feed-through process and suppositories, by parenteral administration, such as, for example, by injections (intramuscular, subcutaneous, intravenous, 20 intraperitoneal and the like), implants, by nasal application, by dermal use in the form, for example, of dipping or bathing, spraying, pouring on and spotting on, washing and powdering, and also with the aid of moulded articles containing the active compound, such as collars, car marks, tail marks, limb bands, halters, marking devices and the like. When used for cattle, poultry, pets and the like, the active compounds of the formula (1) can be used 25 as formulations (for example powders, emulsions, free-flowing compositions), which comprise the active compounds in an amount of from 1 to 80% by weight, directly or after 100 to 10 000-fold dilution, or they can be used as a chemical bath. It has furthermore been found that the compounds according to the invention also have a strong insecticidal action against insects which destroy industrial materials. 30 The following insects may be mentioned as examples and as preferred - but without any limitation: Beetles, such as Hylotrupes bajulus, Chlorophorus pilosis, Anobium punctatum, Xestobium rufovillosum, Ptilinus pecticornis, Dendrobium pertinex, Ernobius mollis, Priobium carpini, Lyctus bmrnneus, Lyctus africanus, Lyctus planicollis, Lyctus linearis, Lyctus pubescens, Trogoxylon WO 2007/144100 -41 - PCT/EP2007/005016 aequale, Minthes rugicollis, Xyleborus spec. Tryptodendron spec. Apate monachus, Bostrychus capucins, Heterobostrychus brunneus, Sinoxylon spec. Dinoderus minutus; Hymenopterons, such as Sirex juvencus, Urocerus gigas, Urocerus gigas taignus, Urocerus augur; Termites, such as Kalotermes flavicollis, Cryptotennes brevis, Heterotermes indicola, Reticulitermes 5 flavipes, Reticulitermes santonensis, Reticulitermes lucifugus, Mastotennes darwiniensis, Zootermopsis nevadensis, Coptotermes formosanus; Bristletails, such as Lepisma saccharina. Industrial materials in the present connection are to be understood as meaning non-living materials, such as, preferably, plastics, adhesives, sizes, papers and cardboards, leather, wood and processed 10 wood products and coating compositions. The ready-to-use compositions may, if appropriate, comprise further insecticides and, if appropriate, one or mom fungicides. With respect to possible additional additives, reference may be made to the insecticides and fungicides mentioned above. 15 The compounds according to the invention can likewise be employed for protecting objects which come into contact with saltwater or brackish water, in particular hulls, screens, nets, buildings, moorings and signalling systems, against fouling. Furthermore, the compounds according to the invention, alone or in combinations with other active compounds, may be employed as antifouling agents. 20 In domestic, hygiene and stored-product protection, the active compounds are also suitable for controlling animal pests, in particular insects, arachnids and mites, which are found in enclosed spaces such as, for example, dwellings, factory halls, offices, vehicle cabins and the like. They can be employed alone or in combination with other active compounds and auxiliaries in domestic insecticide products for controlling these pests. They are active against sensitive and resistant species 25 and against all developmental stages. These pests include: From the order of the Scorpionidea, for example, Buthus occitanus. From the order of the Acarina, for example, Argas persicus, Argas reflexus, Bryobia ssp., Dermanyssus gallinae, Glyciphagus domesticus, Ornithodorus moubat, Rhipicephalus sanguineus, Trombicula alfreddugesi, Neutrombicula autumnalis, Dennatophagoides pteronissimus, 30 Dermatophagoides forinae.

WO 2007/144100 -42- PCT/EP2007/005016 From the order of the Araneae, for example, Aviculariidae, Araneidae. From the order of the Opiliones, for example, Pseudoscorpiones chelifer, Pseudoscorpiones cheiridium, Opiliones phalangium. From the order of the Isopoda, for example, Oniscus asellus, Porcellio scaber. 5 From the order of the Diplopoda, for example, Blaniulus guttulatus, Polydesmus spp. From the order of the Chilopoda, for example, Geophilus spp. From the order of the Zygentoma, for example, Ctenolepisma spp., Lepisma saccharina, Lepismodes inquilinus. From the order of the Blattaria, for example, Blatta orientalies, Blattella germanica, Blattella asahinai, 10 Leucophaca maderne, Panchlora spp., Parcoblatta spp., Periplaneta australasiae, Periplaneta americana, Periplaneta brunnea, Periplaneta filiginosa, Supella longipalpa. From the order of the Saltatoria, for example, Acheta domesticus. From the order of the Dermaptera, for example, Forficula auricularia. From the order of the Isoptera, for example, Kalotermes spp., Reticulitermes spp. 15 From the order of the Psocoptera, for example, Lepinatus spp., Liposcelis spp. From the order of the Coleoptera, for example, Anthrenus spp., Attagenus spp., Dermestes spp., Latheticus oryzae, Necrobia spp., Ptinus spp., Rhizopertha dominica, Sitophilus granarius, Sitophilus oryzae, Sitophilus zeamais, Stegobium paniceum. From the order of the Diptera, for example, Aedes aegypti, Aedes albopictus, Aedes taeniorhynchus, 20 Anopheles spp., Calliphora erythrocephala, Chrysozona pluvialis, Culex quinquefasciatus, Culex pipiens, Culex tarsalis, Drosophila spp., Fannia canicularis, Musca domestic, Phlebotomus spp., Sarcophaga camaria, Simulium spp., Stomoxys calcitrans, Tipula paludosa. From the order of the Lepidoptera, for example, Achroia grisella, Galleria mellonella, Plodia interpunctella, Tinea cloacella, Tinea pellionella, Tineola bisselliella. 25 From the order of the Siphonaptera, for example, Ctenocepbalides canis, Ctenocephalides felis, Pulex irritans, Tunga penetrans, Xenopsylla cheopis. From the order of the Hymenoptera, for example, Camponotus herculeanus, Lasius flliginosus, Lasius niger, Lasius umbratus, Monomorium pharaonis, Paravespula spp., Tetramorium caespitum.

WO 2007/144100 - 43 - PCT/EP2007/005016 From the order of the Anoplura, for example, Pediculus humanus capitis, Pediculus hurnanus corporis, Pemphigus spp., Phylloera vastatrix, Phthirus pubis. From the order of the Heteroptera, for example, Cimex hemipterus, Cimex lectularius, Rhodinus prolixus, Triatoma infestans. 5 In the field of domestic insecticides, they are used alone or in combination with other suitable active compounds, such as phosphoric esters, carbamates, pyrethroids, neonicotinoids, growth regulators or active compounds from other known classes of insecticides. They are used in aerosols, unpressurized spray products, for example pump and atomizer sprays, automatic fogging systems, fogges, foams, gels, evaporator products with evaporator tablets made of 10 cellulose or polymer, liquid evaporators, gel and membrane evaporators, propeller-driven evaporators, unenergized, or passive, evaporation systems, moth papers, moth bags and moth gels, as granules or dusts, in baits for scattering or in bait stations. The preparation and use examples below provide an illustration of the invention, without restricting 15 it.

WO 2007/144100 -44 - PCT/EP2007/005016 Preparation examples Example 5-(3.5-Bis-trifluoromethylpyrazol-l -vlmethyl)-2-(3-chloropyidin-2-vfl-2H-nvrazole-3-carboxylic acid 4-chloro-2-methyl-6-methylcarbamovlhenvl amide (1-1-1): 5 First 300 mg (509 pmol) of 2-[5-(3,5-bistrifluoromethylpyrazol-1-ylmethyl)-2-(3-chloropyridin-2 yl)-2H-pyrazol-3-yl]-6-chloro-8-methyl-benzo[d][1,3]oxazin4-one are introduced in 3.3 ml of tetrahydrofuran and this initial charge is admixed dropwise with 764 I (1.53 mmol) of a 2 M solution of methylamine in tetrahydrofuran. The mixture is stirred at 50"C for 1 I and then cooled, the solvent is removed in vacuo and the residue is purified on silica gel (cyclohexane/ethyl 10 acetate =2:1 -. 1:1). Yield: 200 mg (logP: 3.67) In analogy to the example given above (I-1-1) and also to the general description, the following compounds of the formula (I-1) are obtained. R NR R4 0 N R R A N'N k/ R7 15 Table 1 No. R' R' RR' R' A Q X R' logP 1-1-2 H H i-Pr Cl CH 3

CH

2 ca F N Cl 4.08 CF, N 1-1-3 H H CH 3 CI CH 3

CH

2 N / N Cl 4.39 F~c 2 cy, WO 2007/144100 -45 - PCT/EP2007/005016 No. R' RR R' Rs A Q X R logP I N 1-1-4 H H CH 3 Cl CH 3

CH

2 N CI 2.54 Cl 1-1-5 H H i-Pr Cl CH 3

CH

2 CN I CF N Cl 3.88

CF

3 N 1-1-6 H H i-Pr Cl CH 3

CH

2 CF N Cl 3.27 c N 1-1-7 H H i-Pr Cl CH 3

CH

2 N Cl 2.70 F N 1-1-1 H H i-Pr Cl CH 3

CH

2 Nq N Cl 2.57 C14 1-1-9 H H i-Pr Cl CH 3 CH2 N N Cl 2.45 NC F CF, 1-1-10 H H f-Pr Cl CH 3

CH

2 N , CH Cl 4.70 F,C 9 N I-1-14 H H i-Pr Cl CH 3

CH

2 F C/, N CI 4.29 I N 1-1-12 H H i-Pr CI CH 3

CH

2 N ,N CI 4.8

FC

2 R F, t N 1-1-13 H. H i-Pr Br CH 3

CH

2 CF $4,c N Cl 4.8 WO 2007/144100 - 46 - PCT/EP2007/005016 No. R' .RR3 R' Rt A Q X R' logP t 1-1-16 H H CH Cl CHI, CH 2 N Cl 3.79 N 1-1-17 H H CH, Cl CHI CH 2 CN C 3.35 1-1-18 H H i-Pr Cl CHi C 2 N Cl 3.75 F,C, I 1-1-19 H H C-I Cl CH, CH 2 >i N Cl 3.29 FC N N 2. 1-1-20 H H i-Pr Br CH CHH2 CF" N Cl 4.25 CF I 1-1-21 H H i-Pr Br CH CH 2 N CF.0 I-1-5 H H C 3 Br CH3 CH2F CaN C 1 4.39 I-1-26 H H CH3r C1 CHI CH2 CF N C1 4.07 CNF I 1-1-23 H H i-Pr Cr CHI CH2 >Y-CF. N Cl 4251 I N\ N% 1-1-24 H H OHr Br CHI Cl! 2 ,~ /C3 N CI 4.25 I 1-1-26 H H CHI CI CH, Gil 2 NiiNCA N Cl 4.17 C2 5 I 1-1-27 H H CR, CI CH, CH 2 \ /f N CI 4.17

CF

6

.

WO 2007/144100 -47- PCT/EP2007/005016 No. R R' RiiR Ri A Q X R logP C2F

CF

3 1 1-1-29 H H i-Pr CI CH 3

CH

2 Nr CF N Cl 4.64 CF, N 1-1-30 H H CH 3 Cl CH 3

CH

2 N C 3.77 F,C, Ci I N 1-1-31 H H i-Pr Cl CH 3

CH

2 N Cl 4.21 F,C, CI I 1-1-32 H H CH 2 CN Cl CH 3

CH

2 ) N CI 3.70 FC, c I 1-1-33 H H CH 2 CN Br CH 3

CH

2 N\ \N CI 4.28

FSC

2 CF, I N 1-1-34 H H CH 3 Cl CH 3

CH

2 F,CN Br N CI 3.80 I-1-35~~~~ H H CHSlC3 C2 Fr 134 t CF 1-1-36 H H CH 3 Br CH 3

CH

2 N CF N Cl 3.52 CF 3 1-1-37 H H i-Pr Br CH 3

CH

2 NCF' N Cl 4.73 COF 1-1-38 H H CH 3 Cl CHA 3

CH

2 N N Cl 3.28 N=N 1-1-39 H H CH 3 Br CH 3

CH

2 CF CF' N Cl 4.31 C2 5 WO 2007/144100 -48- PCT/EP2007/005016 No. R' R2 RI R' R5 A Q X R logP t 1-1-40 H H i-Pr Cl CH 3

CH

2 C C- CCI Cl 4.58 CFC NIN 1-1-41 H H CF 3 C CH 3 CH2 CCI Cl 4.13 CFC N 1-1-42 H H CH 3 Cl CH 3

CH

2 NQ N Cl 2.76 CF, N 1-1-43 H H i-Pr Cl CH 3 CH2 N Cl 3.20 CF, I N 1-1-44 H H CH 3 Cl CH 3

CH

2 C 5s C2 N Cl 2.92 1-1-45 H H CH 3 Cl CH 3

CH

2 N C N Cl 2.67 t N 1-146 H H c-Pr Cl CH 3

CH

2 N N CI 4.58 FC 9CF I N 1-1-47 H H CHCN CI CH 3

CH

2 NN Cl 4.31

F

5

C

2

C

2 F, t N 1-1-48 H H H CI CR 3

CF!

2 N NC 15

F

5

C

2 CAP 1 1-1-49 H1 H CH2CN CI CF! 3

CR

2 N y ,CF 3 N CI 3.97

CF

3 1-1-50 H H H CI CF! 3

CF!

2 NtN'CFI N CI 3.88 1-1-51 H H i-Pr Cl CH 3 012 NAJXN N CI 3.52

N=N

WO 2007/144100 -49- PCT/EP2007/005016 No. R' RI2 Ri Ri R A Q X R 7 logP 1-1-52 H H c-Pr Br CH 3 CH2 i N CI 4.59

F

5

C

2

C

2 F5 1-1-53 H H H Br CH 3 CH2 IN N Cl 4.17

F

6

C

3

C

2

F

5 1-1-54 H H c-Pr Br CH3 CH2 C I CF- N CI 3.61 I, N CF/ 3 I-158 HCH3 Br ~ACH2CF CF' N CI 3.40 1-1-55 H H CH 2 CN C CH 3 CH2 C Na CF' N C 3.65 CF? 1-1-56 H H CHCN Br CH 3 CH2 - Ci, N CI 3.44

CF

3 NIN 1-1-57 H H4 Cl-I Br CH 3 CH2 /C, N C 3.7

CF

3 1 1-1-59 H H CH3C Br CH 3 CH2I N/ CF, N Cl 3.6 CFY 3 1-1-60 H H c-Pr Br CH 3 CH, /iii F N Cl 3.91

CF

3 1-1-62 H H CH Br CH 3 Cl-, 2 N CI 3.53 CA 1-1-63 H H i-Pr Cl CH 3 Cl-I N Cl 3.85

CA

WO 2007/144100 -50- PCT/EP2007/005016 No. R' R2 R R' R 5 A Q X R 7 logP N 1-1-64 H H CH 3 Cl CH 3

CH

2

N

4 N Cl 3.21 CF N 1-1-65 H H i-Pr CI CH 3

CH

2

N

4 N Cl 3.67 CaF5 t N 1-1-66 H H CH 3 Cl CH 3

CH

2 N Cl 3.38 FC Br I N 1-1-67 H H i-Pr Ci CH 3

CH

2 N Cl 3.78 FC Br I N 1-1-68 H H CH 3 Br CH 3

CH

2 N N Cl 3.46 FaC Br 1-1-69 H H i-Pr Br CH 3

CH

2 N Cl 3.92

F

3 C Br N 1-1-70 H H CH 3 Br CH 3

CH

2 N CI 3.94

FSC

2 Cl 1 N 1-1-71 H H i-Pr Br CH 3

CH

2 N Cl 4.40 F,C, CI I-1-72 H H CH2CN Br CU 3

CH

2 FC ClN CI 4.14 I N 1-1-74 H H H Br CH 3

CH

2 NN C 3.68

F

5 2 Cl 1-1-75 H H CH ) Cl CH 3

CH

2 NCF N Cl 4.04

C

WO 2007/144100 -51 - PCT/EP2007/005016 No. R' R' R 3 R R 5 A Q X R 7 logP 1-1-76 H H CHf:S C1 CH, CH2 ' N C 4.49 CF/ (S)-CH(CH3) 1-1-77 H H CH20(C--0) Cl CH CH2 N, /rCF' N Cl 3.58

NHC

2

H

5 CF/XN (S)-CH(CH3) 1-1-78 H H CH20(0=0) Cl CH3 CH 2 N CF\ N C1 3.36 NHCH3 CFr7N 1 1-1-79 H H CH2CN Cl CH3 CH 2 C CF' N Cl 3.62 N 1-1-80 H H CH, Br CH3 CH 2 N N Cl 2.99

F

3 C N 1-1-81 H H i-Pr Br CH3 CH 2 N N Cl 3.46 F3C N 1-1-82 H H c-Pr Br CH3 CH 2 N N Cl 3.18 FC 1-1-83 H H H Br CH3 CH 2 N N Cl 2.75 FC IN 1-1-84 H H ()BCH)H CH, OH 2 CF3 CF N C1 3.62 1-1-85 H H CH 2 CN Br CH, CH 2 N N CI 2.98

F

a C -1-1-86 H H CH3 Cl CH3 CH 2 FC CF, N CI 3.78 (-1-87 H H H 3 H CH3 CH2 C IN N CI 2.92 1--8 H H H 2

SO

2 OH, H OH!OH WO 2007/144100 -52 - PCT/EP2007/005016 No. R' Re RR R 5 A Q X iR logP I-1-88 H H CH 3 Cl CH 3

CH

2 N N. CF N Cl 3.61 N=N 1-1-89 H H i-Pr Cl CH 3

CH

2 NC)l N N Cl 3.96 % I N=N 1-1-90 H H CH 3 Cl CH 3

CH

2 NA NN Cl 4.08 N=N CF,

CF

3 1-1-91 H H i-Pr Cl CH 3

CH

2 N N CI 4.51 N=N CF, 1-1-92 H H (S&H(CH 3 ) H CH 3

CH

2 cF CF N Cl 2.65

CH

2

SOCH

3

C

3 1 1-1-93 H H c-Pr Br CH 3

CH

2 N N Cl 3.69 FC Br CF, 1-1-94 H H H Cl CH 3

CH

2 N N Cl 3.85 NN CF 3 1-1-95 H H CH 2 CN Cl CH3 CH 2 N Cl 4.01 N=N CF, 1-1-96 H H CH 3 Cl CH 3

CH

2 IN, N Cl 3.90 N=N Cl I 1-1-97 H H CH 2 CN Br CH 3

CH

2 N N Cl 3.45 FC Br I-1-98 H H (C3 Br CH3 CH2 N N Cl 4.47 F,C Br 1-1-99 H H CHCH Br CH 3

CH

2 N C1 4.10 FC Br WO 2007/144100 -53- PCT/EP2007/005016 No. R' R2 Ri R 4 Ri A Q X R log I I-1-100 H H H Br CH 3

CH

2 N N Cl 3.24 FC Dr I 1-1-101 H H C H Br CH3 CH2 N N Cl 3.32 FrC Or t N 1-1-102 H H CH 3 Cl CH 3

CH

2 C N Cl 2.51 N 1-1-103 H H i-Pr CI CH 3

CH

2 N Cl 2.96 1-1-104 H H CH 3 Cl CH 3

CH

2 N N CF N C 3.79 1-1-105~~~~ H -r lC3 H N N C1 4.74 N=N 1-1-107 H H CH2CN Cl C3 CH2 "N NCF, 136 1-1-105 H H i-Pr Cl CH 3

CH

2 N N ' C N CI 4.14 N=N 1-1-106 H H H Cl CH 3

CH

2 *NN CF N Cl 3.46 N=N 1-1-107 H H CHCN CI CH 3

CH

2 N Cl 3.65 NNN 1-1 -108 H H CH 3 Cl CR 3

CH

2 t N N l39 N0 CF, 1-1-109 H H CR 3 Cl CR 3

CH

2 "'N N N N Cl 3.51 N=N Cl I-1-110 H H CH 3 Cl CR 3

CM

2 NN CI 3.13 I-1-1ll H H i-Pr Cl CH 3

CH

2 N CI 3.58 WO 2007/144100 -54- PCT/EP2007/005016 No. R' R 2 R R 4 RV A Q X i IogP CF, 1-1-112 H H CH 3 Cl CH 3

CH

2 N N Cl 4.28 N=N CF, t 1-1-113 H H CHCH 3 Br CH 3

CH

2 N N Cl 2.97 F,C Br

,F

3 1-1-114 H H H Cl CH 3

CH

2 N Cl 4.03 N=N CF 3 0 1-1-115 H H i-Pr Cl CH 3

CH

2 N N--- N CI 2.31 % i N=N 1-1-116 H H CH 3 Cl CH 3

CH

2 N N' N CI 2.44

CF

3 0 1-1-117 H H i-Pr Cl CH 3

CH

2 N N' N Cl 2.85 NA=

CF

3 0 1-1-118 H H CH 3 Cl CH 3

CH

2 ' ' N Cl 3.10 CF, 1-1-119 H H i-Pr Cl CH 3

CH

2 IN N N CI 3.54 N CF,

(S)-CH(CH

3 ) 1-1-120 H H CH2SO(=NH) Cl CH 3

CH

2 N CF N Ci 2.75 CH CF N I 1-1-121 H H CH2SO rH 3

CH

3

CH

2 N N CI 3.57 FC Br 1-1-122 H H CH 3 Cl CH 3

CH

2 N CF, N Cl 2.51 N=N 1-1-123 H H i-Pr Cl CH 3

CH

2 -N N-C N CI 2.92 N =

CF

3 N N WU UU //1441UU - X3 - rYUlLr4UU//UvUoU] No. R' lR R' R 4 R A Q X R logP 1-1-124 H H (S)-CH(CHC) CH CH 2 N NC N Cl 3.13 CR, SCH3

CF

3 N=N 1-1-125 H H CH 3 Cl CH 3

CH

2 N Cl 2.56 1-1-126 H H i-Pr Cl CH3 CH2 .N 1 4 N Cl 3.18 IN= CF, 1-1-127 H H CH3 Cl CH3 CH2 N Cl 2.74 CF, N 1-1-128 H H CH2SOC3 Cl CH, CH2 N C 3.25 F,C Br I 1-1-129 H H CHHCH) C[ CHI CH2 N N Cl 3.27 1-1-130 H H Cl CH3 CH2 N N Cl 4.11 F,C Br I N 1-1-131 H H HHC Cl CH CH2 N N Cl 4.48 FC Br I N 1-1-132 H H CH3 Cl CH3 CH2 N Cl 2.39

CF

3 1-1-133 H H i-Pr Cl CH3 CH2 N Cl 2.77 CF, 1-1-134 H H C(CH) Br CH3 CH2 CF N C 4.63 CHBSC rC CF' N C 4.2 3 ~CF 3 T 1-1-135 H H (S)-H(CH,) Br CR, CH2 ,C N CI 4.24 CH2SCH3CF 3 WV 2007/144100 - 56 - PCT/EP2007/005016 No. R' R2 R 3 R' Rt A Q X R' ogP t 1-1-136 H H CH2SOCH 3 Cl CH 3

CH

2 N N Cl 3.23

F

3 C Br 1 1-1-137 H H C CH 3

CH

2 N Cl 3.22 ra B I 1-1-139 H H (SCH(CH 3 ) Cl CH 3

CH

2 C C N Cl 3.50 I-1-140 H H CH 2

SOCH

3 B2N C 2.9

F

3 C Br 1 1-1-139 H H CSH3 Br CH 3 CH2 N CF3 N Cl 3.67 I--43H H CH2SC3B H H ~ F N Cl 3.20 I--14 H C2SO2CH3 BrC, C2CF3Cj C 33 Ct 1-1-140 H H (SCH(CH 3 ) Br CH 3

CH

2 N N Cl 3.05 CF, 1111H H (S)-CH(CH 3 ) N~e, i 1111H H CHSO 2

CH

3 ClC3 C2pN Cl 3.26

F

3 C Br 1 I-1-142 H H H O Br CH3 CH 2 C A CF' N CI 3.67 CFN 1-1-143 H H c( 5

C

1 &i, Br CH 3

CE!

2

N)

4 y/CF N CI 3.20 1-1-144 H H C 2

SCH

3 Br CH 3

CE!

2 N rF CF, I 1-1-145 H H ClC3) CN lI I 35 F,C Br t 1-1-146 H H (S)-H(CH 3 ) BrC3 C2N NN F

CHSOCH

3 Br CN 3

C!

2 > CI 3.36 CF, 1-1-147 H H (S)-CH(CH 3 ) N.NrOF, I29

CH

2

SOCH

3 Cl CH 3

CU

2 N l29 CF3 WO 2007/144100 -57- PCT/EP2007/005016 No. R' R2 Rt R' R A Q X RI logP 1-1-148 H H CH 3 Cl CH 3

CH

2 N N Cl 2.91 N=N 1-1-149 H H i-Pr CI CH 3

CH

2 N I N Cl 3.41 N=N 1-1-150 H H CH 3 Cl CH 3

CH

2 N N .r N Cl 3.70 N=N 1-1-151 H H i-Pr Cl CH 3

CH

2 NB\ r N C 4.20 N=N 1-1-152 H H H Cl CH3 CH2 N Br N CI 4.41

CH

2

SCH

3 x N=N 1-1-153 H H CH 3 Cl CH 3

CH

2 -N CK N Cl 3.07 1-1-154 H H i-Pr Cl CH 3

CH

2 tN Ij N Cl 3.56 1-1-155 H H CH 3 CI CH 3

CH

2 N, N C 3.69 N=N Cl c, 1-156 H H i-Pr Cl CH 3

CH

2 N N Cl 4.17 N=N CI 1-1-157 H H CSCM Cl CH 3

CH

2 N C N Cl 4.36 1-1-158 H H (-H(C 3 )CI CH 3

CH

2 NN CI 3.67

CH

2

SCH

3 N I N=N c 1-1-159 H H (S)-CH(CH 3 ) CH 3

C

2 NN N C 3.78

CH

2

SCH

3

-N

WO 2007/144100 -58- PCT/EP2007/005016 No. R R R' R' A Q X Rl IogP 1-1-160 H H CH 3 Cl CH 3 CH2 N N Cl 2.39 1-1-161 H H i-Pr Cl CH3 CH 2 N N Cl 2.87 1-1-162 H H (S)-CH(CH 3 ) C CH 3

CH

2 NN C 3.10

CHSCH

3 C C H2C N Cl 3.15 N I 1-1-164 H H CH I CR 3 CH2 N )-jIN CI 3.15 N-N 1-1-164 H H NH[S(=O)-P N CI 3.35

N(CH

3 )2 CIOH CR 2 N/NC 33 CA; 1-1-165 H H CH 3 Cl CIII CR 2 4 pN roN CI 3.09 N=N 1-1-166 H H i-Pr Cl CH3 CH 2 C1 N Cl 3.60 N=N I 1-1-167 H S(i-Pr) 2 C CH 3 CH2 NCF N Cl 4.44 FA, F I-1-170~~~~~ H H NC3 H 140 1-1-168 H H i-Pr Cl CH 3 CH2 N N. N N Cl 3.79 F I N=N I N 1-14169 H H i-Pr CN 0113 OR, N4 N Cl 4.55 FA CAF I N 1-1-170 H H OH, ON OH, CI, N4NCI40

F

2 C2F, I N 1-1-171 H H OH3 ON CR, 0112 N4NCl34 F,; PCI l34 WO 2007/144100 -59- PCT/EP2007/005016 No. R' R2 Ri RR Re A Q X R 7 IogP I N 1-1-172 H H i-Pr CN CH 3

CH

2 N Cl 3.87 FSC, CI I 1-1-173 H H c-Pr CN CH 3

CH

2 F N Cl 3.59

F

5 ;P CI I N 1-1-174 H H H CN CH 3

CH

2 FN C 3.20 N 1-1-175 H H CH 2 CN CN CH 3

CH

2 N N Cl 3.40

F

5 C, Cl I 1-1-176 H H CH 3 CN CH 3

CH

2 N CF N CI 3.11 1-1-177 H H i-Pr CN CH 3

CH

2 N N CI 3.53 1-1-178 H H c-Pr CN CH 3

CH

2 NC N Cl 3.31 CF, 1-1-179 H H H CN CH3 CH2 CF.yCFa N Cl 2.91 I-1-180 H H CH2CN CN CH 3

CH

2 C N CF3 N Cl 3.11 1-1-181 H H CH 3 CN CH 3

CH

2 C~ N Cl 2.57 CF, 1 1-1-182 H H i-Pr CN CH 3

CH

2 CF N Cl 2.96 CFN N 1-1 -1 83 H H c-Pr CN CE! 3

CE!

2 NN Cl 2.75

CF,)

WO 2007/144100 -60- PCT/EP2007/005016 No. R R2 RR 4 R5 A Q X R' logP N 1-1-184 H H H CN CH 3

CH

2 N Cl 2.42 CFa N 1-1-185 H H CH 2 CN CN CH 3

CH

2 CF N Cl 2.62 3 1-1-186 H H CH3 CN CH3 CH 2 / CF3 N Cl 3.35 CF, c 1-1-187 H H i-Pr CN CH3 CH 2 CFa N CI 3.80 CF. 1-1-188 H H c-Pr CN CH3 CH 2 CF CF N C 3.56

CF

3 1-1-189 H H H CN CH3 CH2 C\ CFa N Cl 3.15 1-1-190 H H CH2CN CN CH CH 2 F C N C1 3.28 CF3, I 1-1-191 H H c-Pr CN CH3 CH 2 N N Cl 4.29

F

5 C, C2F I 1-1-192 H H H CN CH3 CH2 N N Cl 3.91 FC CF, I N 1-1-193 HI H CH2CN CN CHii CH2 N Cl 4.04 1-1-194 H Q CN CH3 CH 2 FN N Cl 2.18 NH pSO, N 1-1-195 H H CHSCH, F CH3 CH2 N C 4.13

FC

2

CI

WO 2007/144100 -61 - PCT/EP2007/005016 No. R' R R Rt Rt' A Q X RI logP -1-1196 H H F CH 3

CH

2 N CI 3.90 00-/~~,C C\/ N C 39 1-1-197 H H CN CH3 CH 2 N Cl 4.50 FA CI A N 1-1-198 H H OH CN CH3 CH2 N CI 3.11 _ N 1-1-199 H H -<c F CH 3 CH2 N N Cl 4.55 F,C, Ci 1-1-200 H NH F CH3 CH 2 FC2 )/ N CI 2.19 NH, FsCr CI I 1-1-201 H . H Cl CH3 CH 2 NN 4 00- N 01 4.21 F,C 'C I (N N 1-1-202 H H Cl CH 3

CH

2 N N Cl 2.30 NH, FCC CI T 1-1-203 H H A. OH F CH 3

CH

2 N C1 3.14 FC, CI 1 1-1-204 H H F CH3 OH 2 N C 4 -1-206 H H H) Cl CH 3

CH

2 N 01 4.88 FaC 2 ci I I-1-206 H H H H Cl CH3 CH2 N Cl 4.41

FC

2 C' I 1-1-207 H H AlOH Cl 0113 OH 2

N

5 CN A N CI 3.37 WO 2007/144100 - 62 - PCT/EP2007/005016 No. R' R1 Rt R' RI A Q X R' logP N 1-1-208 H H CN CH 3

CH

2 N N Cl 3.90

FC

2 CI I-1-209 H H CHCH CN CH 3 CH2 N C 4.05

FC

2 CI I-H CH(CH 3 N OH 3 CH N C . FC, PCl 1-1-210 H H H H C CH3 CH2 NN N Cl 3.34

F

5 C, ci 1-1-211 H H (S)-.L(CH3J CM CH3 CH2 N Cl 3.77 F,C, Cl I

(S)-CH(CH

3 ) N 1-1-212 H H Cl CH3 CH2 N CI 3.25

F

1 C CI 1-1-213 H H CHFCH CH CH2 F N Cl 3.60 I N 1-1-214 H H Cl CH CH2 N N CI 2.77 FC CF I 1-1-215 H H Cl CH 3 CH2 CF CF N Cl 2.62 -1-21 H H (S)-CH(CH 3 ) F CH3 CH2 N C 1--26 H CHSOCH, C\ AH N Cl 3.03 FC4P CI t 1-1-217 H H i-Pr F CH3 CH2 NI N CI 4.47 IN 1-1-218 H H i-Pr F OH 3 Cit 2 N rC3 N CI 3.55 N I CF 1-1-219 H H OH 3 F OH3 CR 2 k -N Cl 3.12

C;F?

WO 2007/144100 - 63 - PCT/EP2007/005016 No. R' lR RR 4 2R5 A Q X Rt' logP N 1-1-220 H H CH 3 F CH 3

CH

2 N Cl 4.06 F; C,F, 1-1-221 H H CH 3 F CH 3

CH

2 Ca/ N Cl 3.32

CF

3 N 1-1-222 H H CH 3 F CH 3

CH

2 N C1 2.58 CFa 1-1-223 H H CH 3 F CH 3

CH

2 N N Cl 3.47 1-1-224 H H i-Pr F CH 3

CH

2 >N C1 3.89 FC' CI I-1-225 H H f-Pr F CH 3

GCH

2 CF C/ N Cl 3.77 N 1-1-226 H H i-Pr F CH 3

CH

2 C;a N Cl 3.00 1-1-227 H H GCl 3 I CH 3 Cit 2 Ca F*N CI 3.87 1-1-228 H H C 2

H

1 I CH 3

CH

2 C\ /~ N Cl 4.06 I-1-229 H H n-Pr I CH 3

CH

2 C / Ca N CI 4.33 I-1 -230 H H i-Pr I GCH 3

CH

2 CF CF N CI 4.29 1-1-231 H H c-Pr I CH 3

CH

2 / CF3 N Cl 4.01

CF,

WO 2007/144100 - 64 - PCT/EP2007/005016 No. R' R R 4 A Q X R logP 1-1-232 H H CH 2

CF

3 I CH 3

CH

2 C CF N Cl 5.28

CF

3 1-1-233 H H I CH3 CH 2 NCF CF* N Cl 4.55 'I 3 1-1-234 H H H I CH3 CH 2 C CF, N Cl 3.56 CF, 1-1-235 H H I CH, CH2 C /a CF' N Cl 4.34 1-1-236 H H I CH3 CH 2 N CF 3 N Cl 4.80 CF 1-1-237 H H CH3 I CH3 CH2 N (>CF* N Cl 3.60 I-1 -238 -H H i-Pr I CH3 CH2 CF >CF* N Cl 4.06 CF. 1-1-239 H H CH3 I CH3 CH2 N Cl 4.51 I N 1-1-240 H H i-Pr I CH3 CH2 N N Cl 4.96

FC

2 C 2 F 1 1-1-241 H H CH2CN I CH3 CH 2 C /N CF3 N Cl 3.73

CF

3 1-1-242 H H i-Pr I CH, CH 2 N Cl 4.40

F

5 C, Cl N 1-1-243 H H CH3 I CH3 CH 2 N Cl 3.96

F,C

2

CI

WO 2007/144100 -65 - PCT/EP2007/005016 No. R' R RlR R' A Q X R logP I- -244 H H C 2 Hs I CH 3 CH2 CF CF' N Cl 3.83 CF CN 1-1-245 H H CH 2 CN I CH 3

CH

2 frca N Cl 3.53 1-1-246 H H CH 2 CN I CH 3

CH

2 -C N C 3.85 5

C

2 PCT l38 1-1-247 H H C-P 3 I CH 3

CH

2 N Cl 3.05 CF N 1-1-248 H H i-Pr I CH 3

CH

2 CF N Cl 3.51 1-1-249 H H C-Pr I CH 3

CH

2 N Cl 3.27 CFa 1-1-250 H H C 2

H

5 I CH 3

CH

2 N\ N CI 3.28 OF, N 1-1-251 H H CH 2 CN I CH 3

CH

2 C F N CI 3.84 1-1-252 H H c-r I CH3 CH 2 N~ CF 3 N C 3.813 CFP 1-1-254 H H c I CH 3

CH

2 N /F N C1 4.1 CFCC 141-254 H H "V I CH 3

CR

2 >N N Cl 4.47 1-1-255 H H I CH 3

CH

2 ~ /N CI 3.60

CF,

WO 2007/144100 -66- PCT/EP2007/005016 No. R' Rz R3 R R 5 A Q X R! logP N 1-1-256 H CH 3

CH

3 I CH3 CH2 C N CI 3.84 F N 1-1-257 H H CH 3 Cl CH3 CH2 N F N Cl 2.92 F I F 1-1-258 H H i-Pr Cl CH13 CH2 N~/ F N CI 3.32 IN 1-1-259 H H i-Pr Cl CI CH 2 N F N CI 3.27 F NO. F } F 1-1-260 H H c-Pr CI CH 3 CH2 F N F N Cl 3.12 F N0 2 N 1-1-261 H H c-Pr Cl Cl CH 2 N I F N C1 3.08 F

NO

2 F 1-1-262 H H i-Pr Cl CH 3

CH

2 -- SNN Cl 2.31 -S N 1-1-263 H H c-Pr C1 CH3 CH 2 N I N CI 2.13 1-1-264 H H Cl CH 3 CH2 N N CI 2.39 -S 1-1-265 H H CH3 Cl CH3 CH2 NI N CI 1.94 -S N t F 1-1-266 H H CH 3 C] Cl CH2 F F N Cl 2.99 F NO, 1-1-267 H H i-Pr I CH3 CH 2 N Cl 3.67 IF

F

WO 2007/144100 -67- PCT/EP2007/005016 No. R' R' R 3 R Rs A Q X R IogP } F 1-1-268 H H c-Pr I CH 3

CH

2 N F N Cl 3.44 1-1-269 H H i-Pr Cl CH 3 CH2 N Cl 3.4 1-1-270 H H CH 3 Cl CH 3

CH

2 N\ / N Cl 2.95 -N 1-1-271 H H c-Pr Cl CH 3

CH

2 N Cl 3.17 1-1-272 H H H I CH 3

CH

2 CF CF N Cl 3.38 CF 3 /r 1-1-273 H H H I CH 3 CH2 CF N Cl 2.84 CFP 1 1-1-274 H H C2H 5 I CH 3

CH

2 N C 4.74 F,C, C2F T 1-1-275 H H c-Pr I CH 3

CH

2 N N Cl 4.71

FSC

2 C 2

F

5 I N 1-1-276 H H c-Pr I CH 3 CH2 N Cl 4.15

F

5 C CI I 1-1-277 H H C2H 5 I CH 3 CH2 N CI 4.17 FC; CI } F 1-1-278 H H CH 3 I CH 3 CH2 F N / F N Cl 3.25 NF C 1-1-279 H H I CH 3 CH2 F CF N Cl 4.47

JFN

wu Luu/1441uu -05- PCT/EP2007/005016 No. R R R R R A Q X Rr o 1-1-280 H H I CH 3

CH

2 CF CF N Cl 6.56 CF, 1-1-281 H H I CH 3

CH

2 N Cl 4.54 CF? 1-1-282 H H I CH 3

CH

2 CF CF, N Cl 4.18

CF

3 1-1-283 H H C 2 Hs I CH 3

CH

2 N I CFa N Cl 3.89 Cjt 1-1-284 H H I CH 3

CH

2 CF CF' N Cl 4.16 1-1-285 H H I CH 3

CH

2 N Cl 4.23 CF) C 1-1-286 H H I CH3 CH 2 F C2 N Cl 4.52 J N 1-1-287 H H I CHa CH 2 N Cl 4.69

F

5

C

2 CI 1-1-288 H H I CH 3

CH

2 N N C 4.40 I 1-1-289 H H kI CH 3

CF!

2 Ns>C N CI 4.63 1-1-290 H H OH 3 cl cl CH 2 N fN CI 3.40 1-1-291 H H i-Pr cl CI OH 2 N N CI 3.76 CF 3

-

WO 2007/144100 - 69- PCT/EP2007/005016 No. R' R' R 3 R R A Q X R log? T I-1-292 H H CH 2 CN CI Cl CH 2 N Cl 2.83 I-1-294 H H "-P C1 Cl CH2 N N CF3.0 F,C2 0F I-1-2963 H H H C C CH 2 C N Cl 3.22 CF/k I N 1-1-294 H H i-Pr CI Cl CH 2 4 N Cl 4.00 FC2 CF5 I 1-1-295 H H c-Pr Cl Cl CH 2 N \>CFS N Cl 2.95 C/ N 11-296 H H H C Cl CH C C N Cl 3.83 N 1-1-297 H H CH 3 CI CI CF! 2 >N Cl 3.59

F

5 CP ; 2C CA I 1-1-298 H H CHC CI Cl CF! 2 CF N CI 3.53 N 1-1-290 H H C-PrN CI Ci CH 2 N C N CI 3.59 'I c 3 1-1-301 H H i-Pr Cl Cl CR 2 7N Cl 2.60 0 1-1-302 H H H Cl Cl CF! 2 N CF, I28 1-1-303 H H CHCN Cl Cl CR 2 N C/ F, N Cl 2.98

CF,

WO 2007/144100 -70- PCT/EP2007/005016 No. R' R RR R' A Q X RW IogP 1-1-304 H H CH 3 Cl Cl CH2 CFC N Cl 3.01 1-1-305 H H i-Pr Cl Cl CH2 C C3 N Cl 3.40 CF, 1-1-306 H H CH 3 Cl Cl CH2 N Cl 2.18 N I-1-307 H H H Cl Cl CH2 FC C 129 1-1-308 H H CH- 3 CI CI CHA 2 N Cl 3.18

F.C

2 Cl T N 1-1-309 H H i-Pr Cl Cl CH2 N Cl 3.53 FC CI 2 N I-1-310 H H CHC Cl cl CH2 PN N Cl 3.13 F,C N I-1-312 H H CR 3 CI Cl CHA 2 CFN CI 2.37 1-1-313 H H CH2CN Cl Cl CH2 CF N Cl 2.43 CFP I 1-1-314 H H i-Pr Cl Cl CH2 CF N CI 2.7 C 3 N 1-1-315 H H c-Pr Cl CI CR 2 .N N Cl 2.54 c , WO 2007/144100 -71 - PCT/EP2007/005016 No. RI R' RiR Re A Q X R 7 logP 1-1-316 H H CH 3 Cl Cl CH 2 N Cl 1.03 1-1-317 H H i-Pr C1 Cl CH2 N Cl 1.31 N 1-1-318 H H i-Pr Cl Cl CH2 N N C1 1.62 1-1-319 H H H CI Cl CH 2 N Cl 2.02 N) 1-1-320 H H CH2CN Cl Cl CH2 N C1 1.49 N 1-1-321 H H CH 3 Cl Cl CH2 N N Cl 1.41 N 1-1-322 H H- CH 3 Cl Cl CII, N CI 1.94 1-1-323 H H i-Pr CI CH 3 CH2 CF, N Cl 3.01 N 1-1-324 H H CHCH 3 Cl Cl CH2 N CI *

FC

2 CAF, 1 1-1-325 H H HH Cl Cl CH2 N CI 3.54

P

5 Ca C 2 F, 1-1-326 H H CH 3 Cl Cl CH2 NrCFs N Cl 2.55 N 1-1-327 H H i-Pr Cl Cl CR, 'Y\)-CA N 01 2.97

N

WO 2007/144100 -72- PCT/EP2007/005016 No. R' RR R R Re A Q X R logP I-1-328 H H HSCH(CH 3 ) CH2 N c N Cl 3.63 N C 2 F 1-1-329 H H CH 3 Cl CH 3 CH2 L c0 N Cl 2.57 NN 1-1-330 H H H Cl CH 3

CH

2 -C2 N Cl 2.39 N 1-1-331 H H c-Pr Cl CH 3

CH

2 Nr2Fs N C1 2.78 _N 1-1-332 H H CH 2 CN Cl CH 3

CH

2 N C2F* N C) 2.59 _N 1-1-333 H H CH 3 CN CH 3

CH

2 N \rc N Cl 2.25 N N 1-1-334 H H i-Pr Cl C- 3 CH2 c N Cl 2.66 N 1-1-335 H H c-Pr Cl Cl CH 2 c/s N CI 2.69 N 1-1-336 H H H- CI Ci CF! 2 N M*,,c N CI 2.32 N 1-1-337 H H CH 2 CN CI Cl CH 2 cr N Cl 2.56 N 1-1-338 H H c-Pr CN CB 3

GB

2 L-\-N CI 2.45 N 1-1-339 H H H CN CF! 3

CF!

2 N Cl 2.11 WO 2007/144100 - 73 - PCT/EP2007/005016 No. R' R2 R'1R Ri A Q X R logP 1-1-340 H H i-Pr Cl Cl CH 2 N CI 2.55 1-1-341 H H i-Pr Cl CH 3

CH

2 NCF N Cl 2.63 1-1-342 H H CH 3 CI Cl CH 2 N C 2.15 N N 1-1-343 H H H Cl CH 3

CH

2 CFa N Cl 2.02 N 1-1-344 H H c-Pr CI Cl CH 2 N N Cl 2.37 1-1-345 H H c-Pr Cl CH 3

CH

2 C-N N Cl 2.42 N-N 1-1-346 H H H Cl Cl CH 2 N CFa N CI 2.01 N 1-1-347 H H CH 3 CI CH 3

CH

2 'N CF3 N Cl 2.19 L-N 1-1-348 H H CH 2 CN Cl Cl 3 CH2 NC 3 N Cl 2.21 1-1-349 H H CH2CN CN Cl CH2 N >CF N Cl 2.19 N 1-1-350 H H H CN CH 3

CS

2 N Cl 1.75 N N 1-1-351 H H CH2CN CN CH 3 CH2 CF3 N Cl 1.96 WO 2007/144100 - 74- PCT/EP2007/005016 No. R' R RiR R5 A Q X i' IogP 1-1-352 H H CH 3 CN CH 3

CH

2 CN C 1.91 1-1-353 H H c-Pr CN CH 3

CH

2 N \XCF3 N Cl 2.08 L-N 1-1-354 H H i-Pr CN CH 3

CH

2 N>-CF, N Cl 2.23 1-1-355 H H CH 3 Cl CH 3

C=NOCH

3 N1, CF 3 N Cl 4.07

CF

3 WO 2007/144100 -75- PCT/EP2007/005016 In analogy to the examples given above and also to the general description, the following compounds of the formula (1-2) are obtained. Rl, N R 2 R N R R (1-2) 0 R6 NN Q Table 2 No. R' R' Ra R Ri R* A Q IogP 1-2-1 H H i-Pr Cl CH 3

CH

3

CH

2 Na / F, 4.08 1-2-2 H H i-Pr Cl Cl i-Pr CH 2 F N CF 3.85 CF~ N -2-3 H H GCl 3 Cl Cl i-Pr

CH

2 Ca 3.3

CF

3 NCH2 C 1-2-4 H H CH 3 Cl Cl

C

2 CF F 1-2-5 H H CH 3 Cl Cl CH 2 C4NC3 2.83

CF

3 1-2-6 H H CH 3 Cl Cl oC C CH 2 N 2.99 1-2-7 H H i-Pr CI Cl %)N

CF.

1-2-8 H H i-Pr Cl C1 Gil 2 N CF 4.68 CF,

OF

WO 2007/144100 -76- PCT/EP2007/005016 No. R1' le W~R R' 11e A Q log!' CrN 1-2-9 H H i-r I CH3 ii CH 2 N CF, 4.98 CCF, j .. N CF 3 1-2-10 H H i-Pr CI CM 3 C)I CF CH 2 /CF F 4.78 CF. 1-2-12 H H c-Pr CI CH- 3 j~k CH 2 4.52 c

CF

3 [-2-13 H H c-Pr CI c CI~l CJ) , Cli NlilN CF, 4.46 CF, NI 1-2414 H H CI OH, CR 2 NliN CF 5.27 cCF, /F' 1-2-15 H H .K CI OH, CH2)CF Nii -N CF, 4.04 NCF F 1-2-16 H H i-E3u CI H CH 2 NliN CF 51 CF, 1-27 H H H Cl OH, CFj1 OH 2 NN C. 4.09 CFF. CF CF 1-2-18 H H CH 2 CN Cl OH, Oja CF H 2 NNCF 4.23

CF

3 NI 1-2-19 H H c-Pr F OH, Ola CF H 2 Nil 4.11

CF

3 1-2-20 H H i-Pr F OH, CH2 il CF 3 44 cl CF3

CF,

WO 2007/144100 -77- PCT/EP2007/005016 No. R' R2 R1 R RsR A Q IogP 1-2-21 H H i-Pr Br CH 3 CI CF, CH2 C 4.75 CF N 1-2-22 H H CH 3 CI CH 3

CH

2 NCF CF 3.53 c CF, OF, 1-2-23 H H CH 3 Cl Cl CH 2 CF' 3.54 CI

CF

3 C 1-2-24 H H c-Pr Br CH 3 ci CF H 2 N CF, 4.63

__CF

3 In analogy to the examples given above and also to the general description, the following compounds of the formula (1-3) are obtained.

RKN,R

2 R* N 1 0 R' O R4 N 0 O A N-N 0 C1 (1-3) 5 WO 2007/144100 -78- PCT/EP2007/005016 Table 3 No. R' R 2 R' R-R 4

R

5 A Q logP 1-3-1 H H i-Pr -CH=CH-CH=CH- Cl CH 2 ,, N CF, 4.08

CF

3 'H NMR data of selected compounds: 1-1-21 (400 MHz, DMSO): 1.11 (d, 6 H), 2.14 (s, 3 H), 3.91 (m, 1 H), 5.55 (s, 2 H), 7.12 (s, 1 H), 5 7.28 (s, I H), 7.39 (s, 1 H), 7.55 (dd, I H), 7.76 (d, I H), 7.99 (s, I H), 8.08 (d, 1 H), 8.43 (d, I H), 8.61 (s, 1 H), 10.12 (s, I H). 1-1-22 (400 MHz, DMSO): 1.18 (d, 6 H), 2.14 (s, 3 H), 3.90 (m, 1 H), 5.87 (s, 2 H), 7.24 (a, I H), 7.42 (a, I H), 7.53 (s, I H), 7.55 (dd, 1 H), 7.80 (d, I H), 8.08 (d, I H), 8.44 (d, I H), 10.07 (a, 1 H). 1-1-26 (400 MHz, DMSO): 2.14 (s, 3 H), 2.67 (d, 3 H), 5.93 (a, 2 H), 7.21 (s, I H), 7.33 (s, I H), 7.40 10 (s, I H), 7.55 (dd, 1 H), 8.00 (d, I H), 8.08 (d, I H), 8.45 (d, I H), 10.12 (s, 1 H). 1-1-48 (400 MHz, DMSO): 2.13 (a, 3 H), 5.69 (s, 2 H), 7.18 (s, 1 H), 7.41 (s, 2 H), 7.55 (dd, I H), 8.10 (d, I H), 8.45 (d, 1 H), 8.80 (s, 1 H), 10.19 (s. 1 H). 1-1-65 (400 MHz, DMSO): 1.06 (d, 6 H), 2.17 (s, 3 H), 3.95 (m, I H), 5.58 (s, 2 H), 7.15 (s, I H), 7.31 (a, I H), 7.42 (a, 1 H), 7.58 (dd, I H), 7.78 (d, 1 H), 7.92 (s, I H), 8.09 (d, I H), 8.46 (d, I H), 15 8.47 (s, 1 H), 10.04 (s, I H). 1-1-75 (400 MHz, DMSO): 1.09 (d, 6 H), 2.00 (s, 3 H), 2.15 (s, 3 H), 2.44 (dd, I H), 2.53 (dd, 1 H), 3.99 (m, 1 H), 5.86 (s, 2 H), 7.23 (s, I H), 7.33 (s, 1 H), 7.42 (s, 1 H), 7.55 (dd, I H), 7.92 (d, 1 H), 8.09 (d, 1 H), 8.44 (d, I H), 10.04 (s, I H). 1-1-88 (400 MHz, DMSO): 2.14 (s, 3 H), 2.67 (d, 3 H), 5.38 (s, 2 H), 7.28 (s, I H), 7.33 (a, 1 H), 7.40 20 (s, I H), 7.55 (dd, I H), 7.96 (d, 2 H), 8.00 (d, 1 H), 8.08 (d, I H), 8.17 (d, 2 H), 8.46 (d, I H), 10.10 (s, 1 H). 1-1-104 (400 MHz, DMSO): 2.13 (s, 3 H), 2.64 (d, 3 H), 6.18 (s, 2 H), 7.28 (s, I H), 7.32 (s, I H), 7.40 (s, 1 H), 7.55 (dd, I H), 7.92 (d, 2 H), 8.00 (d, 1 H), 8.09 (d, 1 H), 8.30 (d, 2 H), 8.45 (d, I H), 10.10 (a, I H).

WO 2007/144100 - 79 - PCT/EP2007/005016 1-1-117 (400 MHz, DMSO): 1.02 (d,6 H), 2.15 (s, 3 H), 3.34 (s,3H), 3.92 (m, I H), 5.10 (s, 2 H), 7.17 (s, 1 H), 7.29 (s, I H), 7.39 (s, I H), 7.55 (dd, I H), 7.78 (d, I H), 8.09 (d, I H), 8.44 (d, 1 H), 10.01 (s, I H). 1-1-126 (400 MHz, DMSO): 0.99-1.10 (m, 4 H), 1.03 (d, 6 H), 2.15 (s, 3 H), 3.00-3.08 (m, I H), 3.92 5 (n, I H), 5.05 (s, 2 H), 7.16 (s, I H), 7.29 (s, I H), 7.40 (s, 1 H), 7.55 (dcL, 1 H), 7.78 (d, 1 H), 8.09 (d, 1 H), 8.44 (d, I H), 10.01 (s, 1 H). 1-1-139 (400 MHz, DMSO): 1.38 (s, 6 H), 2.14 (s, 3 H), 2.89 (s, 3 H), 3.68 (s, 2 H), 5.87 (s, 2 H), 7.21 (s, 1 H), 7.31 (s, I H), 7.40 (s, 1 H), 7.55 (dd, I H), 7.79 (s, 1 H), 8.09 (d, I H), 8.44 (d, 1 H), 9.93 (s, 1 H). 10 1-1-148 (400 MHz, DMSO): 2.14 (s, 3 H), 2.66 (d, 3 H), 6.18 (s, 2 H), 7.29 (s, 1 H), 7.32 (s, 1 H), 7.40 (s, I H), 7.55 (dd, 1 H), 7.70 (d, I H), 8.09 (d, 1 H), 8.11 (d, I H), 8.45 (s, I H), 8.46 (d, 1 H), 9.07 (s, I H), 10.10 (s, I H). 1-1-161 (400 MHz, DMSO): 1.04 (d, 6 H), 1.31 (s, 9 H), 2.14 (s, 3 H), 3.90 (m, 1 H), 5.46 (s, 2 H), 7.11 (s, 1 H), 7.29 (s, I H), 7.39 (s, 1 H), 7.55 (dd, I H), 7.78 (d, I H), 8.09 (d, 1 H), 8.40 (s, 1 H), 15 8.44 (d, I H), 10.10 (s, I H). 1-1-172 (400 MHz, DMSO): 1.04 (d, 6 H), 2.15 (s, 3 H), 3.90 (m, I H), 5.58 (s, 2 H), 7.16 (s, I H), 7.55 (dd, I H), 7.70 (s, I H), 7.78 (s, 1 H), 7.93 (d, I H), 8.09 (d, I H), 8.38 (s, I H), 8.45 (d, I H), 10.32 (s, I H). 1-1-175 (400 MHz, DMSO): 2.21 (s, 3 H), 4.16 (d, I H), 5.57 (s, 2 H), 7.16 (s, 1 H), 7.55 (dd, I H), 20 7.70 (s, I H), 7.78 (s, 1 H), 7.86 (d, 1 H), 8.09 (d, 1 H), 8.37 (s, I H), 8.46 (d, I H), 10.32 (s, 1 H). 1-1-176 (400 MHz, DMSO): 2.19 (s, 3 H), 2.68 (d, 1 H), 5.88 (s, 2 H), 7.25 (s, I H), 7.55 (dd, I H), 7.80 (s, 1 H), 7.97 (s, I H), 8.09 (d, I H), 8.15 (d, I H), 8.44 (d, I H), 10.40 (s, 1 H). 1-1-180 (400 MHz, DMSO): 2.21 (s, 3 H), 4.16 (d, 1 H), 5.87 (s, 2 H), 7.27 (s, I H), 7.55 (dd, 1 H), 7.77 (s, 1 H), 7.86 (s, I H), 8.09 (d, I H), 8.46 (d, I H), 8.96 (d, I H), 10.34 (s, I H). 25 1-1-182 (400 MHz, DMSO): 1.04 (d, 6 H), 2.19 (s, 3 H), 3.92 (m, 1 H), 5.57 (s, 2 H), 6.74 (s, 1 H), 7.15 (s, I H), 7.55 (dd, I H), 7.70 (s, I H), 7.78 (s, I H), 7.91 (d, I H), 8.06 (s, I H), 8.09 (d, 1 H), 8.45 (d, I H), 10.30 (s, 1 H). 1-1-190 (400 MHz, DMSO): 2.21 (s, 3 H), 4.15 (d, 1 H), 5.69 (s, 2 H), 7.18 (s, 1 H), 7.53 (s, 1 H), 7.55 (dd, I H), 7.76 (s, 1 H), 7.85 (s, 1 H), 8.07 (d, 1 H), 8.45 (d, 1 H), 8.95 (s, I H), 10.30 (s, 1 H).

wu 4UU//44iuu - u - FlI tLUU IUUYUIb 1-1-195 (400 MHz, DMSO): 1.11 (d, 6 H), 2.00 (s, 3 H), 2.15 (s, 3 H), 2.44 (dd, I H), 2.53 (dd, 1 H), 4.02 (m, 1 H), 5.57 (s, 2 H), 7.08 (d, 1 H), 7.15 (s, I H), 7.20 (d, 1 H), 7.55 (dd, 1 H), 7.84 (d, I H), 8.09 (d, I H), 8.37 (s, I H), 8.45 (d, 1 H), 10.30 (s, I H). 1-1-196 (400 MHz, DMSO): 2.15 (s, 3 H), 4.34 (d, 1 H), 5.57 (s, 2 H), 6.19 (d, 1 H), 6.29 (d, I H), 5 7.10 (s, 1 H), 7.13 (d, I H), 7.22 (c, 1 H), 7.43 (s, 1 H), 7.55 (dd, 1 H), 8.08 (d, I H), 8.38 (s, I H), 8.46 (d, 1 H), 8.55 (t, 1 H), 10.30 (s, 1 H). 1-1-201 (400 MHz, DMSO): 2.14 (s, 3 H), 4.33 (d, 1 H), 5.57 (s, 2 H), 6.19 (d, I H), 6.29 (d, 1 H), 7.10 (s, 1 H), 7.33 (s, 1 H), 7.44 (2 d, 2 H), 7.55 (dd, I H), 8.08 (d, 1 H), 8.37 (s, I H), 8.45 (d, 1 H), 8.55 (t, 1 H), 10.34 (s, 1 H). 10 1-1-208 (400 MHz, DMSO): 2.14 (s, 3 H), 4.33 (d, I H), 5.57 (s, 2 H), 6.19 (d, 1 H), 6.29 (d, I H), 7.13 (s, I H), 7.45 (s, 1 H), 7.55 (dd, I H), 7.75 (s, I H), 7.80 (s, I H), 8.08 (d, 1 H), 8.38 (s, I H), 8.69 (br s, 1 H), 8.55 (t, I H), 10.34 (s, 1 H). 1-1-241 (400 MHz, DMSO): 1.02 (c, 3 H), 2.11 (s, 3 H), 3.91 (m, I H), 5.57 (s, 2 H), 7.12 (s, I H), 7.55 (dd, I H), 7.57 (s, I H), 7.69 (s, 1 H), 7.76 (d, I H), 8.08 (d, 1 H), 8.37 (s, I H), 8.45 (d, I H), 15 10.02 (s, 1 H). I-1-243 (400 MHz, DMSO): 2.10 (s, 3 H), 2.67 (d, 3 H), 3.07 (q, 2 H), 5.57 (s, 2 H), 7.13 (s, I H), 7.55 (dd, 1 H), 7.60 (s, 1 H), 7.70 (s, 1 H), 7.98 (d, 1 H), 8.10 (d, I H), 8.38 (s, 1 H), 8.45 (d, I H), 10.09 (s, 1 H). 1-1-244 (400 MHz, DMSO): 0.99 (t, 3 H), 2.11 (s, 3 H), 3.07 (q, 2 H), 5.87 (s, 2 H), 7.21 (s, 1 H), 20 7.55 (dd, 1 H), 7.59 (s, I H), 7.70 (s, I H), 7.98 (s, I H), 8.09 (d, 1 H), 8A5 (d, 1 H), 10.05 (s, 1 H). 1-1-248 (400 MHz, DMSO): 1.01 (d, 6 H), 2.10 (s, 3 H), 3.89 (m, I H), 5.56 (s, 2 H), 6.73 (s, I H), 7.11 (s, 1 H), 7.55 (dc, 1 H), 7.56 (s, I H), 7.76 (s, 1 H), 7.75 (d, 1 H), 8.04 (s, 1 H), 8.09 (d, I H), 8.45 (d, I H), 10.01 (s, I H). 1-1-274 (400 MHz, DMSO): 0.99 (t, 3 H), 2.10 (s, 3 H), 3.07 (q, 2 H), 5.68 (s, 2 H), 7.15 (s, I H), 25 7.55 (dd, I H), 7.60 (s, I H), 7.97 (s, I H), 8.08 (d, 1 H), 8.45 (d, 1 H), 10.09 (s, I H). 1-1-275 (400 MHz, DMSO): 0.40-0.47 (m, 2 H), 0.55-0.60 (m, 2 H), 2.10 (s, 3 H), 2.65-2.71 (m, I H), 5.69 (s, 2 H), 7.17 (s, I H), 7.55 (dd, 1 H), 7.56 (s, I H), 7.69 (s, I H), 8.00 (d, I H), 8.08 (d, I H), 8.45 (s, I H), 8.79 (d, 1 H), 10.05 (s, I H). 1-1-276 (400 MHz, DMSO): 0.41-0.45 (m, 2 H), 0.56-0.61 (m, 2 H), 2.10 (s, 3 H), 2.65-2.71 (m, 1 30 H), 5.57 (s, 2 H), 7.14 (s, 1 H), 7.55 (dd, I H), 7.55 (s, I H), 7.69 (s, 1 H), 8.01 (d, I H), 8.08 (d, 1 H), 8.38 (s, I H), 8.46 (d, I H), 10.02 (s, I H).

WO 2007/144100 -81 - PCT/EP2007/005016 I-1-279 (400 MHz, DMSO): 1.34-1.60 (m, 6 H), 1.71-1.78 (mn, 2 H), 2.10 (s, 3 H), 4.01-4.08 (in, I H), 5.87 (s, 2 H), 7.21 (s, I H), 7.55 (dd, 1 H), 7.57 (s, I H), 7.70 (s, 1 H), 7.85 (d, I H), 8.07 (d, I H), 8.43 (s, I H), 10.02 (s, 1 H). 1-1-280 (400 MHz, DMSO): 1.13-1.51 (n, 20 H), 1.71-1.78 (i, 2 H), 2.07 (s, 3 H), 3.93-3.96 (m, 1 5 H), 5.83 (s, 2 H), 7.13 (s, 1 H), 7.55 (dd, 1 H), 7.61 (s, I H), 7.68 (d, 1 H), 8.02 (s, 1 H), 8.07 (d, 1 H), 8.43 (s, I H), 10.02 (s, 1 H). 1-1-282 (400 MHz, DMSO): 1.36 (s, 2 H), 1.56-1.65 (m, 2 H), 1.84-1.94 (m, 2 H), 2.07 (s, 3 H), 4.18 4.24 (m, I H), 5.87 (s, 2 H), 7.18 (s, I H), 7.55 (dd, 1 H), 7.59 (s, I H), 7.70 (d, I H), 8.07 (s, 1 H), 8.19 (d, 1 H), 8.43 (s, I H), 10.02 (s, 1 H). 10 1-1-290 (400 MHz, CDCl 3 ): 2.90 (d, 3 H), 5.74 (s, 2 H), 6.10 (d, 1 H), 7.23 (s, I H), 7.23 (s, 1 H), 7.28 (s, I H), 7.40 (dcL, I H), 7.87 (d, 1 H), 8.46 (d, I H), 9.74 (s, 1 H). I-1 -296 (400 MHz, CDCI 3 ): 5.54 (s, 2 H), 5.62 (s, I H), 6.11 (s, I H), 7.12 (s, I H), 7.39 (s, I H), 7.40 (dd, 1 H), 7.48 (s, I H), 7.90 (d, I H), 7.94 (s, 1 H), 8.48 (d, 1 H), 9.45 (s, I H). 1-1-310 (400 MHz, CDC1 3 ): 4.18 (d, 2 H), 5.48 (s, 2 H), 6.74 (t, 1 H), 7.08 (s, 1 H), 7.32 (s, I H), 7.43 15 (dd, I H), 7.48 (s, I H), 7.92 (d, I H), 7.94 (s, I H), 8.50 (d, I H), 8.93 (s, I H). 1-1 -314 (400 MHz, CDC1 3 ): 1.10 (d, 6 H), 4.08 (m, I H), 5.50 (s, 2 H), 5.92 (d, 1 H), 6.57 (s, 1 H), 7.15 (s, I H), 7.28 (s, I H), 7.39 (s, 1 H), 7.40 (dd, I H), 7.57 (s, 1 H), 7.87 (d, I H), 8.48 (d, 1 H), 9.65 (s, 1 H). 1-1-324 (400 MHz, CDCl 3 ): 1.24 (d, 3 H), 2.10 (s, 3 H), 2.60 (m, 2 H), 4.22 (m, I H), 5.51 (d, 1 H), 20 5.58 (d, I H), 6.13 (d, I H), 7.17 (s, 1 H), 7.35 (s, 1 H), 7.39 (s, I H), 7.40 (dd, 1 H), 7.87 (d, 1 H), 7.90 (s, I H), 8.48 (d, I H), 9.60 (s, 1 H). 1-1-331 (400 MHz, CDCb3): 0.55 (m, 2 H), 0.85 (m, 2 H), 2.16 (s, 3 H), 2.77 (m, I H), 5.57 (s, 2 H), 6.18 (d, I H), 7.12 (s, 1 H), 7.18 (s, I H), 7.24 (s, 1 H), 7.41 (dd, 1 H), 7.88 (d, I H), 8.35 (s, 1 H), 8.48 (d, I H), 10.15 (s, 1 H). 25 1-1 -334 (400 MHz, CDCl 3 ): 1.24 (d, 6 H), 2.23 (s, 3 H), 4.18 (m, I H), 5.58 (s, 2 H), 5.99 (d, 1 H), 7.12 (s, I H), 7.28 (s, 1 H), 7.40 (dd, I H), 7.58 (d, I H), 7.88 (d, I H), 8.36 (s, 1 H), 8.48 (d, 1 H), 10.62 (s, I H). 1-1-340 (400 MHz, CDC1 3 ): 1.24 (d, 6 H), 4.08 (M, I H), 5.58 (s, 2 H), 5.92 (d, 1 H), 7.21 (s, 1 H), 7.30 (s, I H), 7.32 (s, I H), 7.40 (dd, 1 H), 7.77 (d, 1 H), 8.36 (s, 1 H), 8.48 (d, I H), 10.06 (s, I H).

WO 2007/144100 -82- PCT/EP2007/005016 1-1-345 (400 MHz, CDC 3 ): 0.55 (m, 2 H), 0.85 (m, 2 H), 2.77 (m, I H), 5.58 (s, 2 H), 6.20 (d, I H), 7.14 (s, I H), 7.20 (s, 1 H), 7.22 (s, 1 H), 7.40 (dd, 1 H), 7.88 (d, 1 H), 8.32 (s, 1 H), 8.45 (d, 1 H), 10.12 (s, I H). 1-1-354 (400 MHz, CDC 3 ): 1.21 (d, 6 H), 4.15 (m, I H), 5.58 (s, 2 H), 7.16 (s, 1 H), 7.18 (s, 1 H), 5 7.40 (dd, 1 H), 7.58 (s, 1 H), 7.75 (s, 1 H), 7.84 (d, 1 H), 8.38 (s, 1 H), 8.48 (d, 1 H), 10.95 (s, I H). 1-2-4 (400 MHz, CDC 3 ): 1.74 (m, 3 H), 2.16 (m, 2 H), 2.40 (m, 1 H), 2.86 (d, 3 H), 3.70 (m, I H), 3.88 (m, I H), 5.75 (s, 2 H), 5.80 (m, I H), 6.45 (s, 1 H), 6.80 (s, I H), 7.16 (s, 1 H), 7.42 (s, 1 H), 7.56 (s, I H), 9.08 (s, I H). 1-2-7 (400 MHz, CDCl,): 1.24 (m, 6 H), 1.74 (m, 3 H), 2.20 (m, 2 H), 2.40 (m, 1 H), 3.70 (m, 1 H), 10 3.88 (m. I H), 4.10 (n, I H), 5.80 (m, 3 H), 6.25 (s, 1 H), 6.80 (s, 1 H), 7.40 (s, 1 H), 7.52 (s, I H), 8.85 (s, 1 H). The 'H NMR data given above are determined using a Bruker Avance 400 equipped with a BEST system (60 pl volume cell) or with a Bruker Avance 400 using tetramethylsilane as reference (0.0 ppm) and the solvents CDC1 3 at 298 kelvins or d6-DMSO at 304 kelvins. Signal splitting is 15 characterized by s = singlet, d = doublet, t = triplet, q = quartet, m = multiples, dd = doublet of doublet. The logP values stated in the foregoing tables and preparation examples are determined in accordance with EEC Directive 79/831 Annex V.A8 by means of HPLC (High Performance Liquid Chromatography) on a reverse-phase column (C 18). Temperature: 43*C. 20 The determination by LC-MS in the acidic range takes place at a pH of 2.7 using 0.1% aqueous formic acid and acetonitrile (containing 0.1% formic acid) as eluents; linear gradient from 10% acetonitrile to 95% acetonitrile. Calibration is with unbranched alkan-2-ones (having 3 to 16 carbon atoms) of known logP value (logP values determined from the retention times by linear interpolation between two successive 25 alkanones). The lambda-max values are determined from the UV spectra from 200 nin to 400 nm in the maxima of the chromatographic signals. Preparation of starting materials of the formula (V) 30 Example 2 WO 2007/144100 -83 - PCT/EP2007/005016 2-[5-(3.5-Bistrifluoromethylpyrazol-1-vlmethyl)-243-chloropyridin-2-vl)-2H-pyrazol-3-yll-6 chloro-8-methylbenzo[dl r .3loxazin-4-one: Under argon 0.12 ml (1.60 mmol) of methanesulphonyl chloride in 3 ml of acetonitrile are cooled to 0*C and subsequently a solution of 540 mg (1.228 mmol) of 5-(3,5-bistrifluoromethylpyrazol- 5 ylmethyl)-2-(3-chloropyridin-2-yl)-2H-pyrazole-3-carboxylic acid in 0.17ml (2.09mmol) of pyridine and 6 ml of acetonitrile is added dropwise. The mixture is stirred at this temperature for 15 minutes and then a solution of 228 mg (1.228 mmol) of 2-amino-5-chloro-3,N dimethylbenzamide in 0.35 ml (4.30 mmol) of pyridine and 6 ml of acetonitrile is added. After a further 15 minutes at 0*C the mixture is admixed with 0.12 ml (1.60 mmol) of methanesulphonyl 10 chloride and warmed slowly to rom temperature overnight. The solvent is removed in vacuo, 15 ml of water are added and the crystals formed are filtered off with suction. Yield: 500 mg (logP: 5.11) Preparation of starting materials of the formula (IV) Example 3 15 5-(3.5-Bistrifluoromethylpvrazol-l -vlmethyl)-2-(3-chlorovridin-2-vl)-2H-pvrazole-3-carboxylic acid: A solution of 610 mg (1.34 mmol) of methyl 5-(3,5-bistrifluoromethylpyrazol-1 -ylmethyl)-2-(3 chloropyridin-2-yl)-2H-pyrazole-3-carboxylate in 9 ml of ethanol is admixed dropwise with a solution of 699 mg (1.78 mmol) of sodium hydroxide in 7 ml of water. The mixture is stirred at 20 room temperature for 2 hours and concentrated to about 5 ml on a rotary evaporator. This residue is admixed with 5 ml of tert-butyl methyl ether and the organic phase is subsequently washed with water. The combined aqueous phases are adjusted to a pH of about 3 with concentrated hydrochloric acid, with ice cooling, and are extracted with three times 50 ml of ethyl acetate. The combined organic phases are dried over magnesium sulphate and then the solvent is removed on a 25 rotary evaporator. Yield: 560 mg (logP: 2.86) WO 2007/144100 -84- PCT/EP2007/005016 Preparation of starting materials of the formula (IV) Example 4 Methyl 5-(3,5-bistrifluoromethylpyrazol-1 -vlmethyll-2-(3-chloropvridin-2-vl)-2H-pyrazole-3-car boxylate: 5 A solution of 700 mg (2.03 mmol) of methyl 2-(3-chloropyridin-2-yl)-5-methane sulphonyloxymethyl-2H-pyrazole-3-carboxylate in 15 nil of acetonitrile is admixed in succession with 336 mg (2.43 mmol) of potassium carbonate and 413 mg (2.03 mmol) of 3,5 bis(trifluoromethyl)pyrazole and the mixture is subsequently stirred at 60*C for I h. After the mixture has cooled to room temperature, the solvent is concentrated on a rotary evaporator, water is 10 added and extraction is carried out with three times 50 ml of ethyl acetate. The combined organic phases are dried over magnesium sulphate and then the solvent is removed on a rotary evaporator. Yield: 970 mg (logP: 3.71) Preparation of starting materials of the formula (VII) Example 5 15 Methyl 2-(3-chloronvridin-2-vf)-5-methanesulhonyloxvmethyl-2H-pyrazole-3-carboxylate: Under argon 2.10 g (7.85 mmol) of methyl 2-(3-chloropyridin-2-yl)-5-hydroxymethyl-2H-pyrazole 3-carboxylate are introduced in 13 ml of dichloromethane and this initial charge is cooled to 0*C and admixed dropwise in succession with 1.64 ml (11.8 mmol) of triethylamine and 0.67 ml (8.63 mmol) of methanesulphonyl chloride. It is stirred at this temperature for 30 minutes, diluted 20 with 50 ml of dichloromethane and washed successively with 50 ml each of saturated aqueous sodium hydrogen sulphate solution, 10 per cent strength aqueous hydrochloric acid and saturated aqueous sodium chloride solution. The organic phase is dried over magnesium sulphate and then the solvent is removed on a rotary evaporator. Yield: 2.65 g (logP: 1.55) 25 Preparation of starting materials of the formula (X) Example 6 Methyl 2-(3-chlorordin-2-vl)-5-hydroxymethyl-2H-pyrazole-3-carboxylate: Under argon 12.3g (41.7mximol) of dimethyl 1-(3-chloropyridin-2-yl)-IH-pyrazole-3,5 dicarboxylate are introduced in 430 ml of tetrahydrofuran and this initial charge is cooled to - 72*C WO 2007/144100 - 85 - PCT/EP2007/005016 and admixed dropwise with 100 ml (100 mmol of a I M solution in hexane) of diisobutylaluminium hydride. The mixture is allowed to warm to 0*C overnight and 65 ml of water are cautiously added. The solvents are removed on a rotary evaporator and the residue is extracted to exhaustion with methanol on a Soxhlet apparatus. Following removal of the solvent, the residue is purified on silica 5 gel (cyclohexane/ethyl acetate = 2:1 -+ 1:1). Yield: 9.26 g (logP: 1.26) Preparation of starting materials of the formula (XI) Example 7 Dimethyl 1-(3-chloropyridin-2-vl)-1H-pyrazole-3.5-dicarboxylate: 10 One spatula tip of toluenesulphonic acid is added to a solution of 15.6 g (64.8 mmol) of dimethyl 2 pyrrolidino-4-oxo-2-pentenedicarboxylate and 20.4 g (64.8 mmol) of the toluenesulphonic acid salt of 3-chloro-2-pyridin-2-ylhydrazine in 84 ml of methanol and the mixture is heated at 50 0 C for 5 h. It is then admixed with 12.3 g (64.8 mmol) of toluenesulphonic acid monohydrate and stirred initially at 50*C for I h and under reflux for I h. After the mixture has cooled to 0"C, the precipitated crystals 15 are .filtered off with suction and filtration is carried out over silica gel (cyclohexane/ethyl acetate = 1:1). Yield: 8.56 g (logP: 1.97) WO 2007/144100 -86- PCT/EP2007/005016 Examples in relation to the biological activity of the compounds of the invention Example 1 Heliothis virescens test Solvents: 1% N-methylpyrrolidone (NMP) 5 1% diacetone alcohol Dye: Brilliant sulphoflavine to stain the water An appropriate preparation of active compound is prepared by mixing the active compound with the stated amounts of solvent and diluting the concentrate with stained water to the desired concentration. The Heliothis virescens eggs are treated with a preparation of active compound at the desired 10 concentration. After the desired time the effect in % is determined. 100% means that all of the eggs/larvae have been killed; 0% means that no eggs/larvae have been killed. High activity in this test is shown, for example, by the following compounds of the preparation examples: see table Heliothis virescens test Active compound Kill level after Active compound concentration in ppm 6

-

7 d in % 1-1-13 300 100 1-1-14 300 100 1-1-15 300 100 WO 2007/144100 -87- PCT/EP2007/005016 Example 2 Myzus persicae test Solvents: 1% N-methylpyrrolidone (NMP) 1% diacetone alcohol 5 Dye: Brilliant suiphoflavine to stain the water An appropriate preparation of active compound is prepared by mixing the active compound with the stated amounts of solvent and diluting the concentrate with stained water to the desired concentration. The Myzus persicae is provided with a preparation of active compound at the desired concentration for consumption. 10 After the desired time the effect in % is determined. 100% means that all of the aphids have been killed; 0% means that no aphids have been killed. High activity in this test is shown, for example, by the following compounds of the preparation examples: see table Myzus persicae test Active compound Active compound Kill level after concentration in ppm 6

-

7 d in % 1-1-13 30 100 1-1-14 30 100 1-1-15 30 100 WO 2007/144100 -88- PCT/EP2007/005016 Example 3 Aedes aegypti test Solvents: 1% N-methylpyrrolidone (NMP) 1% diacetone alcohol 5 Dye: Brilliant sulphoflavine to stain the water An appropriate preparation of active compound is prepared by mixing the active compound with the stated amounts of solvent and diluting the concentrate with stained water to the desired concentration. The Aedes aegypti larvae are treated with a preparation of active compound at the desired concentration. 10 After the desired time the effect in % is determined. 100% means that all of the Aedes aegypti have been killed; 0% means that no Aedes aegypti have been killed. High activity in this test is shown, for example, by the following compounds of the preparation examples: see table Aedes Aegypti test Active compound Active compound Kill level after concentration in ppm 2 4 d in % 1-1-13 30 100 1-1-14 30 100 1-1-15 30 100 WO 2007/144100 -89- PCT/EP2007/005016 Example 4 Diabrotica undecimpunctata test Solvents: 1% N-methylpyrrolidone (NMP) 1% diacetone alcohol 5 Dye: Brilliant sulphoflavine to stain the water An appropriate preparation of active compound is prepared by mixing the active compound with the stated amounts of solvent and diluting the concentrate with stained water to the desired concentration. The Diabrotica undecimpunctata eggs are treated with a preparation of active compound at the desired concentration. 10 After the desired time the effect in % is determined. 100% means that all of the eggs/larvae have been killed; 0% means that no eggs/larvae have been killed. High activity in this test is shown, for example, by the following compounds of the preparation examples: see table Diabrotica undecimpunctata test Active compound Active compound Kill level after concentration in ppm 2-5d i A 1-1-13 300 100 1-1-14 300 100 1-1-15 300 100 WO 2007/144100 -90- PCT/EP2007/005016 Example 5 Phaedon test (spray treatment) Solvents: 78.0 parts by weight acetone 1.5 parts by weight dimethylformamide 5 Emulsifier 0.5 part by weight alkylaryl polyglycol ether An appropriate preparation of active compound is prepared by mixing I part by weight of active compound with the stated amounts of solvent and emulsifier and diluting the concentrate with emulsifier-containing water to the desired concentration. Leaf discs of Chinese cabbage (Brassica pekinensis) are sprayed with a preparation of active 10 compound at the desired concentration and, after drying, are populated with larvae of the mustard beetle (Phaedon cochleariae). After the desired time the effect in % is determined. 100% means that all of the beetle larvae have been killed; 0% means that no beetle larvae have been killed. In this test an effect of 80% is shown, for example, by the following compounds of the preparation 15 examples at an application rate of 100 g/ha: Ex. No. 1-1-2, 1-1-3, 1-1-4, 1-1-5, I-1-6, 1-1-10, I-I-1I, 1-1-12, 1-1-13, I-1-14, I-1-15, 1-1-16, 1-1-17, I 1-18, 1-1-19, 1-1-22, 1-1-23, 1-1-24, 1-1-25, 1-1-28, 1-1-29, 1-1-30, 1-1-31, 1-1-32, 1-1-33, 1-1-34, I-1 35, 1-1-36, I-1-37, 1-1-38, 1-1-39, 1-140, 1-1-217, 1-1-218, 1-1-219, 1-1-220, 1-1-222, 1-1-223, 1-1-224, 1-1-225, 1-1-226, 1-1-38,1-1-42, 1-1-43,1-1-44, 1--45, 1-1-46,1-1-47, 1-1-48, 1-1-49, 1-1-50, 1-1-51, 1 20 1-52, 1-1-53, 1-1-54, 1-1-55, 1-1-56, 1-1-57, 1-1-58, 1-1-59, 1-1-60, 1-1-61, 1-1-62, 1-1-63, 1-1-64, 1-1 65, 1-1-66, 1-1-68, 1-1-69, 1-1-70, 1-1-71, 1-1-72, 1-1-73, 1-1-74, 1-1-75, 1-1-76, 1-1-77, 1-1-78, 1-1-79, 1-1-80, 1--81, 1-1-82, 1-1-83, 1-1-84, 1-1-85, 1-1-86, 1-1-87, 1-1-92, 1-1-93, 1-1-97, 1-1-99, 1-1-100, I 1-101, 1-1-113, 1-1-120, 1-1-121, 1-1-125, 1-1-128, 1-1-129, 1-1-130, 1-1-131, 1-1-134, 1-1-135, 1-1 137, 1-1-138, 1-1-139, 1-1-140, 1-1-141, 1-1-142, 1-1-144, 1-1-145, 1-1-146, 1-1-147, 1-1-148, 1-1-149, 25 I-1-150, 1-1-151, 1-1-152, 1-1-155, 1-1-156, 1-1-157, 1-1-158, 1-1-163, 1-1-165, 1-1-166, 1-1-167, I-1 168, 1-1-169, 1-1-170, 1-1-171, 1-1-172, 1-1-173, 1-1-174, 1-1-175, 1-1-176, 1-1-177, 1-1-178, 1-1-179, 1-1-180, 1-1-181, 1-1-182, 1-1-183, 1-1-184, 1-1-185, 1-1-186, 1-1-187, 1-1-188, 1-1-189, 1-1-190, 1-1 191, 1-1-192, 1-1-193, 1-1-195, 1-1-196, 1-1-199, 1-1-201, 1-1-203, 1-1-204, 1-1-206, 1-1-207, 1-1-208, 1-1-209, 1-1-210, I-1-211, 1-1-212, 1-1-213, 1-1-214, 1-1-215, 1-1-216, 1-1-227, 1-1-228, 1-1-230, 1-1 30 231, 1-1-233, 1-1-234, 1-1-235, 1-1-236, 1-1-237, 1-1-238, 1-1-239, 1-1-240, 1-1-241, 1-1-242, 1-1-243, 1-1-244, 1-1-245,.1-1-246, 1-1-247, 1-1-248, 1-1-251, 1-1-252, 1-1-253, 1-1-255, 1-1-258, 1-1-259, I-1 260, 1-1-267, 1-1-272,1-1-273, 1-1-274, 1-1-275, 1-1-276, 1-1-277, 1-1-279, [-1-282, 1-1-283, 1-1-284, WO 2007/144100 -91 - PCT/EP2007/005016 1-1-285, 1-1-286, 1-1-287, 1-1-288, 1-1-289, 1-1-290, 1-1-291, 1-1-292, 1-1-293, 1-1-294, 1-1-295, 1-i 296, 1-1-297, 1-1-298, 1-1-299, 1-1-300, 1-1-302, 1-1-303, 1-1-304, 1-1-305, 1-1-307, 1-1-308, 1-1-309, 1-1-310, 1-1-312, 1-1-313, 1-1-324, 1-1-326, 1-1-327, 1-1-328, 1-1-329, 1-1-330, 1-1-331, 1-1-332, 1-1 333, 1-1-334, 1-1-335, 1-1-336, 1-1-337, 1-1-338, 1-1-339, 1-1-340, 1-1-342, 1-1-343, 1-1-346, 1-1-347, 5 1-1-348, 1-1-349, 1-1-350, 1-1-352, 1-1-353, 1-1-354,1-1-355,1-2-2 WO 2007/144100 - 92 - PCT/EP2007/005016 Examle 6 Spodoptera frugiperda test Solvent: 7 parts by weight dimethylformamide Emulsifier: 2 parts by weight alkylaryl polyglycol ether 5 An appropriate preparation of active compound is prepared by mixing I part by weight of active compound with the stated amounts of solvent and emulsifier and diluting the concentrate with emulsifier-containing water to the desired concentration. Cabbage leaves (Brassica oleracea) are treated by immersion into a preparation of active compound at the desired concentration and, are populated with caterpillars of the armyworm (Spodoptera 10 frugiperda) while the leaves are still wet. After the desired time the effect in % is determined. 100% means that all of the caterpillars have been killed; 0% means that no caterpillars have been killed. High activity in this test is shown, for example, by the following compounds of the preparation examples: see table Spodoptera frugiperda test Active compound Kill level Active compound concentration in g/ha after 7 d in % 1-171 100 100 1-1-2 100 100 1-1-3 100 100 1-1-4 100 100 I-1-5 100 100 1-1-6 100 100 1-1-7 100 100 1-1-8 100 100 1-1-10 100 100 1-1-11 100 100 1-1-12 100 100 1-1-13 100 100 1-1-14 100 100 WO 2007/144100 -93 - PCT/EP2007/005016 Spodoptera frugiperda test Active compound Active compound Kill level Active compound _ concentration in g/ha after 7 din % 1-1-15 100 100 I-1-16 100 100 I-1-17 100 100 1-1-18 100 100 I-1-19 100 100 1-1-20 100 100 1-1-21 100 100 1-1-22 100 100 1-1-23 100 100 1-1-24 100 100 1-1-25 100 100 1-1-26 100 100 1-1-27 20 83 [-1-28 100 100 1-1-29 100 100 1-1-30 100 100 1-1-31 100 100 1-1-32 100 100 1-1-33 100 100 1-1-34 100 100 1-1-35 100 100 1-1-36 100 100 1-1-37 100 100 1-1-39 10010 1-140 10010 WO 2007/144100 -94- PCT/EP2007/005016 Example 7 Spodoptera exigua test Solvent: 7 parts by weight dimethylformamide Emulsifier: 2 parts by weight alkylaryl polyglycol ether 5 An appropriate preparation of active compound is prepared by mixing 1 part by weight of active compound with the stated amounts of solvent and emulsifier and diluting the concentrate with emulsifier-containing water to the desired concentration. If it is necessary to add ammonium salts, penetrants, or ammonium salts and penetrants, they are added by pipette at a concentration of 1000 ppm after dilution, the addition taking place in each case to the completed solution of the 10 products. Examples 1-1-3, I-1-5, 1-1-6, I-1-8 and 1-1-22 are tested without addition of ammonium salts or penetrants. Cabbage plants (Brassica oleracea) are treated by being sprayed with the preparation of active compound at the desired concentration and are populated with caterpillars of the beet armyworm (Spodoptera exigua) while the leaves are still wet. 15 After the desired time the kill in % is determined. 100% means that all of the caterpillars have been killed; 0% means that no caterpillars have been killed. In this test an effect of > 80 % is shown, for example, by the following compounds of the preparation examples at an application rate of 4 ppm: Ex. No. 1-1-3, I-1-5, 1-1-6, I-1-8, 1-1-22, 1-1-31, 1-1-35, 1-1-47, 1-1-48, 1-1-52, 1-1-53, 1-1-55, 1-1-57, 20 1-1-170, 1-1-291, 1-1-295, 1-1-296, 1-1-297,1-1-299,1-1-54 WO 2007/144100 - 95 - PCT/EP2007/005016 Example 8 Plutella xylostefla test Solvent: 7 parts by weight dimethylfomamide Emulsifier: 2 parts by weight alkylaryl polyglycol ether 5 An appropriate preparation of active compound is prepared by mixing I part by weight of active compound with the stated amounts of solvent and emulsifier and diluting the concentrate with emulsifier-containing water to the desired concentration. If it is necessary to add ammonium salts, penetrants, or ammonium salts and penetrants, they are added by pipette at a concentration of 1000 ppm after dilution, the addition taking place in each case to the completed solution of the 10 products. Examples 1-1-3, 1-1-5, 1-1-6, 1-1-8 and 1-1-22 are tested without addition of ammonium salts or penetrants. Cabbage leaves (Brassica oleracea) are treated by being sprayed with the preparation of active compound at the desired concentration and are populated with caterpillars of the cabbage moth (Plutella xylostella) while the leaves are still wet. 15 After the desired time the kill in % is determined. 100% means that all of the caterpillars have been killed; 0% means that no caterpillars have been killed. In this test an effect of> 80 % is shown, for example, by the following compounds of the preparation examples at an application rate of 20 ppm: Ex. No.1-1-3, I-1-5, 1-1-6, I-I-8, I-1-22, I-1-65, 1-1-239, 1-1-240, 1-1-245, 1-1-217, 1-1-220, 1-1-223, 20 1-1-224, 1-1-31, 1-1-55, 1-1-56, 1-1-57, 1-1-63, 1-1-66, 1-1-68, 1-1-69, 1-1-76, 1-1-92, 1-1-97, 1-1-98, I 1-101, 1-1-113, 1-1-121, 1-1-147, 1-1-170, 1-1-192, 1-1-195, 1-1-204, 1-1-206, 1-1-209, 1-1-210, 1-1 212, 1-1-215, 1-1-238, 1--244, 1-1-247, 1-1-248, 1-1-249, 1-1-250, 1-1-251, 1-1-274, 1-1-275, 1-1-276, 1-1-291, 1-1-295, 1-1-296, 1-1-297, 1-1-299, 1-1-25, 1-1-35, 1-1-36, 1-1-38, 1-1-43,1-1-46, 1-1-47, 1-1 48,1-1-52,1-1-53,1-1-54,1-1-104, 1-1-106, 1-1-107, 1-1-108, 1-1-143, 1-1-88,1-1-139 WO 2007/144100 -96- PCT/EP2007/005016 Example 9 Spodoptera frugiperda test Solvent: 7 parts by weight dimethylfonnamide Emulsifier: 2 parts by weight alkylaryl polyglycol ether 5 An appropriate preparation of active compound is prepared by mixing 1 part by weight of active compound with the stated amounts of solvent and emulsifier and diluting the concentrate with emulsifier-containing water to the desired concentration. Cabbage leaves (Brassica oleracea) are treated by immersion into a preparation of active compound at the desired concentration and are populated with caterpillars of the arnyworm (Spodoptera 10 frugiperda) while the leaves are still wet. After the desired time the effect in % is determined. 100% means that all of the caterpillars have been killed; 0% means that no caterpillars have been killed. High activity in this test is shown, for example, by the following compounds of the preparation examples: see table Spodoptera frugiperda -Test Active compound Active compound Kill level concentration in ppm after 7 ' in % 1-1-3 0.8 100 I-1-5 0.8 100 1-1-6 0.8 100 1-1-8 0.8 100 1-1-9 100 100 1-1-22 4 100 15 Example 10 WO 2007/144100 - 97 - PCT/EP2007/005016 Heliothis armigera test Solvent: 7 parts by weight dimethylfornamide Emulsifier 2 parts by weight alkylaryl polyglycol ether An appropriate preparation of active compound is prepared by mixing 1 part by weight of active 5 compound with the stated amounts of solvent and emulsifier and diluting the concentrate with emulsifier-containing water to the desired concentration. If it is necessary to add ammonium salts, penetrants, or ammonium salts and penetrants, they are added by pipette at a concentration of 1000 ppm after dilution, the addition taking place in each case to the completed solution of the products. Examples 1-1-3, 1-1-5, 1-1-6, 1-1-8 and 1-1-22 are tested without addition of ammonium 10 salts or penetrants. Cotton plants (Gossypium hirsurum) are treated by being sprayed with the preparation of active compound at the desired concentration and are populated with caterpillars of the cotton budworm (Heliothis annigera) while the leaves are still wet. After the desired time the kill in % is determined. 100% means that all of the caterpillars have been 15 killed; 0% means that no caterpillars have been killed. In this test an effect of 2: 80 % is shown, for example, by the following compounds of the preparation examples at an application rate of 20 ppm: Ex. No. I-1-3, 1-1-5, 1-1-6, 1-1-8, 1-1-22, 1-1-63, 1-1-65, 1-1-66, 1-1-68, 1-1-69, 1-1-192, 1-1-240, 1-1 245, 1-1-217,1-1-220,1-1-223, 1-1-224, 1-1-31, 1-1-35, 1-1-36, 1-1-38, 1-1-43, 1-146,1-1-47, 1-1-48, 1 20 1-52, 1-1-53,1-1-54, 1-1-55, 1-1-56, 1-1-57, 1-1-76, I-1-88, 1-1-131, 1-1-139, 1-1-92, 1-1-97, 1-1-98, I-1 100, 1-1-101, 1-1-113,1-1-121, 1-1-147, 1-1-170, 1-1-195, 1-1-204, 1-1-206, 1-1-212, 1-1-215, 1-1-238, 1-1-244,1-1-247, 1-1-248, 1-1-249, 1-1-250, 1-1-251, 1-1-274, 1-1-275, 1-1-276, 1-1-291, I-1-295, I-1 296,1-1-297, 1-1-299, 1-1-104,1-1-106,1-1-107,1-1-108, 1-1-143 WO 2007/144100 - 98 - PCTIEP2007/005016 Example 11 Spodoptera exigua test; resistant strain Solvent: 7 parts by weight dimethylformanide Emulsifier 2 parts by weight alkylaryl polyglycol ether 5 An appropriate preparation of active compound is prepared by mixing I part by weight of active compound with the stated amounts of solvent and emulsifier and diluting the concentrate with emulsifier-containing water to the desired concentration. If it is necessary to add ammonium salts, penetrants, or ammonium salts and penetrants, they are added by pipette at a concentration of 1000 ppm after dilution, the addition taking place in each case to the completed solution of the 10 products. Examples I-1-5, 1-1-6, and 1-1-22 are tested without addition of ammonium salts or penetrants. Cabbage plants (Brassica oleracea) are treated by being sprayed with the preparation of active compound at the desired concentration and are populated with caterpillars of the beet armyworm (Spodoptera exigua, resistant strain), while the leaves are still wet. 15 After the desired time the kill in % is determined. 100% means that all of the caterpillars have been killed; 0% means that no caterpillars have been killed. In this test an effect of> 80 % is shown, for example, by the following compounds of the preparation examples at an application rate of 4 ppm: Ex. No.I-1-5, I-1-6, 1-1-22, 1-1-31, -1-35, 1-1-38, I-1-46, 1-1-47, 1-148, 1-1-52, 1-1-53, 1-1-54, 1-1 20 56,1-1-57,1-1-170,1-1-295, 1-1-296, 1-1-297, 1-1-299 WO 2007/144100 -99- PCT/EP2007/005016 Example 12 Liriomyza trifolil Solvents: 78 parts by weight acetone 1.5 parts by weight dimethylformamide 5 Emulsifier 0.5 part by weight alkylaryl polyglycol ether An appropriate preparation of active compound is prepared by mixing 1 part by weight of active compound with the stated amounts of solvent and emulsifier and diluting the concentrate with emulsifier-containing water to the desired concentration. Bean leaf discs (Phaseolus vulgaris) infested by larvae of the leafniner fly (Liriomyza trifolit) are 10 sprayed with a preparation of active compound at the desired concentration. After the desired time the effect in % is determined. 100% means that all of the leafminer flies have been killed; 0% means that no leafininer flies have been killed. High activity in this test is shown, for example, by the following compounds of the preparation examples: see table Liriomyza trifolii Test Active compound Kill level Active compound concentration in ppm after 7 d in % 1-1-3 500 98 1-1-4 500 95 1-1-22 500 98 WO 2007/144100 - 100- PCT/EP2007/005016 Example 13 Lucilia cuprina test Solvent: Dimethyl sulphoxide An appropriate preparation of active compound is prepared by mixing 1 part by weight of active 5 compound with the stated amounts of solvent and emulsifier and diluting the concentrate with water to the desired concentration. Vessels containing horsemeat treated with the preparation of active compound at the desired concentration are populated with Lucilia cuprina larvae. After the desired time the kill in % is determined. 100% means that all of the larvae have been killed; 10 0% means that no larvae have been killed. In this test an effect of 80 % is shown, for example, by the following compounds of the preparation examples at an application rate of 100 ppm: Ex. No. 1-1-1, 1-1-2,1-1-3,1-4, I-1-5, 1-1-6, 1-1-7, 1-1-8, 1-1-9, 1-1-12, 1-1-14, 1-1-15, 1-1-16, I-1-17, 1-1-18, 1-1-19, 1-1-21, 1-1-22, 1-1-29, 1-1-30, 1-1-31, 1-1-217, 1-1-220, 1-1-223, 1-1-224, 1-1-42,1-1-43, 15 1-146,1-147,1-148,1-1-52,1-1-53, 1-1-54, 1-1-55, 1-1-56, 1-1-57, 1-1-64, 1-1-65, 1-1-66, 1-1-67, I-1 68, 1-1-74, 1-1-88, 1-1-92, 1-1-97, 1-1-104, 1-1-107, 1-1-108, 1-1-109, 1-1-111, 1-1-114, 1-1-122, 1-1 123, 1-1-192, 1-1-238, 1-1-239, 1-1-240,1-1-244, 1-1-247, 1-1-274, 1-1-275, 1-1-291, 1-1-295, 1-1-296, 1-1-297, 1-1-299, 1-1-323 WO 2007/144100 -101 - PCT/EP2007/005016 Example 14 Boophilus microplus test (Injection) Solvent: Dimethyl sulphoxide An appropriate preparation of active compound is prepared by mixing 1 part by weight of active 5 compound with the stated amounts of solvent and emulsifier and diluting the concentrate with solvent to the desired concentration. The solution of active compound is injected into the abdomen (Boophilus microplus) and the animals are transferred to dishes and kept in a climatized room. After the desired time the effect in % is determined. 100% means that none of the ticks has laid fertile 10 eggs. In this test an effect of 80 % is shown, for example, by the following compounds of the preparation examples at an application rate of 20 pg/animal: Ex. No. 1-1-1, 1-1-2, 1-1-3, 1-1-4, 1-1-5, 1-1-6, 1-1-7, 1-1-8, 1-1-9, 1-1-12, 1-1-14, 1-1-15, 1-1-16, 1-1-17, 1-1-18, 1-1-19, 1-1-21, 1-1-29,1-1-30,1-1-31,1-1-217, 1-1-222, 1-1-223,1-1-224, 1-1-42, 1-1-43,1-146, 15 1-1-47,1-148,1-1-52,1-1-53, 1-1-54, 1-1-55, 1-1-56, 1-1-57, 1-1-64, 1-1-65, 1-1-66, 1-1-67, 1-1-68, I-1 74, 1-1-88, 1-1-92, 1-1-97, 1-1-104, 1-1-107, 1-1-108, 1-1-109, 1-1-111, 1-1-114, 1-1-122, 1-1-123, 1-1 192, 1-1-238, 1-1-239, 1-1-240, I-1-244, 1-1-247, 1-1-274, 1-1-275, 1-1-291,1-1-295, 1-1-296, 1-1-297, 1-1-299, 1-1-323 WO 2007/144100 - 102 - PCT/EP2007/005016 Example 15 Musca domestica test Solvent: Dimethyl sulphoxide An appropriate preparation of active compound is prepared by mixing 1 part by weight of active 5 compound with the stated amounts of solvent and emulsifier and diluting the concentrate with water to the desired concentration. Vessels containing a sponge treated with the preparation of active compound at the desired concentration are populated with Musca domestic adults. After the desired time the kill in % is determined. 100% means that all of the flies have been killed; 10 0% means that no flies have been killed. In the case of Examples 1-1-16, 1-1-19 and 1-1-30 the effect in question is a knock-down effect. In this test an effect of2 80 % is shown, for example, by the following compounds of the preparation examples at an application rate of 100 ppm: Ex. No. 1-1-16 1-1-19, 1-1-30, 1-1-217, 1-1-42, 1-143, 1-146, 1-147, I-148, 1-1-52, 1-1-53, 1-1-55, I 15 1-64, 1-1-66, 1-1-107, 1-1-114, 1-1-192, 1-1-274, 1-1-275, 1-1-296, 1-1-297, 1-1-299 WO 2007/144100 - 103 - PCT/EP2007/005016 Example 16 Spodoptera frugiperda test (spray treatment) Solvents: 78.0 parts by weight acetone 1.5 parts by weight dimethylformamide 5 Emulsifier. 0.5 part by weight alkylaryl polyglycol ether An appropriate preparation of active compound is prepared by mixing 1 part by weight of active compound with the stated amounts of solvent and emulsifier and diluting the concentrate with emulsifier-containing water to the desired concentration. Leaf discs of maize (Zea mays) are sprayed with a preparation of active compound at the desired 10 concentration and, after drying, are populated with larvae of the armyworm (Spodopterafrugiperda). After the desired time the effect in % is determined. 100% means that all of the caterpillars have been killed; 0% means that no caterpillars have been killed. In this test an effect of k 80% is shown, for example, by the following compounds of the preparation examples at an application rate of 100 g/ha: 15 Ex. No. 1-1-217, 1-1-218, 1-1-219, 1-1-220, 1-1-221, 1-1-222, 1-1-223, 1-1-224, 1-1-38, 1-1-42, 1-1-43, 1-1-44, 1-1-45, 1-1-46,1-1-47, 1-1-48, 1-1-49, 1-1-50, I--51, 1-1-52, I-1-53, 1-1-54, 1-1-55, 1-1-56, I-I 57,1-1-58, 1-1-59, 1-1-60, 1-1-61, 1-1-62, 1-1-63, 1-1-64, 1-1-65, 1-1-66, 1-1-68, 1-1-69, 1-1-70, 1-1-71, 1-1-72, 1-1-73, 1-1-74, 1-1-75, 1-1-76, 1-1-77, 1-1-78, 1-1-79, 1-1-80, 1-1-81, 1-1-82, 1-1-83, 1-1-84, 1-1 85, 1-1-86,1-1-87,1-1- 92, 1-1-93, 1-1-97, 1-1-99, 1-1-100, 1-1-101, 1-1-102, 1-1-103, 1-1-113, 1-1-116, 20 1-1-11-119, 1-1-120, 1-1-121, 1-1-125, 1-1-126, 1-1-127, 1-1-128, 1-1-129, 1-1-130, I-1 131, 1-1-134, 1-1-135, 1-1-136, 1-1-137, 1-1-138, 1-1-139, 1-1-140, 1-1-141, 1-1-142, 1-1-144, 1-1-145, 1-1-146, 1-1-147, 1-1-148, 1-1-149, 1-1-150, 1-1-151, 1-1-152, 1-1-153, 1-3-154, 1-1-155, 1-1-156, 1-1 157, 1-1-158, 1-1-160, 1-1-161, 1-1-163, 1-1-165, 1-1-166, 1-1-167, 1-1-168, 1-3-1, 1-1-169, 1-1-170, 1 1-171, 1-1-172, 1-1-173, 1-1-174, 1-1-175, 1-1-176, 1-1-177, 1-1-178, 1-1-179, 1-1-180, 1-1-181, I-1 25 182, 1-1-183, 1-1-184, 1-1-185, 1-1-186, 1-1-187, 1-1-188, 1-1-189, 1-1-190, 1-1-191, 1-1-192, 1-1-193, 1-1-195, 1-1-196, 1-1-199, 1-1-200, 1-1-201, 1-1-202, 1-1-203, 1-1-204, 1-1-205, 1-1-206, 1-1-207, 1-1 208, 1-1-209, 1-1-210, 1-1-211, 1-1-212, 1-1-213, 1-1-214, 1-1-215, 1-1-216, 1-1-225, 1-1-226, 1-1-227, 1-1-228, 1-1-231, 1-1-233, 1-1-234, 1-1-235, 1-1-237, 1-1-238, 1-1-239, 1-1-240, 1-1-241, 1-1-242, I-1 243, 1-1-244, 1-1-245, 1-1-246, 1-1-247, 1-1-248, 1-1-249, 1-1-250, 1-1-251, 1-1-252, 1-1-253, 1-1-255, 30 1-1-257, 1-1-258, 1-1-259, 1-1-260, 1-1-261, 1-1-262, 1-1-263, 1-1-264, 1-1-266, 1-1-267, 1-1-268, I-1 269, 1-1-270, 1-1-271, 1-1-272, 1-1-273, 1-1-274, 1-1-275, 1-1-276, [-1-277, 1-1-279, 1-1-282, 1-1-283, 1-1-284, 1-1-285, 1-1-286, 1-1-287, 1-1-289, 1-2-8, 1-2-12, 1-2-17, 1-2-19, 1-1-290, 1-1-291, 1-1-292, 1- WO 2007/144100 - 104- PCT/EP2007/005016 1-293, 1-1-294, 1-1-295, 1-1-296, 1-1-297, 1-1-298, 1-1-299, 1-1-300, 1-1-301, 1-1-302, 1-1-303, 1-1 304,1-1-305,1-1-307,1-1-308, 1-1-309, 1-1-310, 1-1-311, 1-1-312, 1-1-313, 1-1-314, 1-1-315, 1-1-318, 1-1-324, 1-1-326, 1-1-327, 1-1-328, 1-1-329, 1-1-330, 1-1-331, 1-1-332, 1-1-333, 1-1-334, 1-1-335, I-I 336, 1-1-337, 1-1-338, 1-1-339,1-1-341, 1-1-343, 1-1-344, 1-1-346, 1-1-347, 1-1-348, 1-1-349, 1-1-350, 5 1-1-351, 1-1-352, 1-1-353, 1-1-354,1-1-355,1-2-2, 1-2-3 WO 2007/144100 - 105- PCT/EP2007/005016 Example 17 Myzus test (spray treatment) Solvents: 78.0 parts by weight acetone 1.5 parts by weight dimethylformamide 5 Emulsifier: 0.5 part by weight alkylaryl polyglycol ether An appropriate preparation of active compound is prepared by mixing I part by weight of active compound with the stated amounts of solvent and emulsifier and diluting the concentrate with emulsifier-containing water to the desired concentration. Leaf discs of Chinese cabbage (Brassica pekinensis) infested by all stages of the green peach aphid 10 (Myzuspersicae) are sprayed with a preparation of active compound at the desired concentration. After the desired time the effect in % is determined. 100% means that all of the aphids have been killed; 0% means that no aphids have been killed. In this test an effect of 280% is shown, for example, by the following compounds of the preparation examples at an application rate of 100 g/ha: 15 Ex. No. 1-1-64, 1-1-68,1-1-74,1-1-75, 1-1-76, 1-1-77, 1-1-78, I-1-80, 1-1-81, 1-1-83, 1-1-84, 1-1-92, I-1 97,1-1-99, 1-1-100, 1-1-101, 1-1-113,1-1-116,1-1-117, 1-1-118, 1-1-20, 1-1-121, 1-1-126, 1-1-127, I 1-128, 1-1-130, 1-1-131, 1-1-134, 1-1-135, 1-1-36, 1-1-137, 1-1-138, 1-1-139, 1-1-142, 1-1-144, 1-1-145, 1-1-146, 1-1-150, 1-1-152, 1-1-163, 1-1-174, 1-1-176, 1-1-177, 1-1-178, 1-1-179, 1-1-180, 1-1-184, 1-1 185, 1-1-186, 1-1-198, 1-1-203, 1-1-207, 1-1-209, 1-1-211, 1-1-212, 1-1-216, 1-1-272, 1-2-10, 1-1-308, 1 20 1-326, 1-1-327,1-1-329, 1-1-330, 1-1-331, 1-1-332, 1-1-333, 1-1-336,1-1-338, 1-1-339,1-1-354 WO 2007/144100 - 106- PCT/EP2007/005016 Example 18 Aphis gossypii test Solvent: 7 parts by weight dimethylformamide Emulsifier: 2 parts by weight alkylaryl polyglycol ether 5 An appropriate preparation of active compound is prepared by mixing 1 part by weight of active compound with the stated amounts of solvent and emulsifier and diluting the concentrate with emulsifier-containing water to the desired concentration. If it is necessary to add ammonium salts, penetrants, or ammonium salts and penetrants, they are added by pipette at a concentration of 1000 ppm after dilution, the addition taking place in each case to the completed solution of the 10 products. Cotton leaves (Gossypium hirsutum) heavily infested by the cotton aphid (Aphis gossypii) are sprayed with the preparation of active compound at the desired concentration. After the desired time the kill in % is determined. 100% means that all of the aphids have been killed; 0% means that no aphids have been killed. 15 In this test an effect of > 80 % is shown, for example, by the following compounds of the preparation examples at an application rate of 100 ppm: Ex. No. 1-1-68, 1-1-75, 1-1-76, 1-1-88, 1-1-98, I-1-99, 1-1-104, 1-1-108, 1-1-113, 1-1-131, 1-1-139, I-1 143,1-1-176,1-1-251

Claims (13)

1. Compounds of the formula (1) R3 2 RN ,R (R), 0 N R A -6/ N'N Q in which 5 R 1 represents hydrogen, amino or hydroxyl or represents C-C 6 -alkyl, C-C-alkenyl, C 2 -C 6 -alkynyl or C 3 -C 6 -cycloalkyl each of which is unsubstituted or substituted one or more times by identical or different substituents selectable independently of one another from halogen, cyano, nitro, hydroxyl, C-C 4 -alkoxy, CI-C 4 -alkylthio, C,-Ce alkylsulphinyl, C,-C 4 -alkylsulphonyl, (C-Cr-alkoxy)carbonyl, C-C 4 -alkylamino, 10 di(C-C 4 -alkyl)amino, C 3 -C 6 -cycloalkylamino or (C-C 4 -alkyl)C 3 -C 6 -cycloalkyl amino, R2 represents hydrogen, C-C 6 -alkyl, C 2 -C 6 -alkenyl, C-C-alkynyl, C 3 -C 6 -cycloalkyl, C,-C 4 -alkoxy, C-C 4 -alkylamino, di(C,-C 4 -alkyl)amino, C 3 -C 6 -cycloalkylamino, C 2 -C 6 -alkoxycarbonyl or C 2 -C 6 -alkylcarbonyl, 15 R 3 represents hydrogen or represents C,-C 6 -alkyl, C-C 6 -alkoxy, C 2 -C 6 -alkenyl, C 2 -C 6 alkynyl each of which is optionally substituted one or more times by identical or different substituents selectable independently of one another from halogen, cyano, nitro, bydroxyl, amino, C-C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkylamino, C C 4 -alkoxy, C-C 4 -haloalkoxy, C,-C 4 -alkylthio, C-C 4 -alkylsulphinyl, CeCe 20 alkylsulphonyl, C,-C 4 -alkylsulphimino, C-C 4 -alkylsulphimino-C -C 4 -alkyl, C,-Ce alkylsulphimino-C 2 -C 5 -alkylcarbonyl, C-C 4 -alkylsulphoximino, C-C 4 -alkyl sulphoximino-C-C 4 -alkyl, C-C 4 -alkylsulphoximino-C 2 -C-alkylcarbonyl, C 2 -Cr alkoxycarbonyl, C 2 -C 6 -alkylcarbonyl, C 3 -C 6 -trialkylsilyl, or a 5- or 6-membered heteroaromatic ring, 25 R2 and R 3 can be joined to one another via two to six carbon atoms and form a ring which where appropriate additionally contains a further nitrogen, sulphur or oxygen atom WO 2007/144100 -108- PCT/EP2007/005016 and where appropriate may be substituted one to four times by C 1 -C 2 -alkyl, halogen, cyano, amino or C -C 2 -alkoxy, or R 2 and R3 further together represent =S(C-C 4 -alkyl) 2 or =S(0)(C-C 4 -alkyl) 2 , R 4 represents hydrogen, halogen, cyano, nitro, C,-C 4 -alkyl, C-C 4 -haloalkyl, C 2 -C 6 5 alkenyl, C 2 -C 6 -haloalkenyl, C 2 -C 6 -alkynyl, C-C 4 -alkoxy, C-C 4 -haloalkoxy, SF 5 , C 1 -C 4 -alkylthio, C,.C 4 -alkylsulphinyl, C-C 4 -alkylsulphonyl, C-C 4 -haloalkylthio, C,-C 4 -haloalkylsulphinyl, C,-C 4 -haloalkylsulphonyl, C,-C 4 -alkylamino, di(C-C 4 alkyl)amino, C 3 -C 6 -cycloalkylamino, (C -C 4 -alkoxy)imino, (C-C 4 -alkyl)(C-Ce alkoxy)imino, (CI-C 4 -haloalkyl)(C-C 4 -alkoxy)imino or C 3 -C 6 -trialkylsilyl, or 10 two Rs, via adjacent carbon atoms, form a ring which represents -(CH 2 ) 3 -, -(CH 2 )r, -(CH 2 ) 5 -, -(CH=CH-) 2 -, -OCH 2 0-, -O(CH 2 ) 2 0-, -OCF 2 0-, -(CF 2 ) 2 0-, -O(CF 2 ) 2 0-, -(CH=CH CH=N)- or -(CH=CH-N=CH)-, or two Ws, via adjacent carbon atoms, form the following fused rings, which where appropriate are substituted one or more times by identical or different substituents selectable 15 independently of one another from hydrogen, C-C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 haloalkyl, C 3 -C 6 -halocycloalkyl, halogen, C,-C 6 -alkoxy, C-C 4 -alkylthio(C-C 6 alkyl), C-C 4 -alkylsulphinyl(C-C 6 -alkyl), C-C 4 -alkylsulphonyl(C-C 6 -alkyl), C-C 4 alkylamino, di(C-C 4 -alkyl)amino or C 3 -C 6 -cycloalkylamino, N N N N H H N NNN N NN,,, N N N N NN H SNO' H N N N N HNN NW N NH H H 20 n represents 0 to 3, R 5 represents C-C 6 -alkyl, C 3 -C 6 -cycloalkyl, C-C 6 -haloalkyl, C 1 -C 6 -halocycloalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -haloalkenyl, C-C 6 -alkynyl, C-C 6 -haloalkynyl, C-C 4 -alkoxy, WO 2007/144100 - 109- PCT/EP2007/005016 Cl-C 4 -haloalkoxy, C-C 4 -alkylthio, C 1 -C 4 -alkylsulphinyl, C-C 4 -alkylsulphonyl, C,-C 4 -haloalkylthin, C-C 4 -haloalkylsulphinyl, C-C 4 -haloalkylsulphonyl, halogen, cyano, nitro or C 3 -C 6 -trialkylsilyl, R6 represents hydrogen, C-C 6 -alkyl, C 2 -C 6 -alkenyl, C-C 6 -alkynyl, 0 3 -C 6 -cycloalkyl, 5 C 3 -C 6 -cycloalkoxy, C,-C 6 -haloalkyl, C 2 -C 6 -haloalkenyl or (R % R 7 represents independently at each occurrence hydrogen, C-C 6 -alkyl, C 3 -C 6 -cyclo alkyl, C-C 6 -haloalkyl, halogen, cyano, nitro, C,-C 4 -alkoxy, C-C 4 -haloalkoxy, C,-C 4 -alkylthio or C-C 4 -haloalkylthio, 10 m represents 0 to 4, X represents N, CH, CF, CCI, CBr or CI, A represents -CH 2 -, -CH 2 0-, -CH20CH 2 -, -CH2S-, -CH 2 SCH 2 -, -CH 2 N(C C 6 -alkyl)-, -CH 2 N(C-C 6 -alkyl)CH 2 -, -CH[C0 2 (CI-C 6 -alkyl)]-, -CH(CN)-, -CH(C-C- 6 -alkyl)-, -C(di-Cl-C 6 -alkyl)-, -CH 2 CH 2 - or -C=NO(C,-C 6 -alkyl)-, 15 Q represents a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10 membered fused heterobicyclic ring system, the ring system being unsubstituted or substituted one or more times by identical or different substituents selectable independently of one another from hydrogen, C,-Cralkyl, C 2 -C 6 -alkenyl, C-C 6 alkynyl, C 3 -C 6 -cycloalkyl, C-C 6 -haloalkyl, C 2 -C 6 -haloalkenyl, C 2 -C 6 -haloalkynyl, 20 C 3 -C 6 -halocycloalkyl, halogen, CN, CO 2 H, CO 2 NH2, NO2, OH, C-C-alkoxy, C C 4 -haloalkoxy, C-C 4 -alkylthio, Cl-C 4 -alkylsulphinyl, C-C 4 -alkylsulphonyl, C-C 4 haloalkylthio, C 1 -C 4 -haloalkylsulphinyl, C -C 4 -haloalkylsulphonyl, C-C 4 alkylamino, di(C-C 4 -alkyl)amino, C 3 -C 6 -cycloalkylamino, (CI-C 6 -alkyl)carbonyl, (C-C-alkoxy)carbonyl, (C-C 6 -alkyl)aminocarbonyl, di(C-C 4 -alkyl)amino 25 carbonyl, tri-alkyl)silyl and (C-C 4 -alkyl)(C-C 4 -alkoxy)imino, or Q further represents a 5- or 6-membered heteroaromatic or heterocyclic ring or an aromatic 8-, 9- or 10-membercd fused heterobicyclic ring system, the ring or the ring system being unsubstituted or substituted one or more times by identical or different substituents selectable independently of one another from hydrogen, C-C 6 -alkyl, C 2 30 C 6 -alkenyl, C-C 6 -alkynyl, C 3 -C 6 -cycloalkyl, C,-C 6 -haloalkyl, C 2 -C 6 -halaalkenyl, WO 2007/144100 - 110- PCT/EP2007/005016 C 2 -C 6 -haloalkynyl, C 3 -C 6 -halocycloalkyl, halogen, CN, CO 2 H, CO 2 NH 2 , NO 2 , OH, CI-C 4 -alkoxy, C-C 4 -haloalkoxy, C -C 4 alkylthio, Ct-C 4 -alkylsulphinyl, C -C 4 -alkylsulphonyl, C-C 4 -haloalkylthio, C-C 4 -haloalkylsulphinyl, C-C 4 -halo alkylsulphonyl, C-C 4 -alkylamino, di(C-C 4 -alkyl)amino, C-C 6 -cycloalkylamino, 5 (C-C 6 -alkyl)carbonyl, (C-C 6 -alkoxy)carbonyl, (C-C 6 -alkyl)aminocarbonyl, di(C C 4 -alkyl)aminocarbonyl, tri-alkyl)silyl and (C-C 4 -alkyl)(C C 4 -alkoxy)imino, or the substituents being selectable independently of one another from phenyl or a 5 or 6-membered heteroaromatic ring, it being possible for phenyl or the ring to be unsubstituted or substituted one or more times by identical or different CI-C 6 -alkyl, 10 C 2 -C 6 -alkenyl, C-C 6 -alkynyl, C 3 -C 6 -cycloalkyl, C-C 6 -haloalkyl, C 2 -C 6 -haloalkenyl, C 2 -C-haloalkynyl, C 3 -C 6 -halocycloalkyl, halogen, CN, NO 2 , OH, C 1 -C 4 -alkoxy, C C 4 -haloalkoxy substituents, and also their N-oxides and salts.

2. Compounds of the formula () according to Claim 1, in which 15 R' represents hydrogen, amino or hydroxyl or represents C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C,-C 6 -alkynyl or C 3 -C 6 -cycloalkyl each of which is unsubstituted or substituted one or more times by identical or different substituents selectable independently of one another from halogen, cyano, nitro, hydroxyl, C-C 4 -alkoxy, CI-C 4 -alkylthio, C-C 4 alkylsulphinyl, Ci-C 4 -alkylsulphonyl, (C 1 -C 4 -alkoxy)carbonyl, C-C 4 -alkylamino, 20 di(CI-C 4 -alkyl)amino, C 3 -C 6 -cycloalkylamino or (C-C 4 -alkyl)C 3 -C 6 -cycloalkyl amino, R2 represents hydrogen, C-C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 3 -C 6 -cycloalkyl, C,-C 4 -alkoxy, C-C 4 -alkylamino, di(C-C 4 -alkyl)amino, C 3 -C 6 -cycloalkylamino, C 2 -C 6 -alkoxycarbonyl or C 2 -C 6 -alkylcarbonyl, 25 R 3 represents hydrogen or represents CI-C 6 -alkyl, C-C 6 -alkoxy, C 2 -C 6 -alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 -cycloalkyl, each of which is optionally substituted one or more times by identical or different substituents selectable independently of one another from halogen, cyano, nitro, hydroxyl, C,-C 6 -alkyl, C 3 -C 6 -cycloalkyl, C,-C 4 -alkoxy, CrC4 haloalkoxy, C -C 4 -alkylthio, C,-C 4 -alkylsulphinyl, C-C 4 -alkylsulphonyl, Cr-C4e 30 alkylsulphimino, C,-C 4 -alkylsulphimino-C,-C 4 -alkyl, CI-C 4 -alkylsulphimino-C 2 -C alkylcarbonyl, C 1 -C 4 -alkylsulphoximino, C-C 4 -alkylsulphoximino- 1 -C 4 -alkyl, C, C 4 -alkylsulphoximino-C 2 -C 5 -alkylcarbonyl, C 2 -C 6 -alkoxycarbonyl, C2rC6r alkylcarbonyl or C 3 -C 6 -trialkylsilyl, WO 2007/144100 - 111 - PCT/EP2007/005016 R 4 represents hydrogen, halogen, cyano, nitro, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 -haloalkenyl, C 2 -C 6 -alkynyl, C-C 4 -alkoxy, C-C 4 -haloalkoxy, SF 5 , C C 4 -alkylthio, C 1 .C 4 -alkylsulphinyl, C-C 4 -alkylsulphonyl, C 1 -C 4 -haloalkylthio, C 1 -C 4 -haloalkylsulphinyl, C 1 -C 4 -haloalkylsulphonyl, C,-C 4 -alkylamino, di(C-C 4 5 alkyl)amino, CrC 6 -cycloalkylamino, (C-C 4 -alkoxy)inino, (C-C 4 -alkyl)(C 1 -C 4 alkoxy)imino, (C C 4 -haloalkyl)(C-C 4 -alkoxy)imino or C 3 -C 6 -trialkylsilyl, or two Rs, via adjacent carbon atoms, form a ring which represents -(CH 2 ) 3 -, -(CH 2 ) 4 -, -(CH 2 )-, -(CH=CH-) 2 -, -OCH 2 0-, -O(CH 2 )20-, -OCF20-, -(CF 2 ) 2 0-, -O(CF 2 )20-, -(CH=CH CH=N)- or -(CH=CH-N=CH)-, 10 n represents 0 to 3, R' represents C,-C 6 -alkyl, C 3 -C 6 -cycloalkyl, C,-C 6 -haloalkyl, C 1 -C 6 -halocycloalkyl, C 2 -Cralkenyl, C 2 -C 6 -haloalkenyl, 0 2 -C 6 -alkynyl, C 2 -C 6 -haloalkynyl, C-C 4 -alkoxy, C,-C 4 -haloalkoxy, C-C 4 -alkylthio, C-C 4 -alkylsulphinyl, Cl-C 4 -alkylsulphonyl, Cl-C 4 -haloalkylthio, C-C 4 -haloalkylsulphinyl, C,-C 4 -haloalkylsulphonyl, halogen, 15 cyano, nitro or C 3 -C 6 -trialkylsilyl, R 6 represents hydrogen, C,-C 6 -alkyl, C-C 6 -alkenyl, C 2 -C 6 -alkynyl, C-C 6 -cycloalkyl, C,-C 6 -haloalkyl, C 2 -C 6 -haloalkenyl or R7 represents independently at each occurrence hydrogen, C-C 6 -alkyl, C 3 -C 6 -cyclo 20 alkyl, Cl-C 6 -haloalkyl, halogen, cyano, nitro, C-C 4 -alkoxy, C,-C 4 -haloalkoxy, C,-C 4 -alkylthio or Ci-C 4 -haloalkylthio, m represents 0 to 4, X represents N, CH, CF, CCI, CBr or CI, A represents -CH2, CH(CH) 3 C(CH 3 )2, or CH2CH 2 , 25 Q represents a 5- or 6-membered heteroatomatic ring or an aromatic 8-, 9- or 10 membered fused heterobicyclic ring system, the ring or the ring system being unsubstituted or substituted one or more times by identical or different substituents selectable independently of one another from hydrogen, C,-C 6 -alkyl, C,-C 6 -alkenyl, C 2 -C 6 -alkynyl, C 3 -C 6 -cycloalkyl, C-C 6 -haloalkyl, C 2 -C 6 haloalkenyl, C 2 -C 6 - WO 2007/144100 -112- PCTIEP2007/005016 haloalkynyl, C 3 -C 6 -halocycloalkyl, halogen, CN, CO 2 H, CO2NH 2 , NO 2 , OH, C-C 4 alkoxy, C,-C 4 -haloalkoxy, C-C 4 -alkylthio, C-C 4 -alkylsulphinyl, C,-C 4 -alkylsulphonyl, C,-C 4 -haloalkylthio, Cl-C 4 -haloalkylsulphinyl, C-C 4 -halo alkylsulphonyl, C,-C 4 -alkylamino, di(C,-C 4 -alkyl)amino, C 3 -C 6 -cycloalkylamino, 5 (C,-C 6 -alkyl)carbonyl, (C-C 6 -alkoxy)carbonyl, (C-C 6 -alkyl)aminocarbonyl, di(C C 4 -alkyl)aminocarbonyl, tri-alkyl)silyl and (C,-C 4 -alkyl)(C,-C 4 -alkoxy)imino, and also their N-oxides and salts.

3. Compounds of the formula (1-1) R 2 RN 'R' R4 NA N N'N O 10 in which R' represents hydrogen, R 2 represents hydrogen, R 3 represents C,-C 4 -alkyl (methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec butyl or tert-butyl) or cyano-C,-C 3 -alkyl (cyanomethyl, I -cyanoethyl, 2-cyanoethyl, 15 1 -cyano-n-propyl, 2-cyano-n-propyl, 3-cyano-n-propyl, I -cyanoisopropyl, 2-cyano isopropyl), R 4 represents hydrogen, methyl, trifluoromethyl, cyano, fluorine, chlorine, bromine, iodine or trifluoromethoxy, R 5 represents methyl, fluorine, chlorine, bromine or iodine, 20 R 7 represents fluorine, chlorine or bromine, X represents N, CCI or CH, A represents CH 2 or CH(CH 3 ), WO 2007/144100 - 113- PCTIEP2007/005016 Q represents an optionally mono- or polysubstituted aromatic heterocyclic ring of series Q-37, Q-38, Q-39, Q-40, Q-58 and Q-59, and also represents a 5-membered heterocyclic ring Q-60, the substituents being selectable independently of one another from C-C 3 -alkyl, C-C 3 -haloalkyl, C,-C 2 -alkoxy, halogen, cyano, hydroxyl, 5 nitro or Ci-C 2 -haloalkoxy, or the substituents being selectable independently of one another from phenyl or a 5 or 6-membered heteroaromatic ring, it being possible for phenyl or the ring to be unsubstituted or substituted one or more times by identical or different C-C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C-C 6 -cycloalkyl, C-C 6 -haloalkyl, C 2 -C 6 -haloalkenyl, 10 C 2 -C 6 -haloalkynyl, C 3 -Crhalocycloalkyl, halogen, CN, NO 2 , C 1 -C 4 -alkoxy or C-C 4 haloalkoxy substituents, and also their N oxides and salts.

4. Pyrazolecarboxylic acid derivatives of the formula (IV), 0 HO A / N'N O R (IV) 15 in which A, Q and R 6 have the definition stated in Claims I to 2.

5. Pyrazolecarboxylic esters of the formula (VI), VR O O A Q N--N R 6 in which A, Q and R 6 have the definition stated in Claims 1 to 2, and R represents C-C 6 alkyl. 20

6. Alcohols of the formula (X), WO 2007/144100 - 114- PCT/EP2007/005016 R 0 O O O A,0 N-N RW in which A and R 6 have the definition stated in Claims I and 2, and R represents C 1 -C 6 alkyl.

7. Use of compounds of the formula (I) according to Claims I to 2 to control animal pests.

8. Method of controlling animal pests, characterized in that compounds of the formula (I) 5 according to Claims 1 to 2 are caused to act on animal pests and/or phytopathogenic fungi and/or their habitat and/or seed.

9. Process for producing agrochemical compositions, characterized in that compounds of the formula (I) according to Claims I to 2 are mixed with extenders and/or surface-active substances.

10 10. Use of compounds of the formula (I) according to Claims I to 2 to treat seed,

11. Use of compounds of the formula (I) according to Claims I to 2 to treat transgenic plants.

12. Use of compounds of the formula (1) according to Claims I to 2 to treat seed of transgenic plants.

13. Seed treated with a compound of the formula (I) according to Claims 1 to 2.